Medications for human use with 2-4 active ingredients.

Médicaments à usage humain avec 2-4 ingrédients actifs.

Updated | Mise à jour : 2021-07-04
∙ Product name | Nom du produit;
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Number of active ingredients | Nombre d’ingrédients actfs;
∙ Original market date | Date de commercialisation originale;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN
Monograph | Monographie
KIVEXA
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2005-08-17;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02269341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75473
APO-ABACAVIR-LAMIVUDINE
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2016-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02399539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88441
TEVA-ABACAVIR/LAMIVUDINE
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2016-03-14;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02416662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90124
MYLAN-ABACAVIR/LAMIVUDINE
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2016-03-29;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02450682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93683
AURO-ABACAVIR/LAMIVUDINE
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2016-08-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02454513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94109
PMS-ABACAVIR-LAMIVUDINE
abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2016-10-31;
Oral;
Tablet;
08:18.20 – INTERFERONS;
Prescription;
PHARMASCIENCE INC
DIN: 02458381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94550
NEOCITRAN ULTRA STRENGTH TOTAL FLU
acetaminophen 1000 mg / sachet , dextromethorphan hydrobromide 30 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet;
Number of active ingredients: 3.00;
2014-10-06;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02404966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88979
NEOCITRAN ULTRA STRENGTH TOTAL FLU NIGHT
acetaminophen 1000 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , chlorpheniramine maleate 4 mg / sachet , dextromethorphan hydrobromide 30 mg / sachet;
Number of active ingredients: 4.00;
1998-08-28;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02217147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37105
CHILDREN’S TYLENOL COLD
acetaminophen 160 mg / 5 ml , chlorpheniramine maleate 1 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 3.00;
1997-08-11;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02039982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26863
BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER NIGHTIME
acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
Number of active ingredients: 3.00;
2008-09-01;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02305666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79122
CHILDREN’S TYLENOL COMPLETE COLD, COUGH & FEVER NIGHTTIME
acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml , dextromethorphan hydrobromide 5 mg / 5 ml;
Number of active ingredients: 3.00;
2014-06-15;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02416050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90063
CHILDREN’S TYLENOL COLD & STUFFY NOSE
acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 2.00;
1997-10-08;
Oral;
Suspension;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02229538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47448
COLD AND SINUS COMPLETE LIQUID GELS
acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2016-06-01;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02349523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83481
TEVA-LENOLTEC NO. 2
acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 15 mg;
Number of active ingredients: 3.00;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00653241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6764
TEVA-LENOLTEC NO. 1
acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 8 mg;
Number of active ingredients: 3.00;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00653233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6763
ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS
acetaminophen 300 mg , caffeine 15 mg , codeine phosphate 8 mg;
Number of active ingredients: 3.00;
1996-10-11;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
DIN: 02154234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33917
TEVA-EMTEC-30
acetaminophen 300 mg , codeine phosphate 30 mg;
Number of active ingredients: 2.00;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00608882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5780
TRIATEC-30
acetaminophen 300 mg , codeine phosphate 30 mg;
Number of active ingredients: 2.00;
1989-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
DIN: 00789828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9626
TEVA-LENOLTEC NO. 4
acetaminophen 300 mg , codeine phosphate 60 mg;
Number of active ingredients: 2.00;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00621463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6824
ACETAMINOPHEN WITH CODEINE – CAPLET
acetaminophen 300 mg , codeine phosphate 8 mg , caffeine 15 mg;
Number of active ingredients: 3.00;
1997-10-28;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02143933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31568
MERSYNDOL WITH CODEINE
acetaminophen 325 mg , codeine phosphate 8 mg , doxylamine succinate 5 mg;
Number of active ingredients: 3.00;
1982-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
SANOFI-AVENTIS CANADA INC
DIN: 02047667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15805
VICKS DAYQUIL COMPLETE COLD & FLU CAPLETS
acetaminophen 325 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 4.00;
2014-08-15;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02409526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89421
VICKS DAYQUIL COLD & FLU MULTI-SYMPTOM RELIEF LIQUICAPS
acetaminophen 325 mg , dextromethorphan hydrobromide 10 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 3.00;
2006-06-26;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02272784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75828
MUCINEX MULTI-ACTION COLD & SINUS CAPLETS
acetaminophen 325 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 3.00;
2020-08-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02433451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91782
MUCINEX MULTI-ACTION COLD, FLU & SORE THROAT CAPLETS
acetaminophen 325 mg , guaifenesin 200 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg;
Number of active ingredients: 4.00;
2020-08-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02433435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91781
COMBOGESIC
acetaminophen 325 mg , ibuprofen 97.5 mg;
Number of active ingredients: 2.00;
2020-12-14;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BIOSYENT PHARMA INC
DIN: 02488280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97838
ROBAXACET
acetaminophen 325 mg , methocarbamol 400 mg;
Number of active ingredients: 2.00;
1993-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02026805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14509
DILOTAB II
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 2.00;
2006-04-17;
Oral;
Tablet;
12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
ZEE MEDICAL
DIN: 02266148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75158
DAYQUIL SINUS LIQUICAPS
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 2.00;
2006-06-11;
Oral;
Capsule;
12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
PROCTER & GAMBLE INC
DIN: 02273829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75930
COLTALIN COLD & ALLERGY TABLETS
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2002-01-09;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FORTUNE PHARMACAL CO. LTD.
DIN: 02244263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68230
VICKS NYQUIL COMPLETE COLD & FLU LIQUICAPS
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg;
Number of active ingredients: 4.00;
2019-07-08;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02483351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97379
DAYQUIL COMPLETE + VICKS VAPOCOOL
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg;
Number of active ingredients: 4.00;
2020-07-20;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02481936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97240
VICKS DAYQUIL COMPLETE COLD & FLU LIQUICAPS
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 200 mg;
Number of active ingredients: 4.00;
2019-07-08;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02483378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97380
HISTENOL II
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 200 mg;
Number of active ingredients: 4.00;
2007-03-06;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
ZEE MEDICAL
DIN: 02276119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76178
NYQUIL SINUS LIQUICAPS
acetaminophen 325 mg , phenylephrine hydrochloride 5 mg , doxylamine succinate 6.25 mg;
Number of active ingredients: 3.00;
2006-06-11;
Oral;
Capsule;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02273810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75929
MEDICAMENT POUR LES SINUS, REGULIER
acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2000-04-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
LABORATOIRE RIVA INC.
DIN: 02240562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64134
APO-TRAMADOL/ACET
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2009-11-09;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
APOTEX INC
DIN: 02336790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82241
TEVA-TRAMADOL/ACETAMINOPHEN
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2012-09-04;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02347180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83257
TARO-TRAMADOL/ACET
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2012-10-01;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02388197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87374
JAMP-ACET-TRAMADOL
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2012-09-05;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02388308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87385
MAR-TRAMADOL/ACET
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2012-09-04;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02388324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87386
MINT-TRAMADOL/ACET
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2012-09-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02389800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87528
AURO-TRAMADOL/ACETAMINOPHEN
acetaminophen 325 mg , tramadol hydrochloride 37.5 mg;
Number of active ingredients: 2.00;
2015-04-08;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
AURO PHARMA INC
DIN: 02439050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92342
HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU REGULAR STRENGTH
acetaminophen 325 mg / sachet , pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , ascorbic acid 50 mg / sachet;
Number of active ingredients: 4.00;
1999-01-06;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02047349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=32780
BUCKLEY’S COMPLETE PLUS EXTRA STRENGTH MUCUS RELIEF
acetaminophen 325 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 20 mg / 5 ml;
Number of active ingredients: 3.00;
2012-10-04;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02357232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84236
BUCKLEY’S COMPLETE
acetaminophen 325 mg / 5 ml , menthol 20 mg / 5 ml;
Number of active ingredients: 2.00;
2006-08-09;
Oral;
Liquid;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02279703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76530
MENSTRUAL MIDOL COMPLETE
acetaminophen 500 mg , caffeine 60 mg , pyrilamine maleate 15 mg;
Number of active ingredients: 3.00;
2006-06-22;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
BAYER INC
DIN: 02275201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76086
MENSTRUAL COMPLETE
acetaminophen 500 mg , caffeine 60 mg , pyrilamine maleate 15 mg;
Number of active ingredients: 3.00;
2013-07-09;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.08 – ETHYLENEDIAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
DIN: 02397420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88238
TYLENOL ULTRA RELIEF
acetaminophen 500 mg , caffeine 65 mg;
Number of active ingredients: 2.00;
2005-01-05;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02254468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73935
ULTRA HEADACHE RELIEF
acetaminophen 500 mg , caffeine 65 mg;
Number of active ingredients: 2.00;
2005-06-17;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02264870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75038
ACETAMINOPHEN 500MG AND CAFFEINE 65MG
acetaminophen 500 mg , caffeine 65 mg;
Number of active ingredients: 2.00;
2007-06-21;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02269988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75534
COLDASIDE COLD & FLU EXTRA STRENGTH
acetaminophen 500 mg , chlorpheniramine maleate 2 mg , dextromethorphan hydrobromide 15 mg;
Number of active ingredients: 3.00;
2009-01-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
DIN: 02305216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79071
EXTRA STRENGTH ALLERGY SINUS MEDICATION
acetaminophen 500 mg , chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 3.00;
1996-10-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02159546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34150
EXTRA STRENGTH TYLENOL COLD NIGHTTIME
acetaminophen 500 mg , dextromethorphan hydrobromide 10 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 4.00;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02276259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76192
BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH
acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
1997-08-06;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02218186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37150
EXTRA STRENGTH TYLENOL NIGHTTIME
acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 2.00;
2012-10-02;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02385619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87122
EXTRA STRENGTH TYLENOL BACK PAIN
acetaminophen 500 mg , methocarbamol 400 mg;
Number of active ingredients: 2.00;
2009-07-10;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02290510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77584
PAINAID PMF PREMENSTRUAL FORMULA
acetaminophen 500 mg , pamabrom 25 mg;
Number of active ingredients: 2.00;
2004-12-20;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
ZEE MEDICAL
DIN: 02246308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70470
PMS MIDOL COMPLETE
acetaminophen 500 mg , pamabrom 25 mg , pyrilamine maleate 15 mg;
Number of active ingredients: 3.00;
2006-07-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
BAYER INC
DIN: 02275228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76087
BENYLIN EXTRA STRENGTH COLD & SINUS DAY
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 2.00;
2006-08-16;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02273462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75895
EXTRA STRENGTH TYLENOL SINUS DAYTIME
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg;
Number of active ingredients: 2.00;
2006-07-24;
Oral;
Tablet;
12:12.00 – SYMPATHOMIMETIC (ADRENERGIC) AGENTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02276003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76168
EXTRA STRENGTH TYLENOL SINUS NIGHTTIME
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2006-07-24;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02276038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76170
BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2008-09-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02306409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79195
EXTRA STRENGTH TYLENOL FLU NIGHTTIME
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , chlorpheniramine maleate 2 mg , dextromethorphan hydrobromide 10 mg;
Number of active ingredients: 4.00;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02276046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76171
EXTRA STRENGTH TYLENOL FLU DAYTIME
acetaminophen 500 mg , phenylephrine hydrochloride 5 mg , dextromethorphan hydrobromide 10 mg;
Number of active ingredients: 3.00;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02275996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76167
EXTRA STRENGTH SINUTAB SINUS DAYTIME
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 01938371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13120
MEDICAMENT POUR LES SINUS, EXTRA-FORT
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2000-04-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
LABORATOIRE RIVA INC.
DIN: 02240563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64135
EXTRA STRENGTH TYLENOL COLD & SINUS DAYTIME
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2010-08-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02348071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83343
SINUS MEDICATION DAYTIME RELIEF
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2012-01-13;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02368854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85382
COLD AND SINUS DAYTIME RELIEF
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2014-07-15;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02385252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87089
EXTRA STRENGTH SINUTAB SINUS & ALLERGY
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
1986-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 01986988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17113
EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2010-08-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02348098
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83344
BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 3.00;
2005-09-23;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02256576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74181
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU NIGHTTIME
acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 3.00;
2011-08-08;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02365766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85064
COUGH & COLD RELIEF
acetaminophen 500 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
Number of active ingredients: 3.00;
2020-01-14;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Otc;
JUNO OTC INC
DIN: 02487004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97715
NEOCITRAN TOTAL COLD NIGHT
acetaminophen 500 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
Number of active ingredients: 3.00;
2017-08-01;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02413280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89795
ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH
acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , chlorpheniramine maleate 2 mg / 15 ml;
Number of active ingredients: 4.00;
2008-08-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02291371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77675
BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION
acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml;
Number of active ingredients: 4.00;
2009-08-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02321432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80682
NIGHT TIME TOTAL EXTRA STRENGTH
acetaminophen 650 mg / sachet , chlorpheniramine maleate 4 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
Number of active ingredients: 4.00;
2010-12-08;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02344548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83004
EXTRA STRENGTH TOTAL SYMPTOM RELIEF SUGAR-FREE
acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
Number of active ingredients: 3.00;
2014-12-04;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02420937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90552
COLD AND FLU RELIEF
acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
Number of active ingredients: 3.00;
2015-10-02;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02432498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91694
COLD STIX SUPER STRENGTH
acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet , phenylephrine hydrochloride 10 mg / sachet;
Number of active ingredients: 3.00;
2013-10-10;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
LABORATOIRE RIVA INC.
DIN: 02377888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86368
NEOCITRAN EXTRA STRENGTH TOTAL COLD
acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
Number of active ingredients: 3.00;
2008-07-21;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02293994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77936
HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU EXTRA STRENGTH
acetaminophen 650 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , pheniramine maleate 20 mg / sachet , ascorbic acid 50 mg / sachet;
Number of active ingredients: 4.00;
2001-09-01;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02238890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62330
HOT LEMON RELIEF FOR SYMPTOMS OF COUGH, COLD AND FLU EXTRA STRENGTH
acetaminophen 650 mg / sachet , pseudoephedrine hydrochloride 60 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet , chlorpheniramine maleate 4 mg / sachet;
Number of active ingredients: 4.00;
2004-02-13;
Oral;
Powder For Solution;
48:08.00 – ANTITUSSIVES;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02246848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71050
VICKS NYQUIL COMPLETE COLD & FLU
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
Number of active ingredients: 4.00;
2014-08-15;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02409542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89423
VICKS DAYQUIL COMPLETE COLD & FLU LIQUID
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
Number of active ingredients: 4.00;
2014-08-15;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02409534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89422
DAYTIME COMPLETE
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
Number of active ingredients: 4.00;
2020-01-14;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02458470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94560
DAYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , guaifenesin 400 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
Number of active ingredients: 4.00;
2020-07-20;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02482428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97287
DAYQUIL COLD & FLU
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
Number of active ingredients: 3.00;
2009-08-23;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02300842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78620
VICKS NYQUIL COLD & FLU NIGHTTIME RELIEF
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 30 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
Number of active ingredients: 3.00;
2012-07-09;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02374277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85947
ROBITUSSIN TOTAL COUGH, COLD & FLU
acetaminophen 650 mg / 30 ml , dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 30 mg / 30 ml;
Number of active ingredients: 3.00;
2008-08-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02291363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77674
DAYTIME COLD/FLU MEDICINE
acetaminophen 650 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml;
Number of active ingredients: 3.00;
2007-08-20;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02290863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77628
NYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID
acetaminophen 650 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml , dextromethorphan hydrobromide 20 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
Number of active ingredients: 4.00;
2020-07-20;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02482401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97286
ANACIN
acetylsalicylic acid 325 mg , caffeine 32 mg;
Number of active ingredients: 2.00;
2011-01-05;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 28:20.32 – Respiratory and CNS Stimulants;
Otc;
PALADIN LABS INC.
DIN: 02332450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81810
TEVA-OXYCODAN
acetylsalicylic acid 325 mg , oxycodone hydrochloride 5 mg;
Number of active ingredients: 2.00;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00608157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5777
ALKA-SELTZER FLAVOURED
acetylsalicylic acid 325 mg , sodium bicarbonate 1700 mg , citric acid 1000 mg;
Number of active ingredients: 3.00;
2002-09-10;
Oral;
Tablet (Effervescent);
56:04.00 – ANTACIDS AND ADSORBENTS , 28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
DIN: 02245367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69406
ALKA-SELTZER
acetylsalicylic acid 325 mg / evt , citric acid 1000 mg / evt , sodium bicarbonate 1916 mg / evt;
Number of active ingredients: 3.00;
1995-12-31;
Oral;
Tablet (Effervescent);
28:08.04.24 – SALICYLATES;
Otc;
BAYER INC
DIN: 02152746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42652
FIORINAL-C 1/4
acetylsalicylic acid 330 mg , caffeine 40 mg , butalbital 50 mg , codeine phosphate 15 mg;
Number of active ingredients: 4.00;
1970-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:24.04 – BARBITURATES;
Narcotic (Cdsa I);
ARALEZ PHARMACEUTICALS CANADA INC
DIN: 00176192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=872
FIORINAL-C 1/2
acetylsalicylic acid 330 mg , caffeine 40 mg , codeine phosphate 30 mg , butalbital 50 mg;
Number of active ingredients: 4.00;
1970-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:24.04 – BARBITURATES;
Narcotic (Cdsa I);
ARALEZ PHARMACEUTICALS CANADA INC
DIN: 00176206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=873
METHOXISAL EXTRA STRENGTH
acetylsalicylic acid 500 mg , methocarbamol 400 mg;
Number of active ingredients: 2.00;
2002-11-15;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
TEVA CANADA LIMITED
DIN: 02242978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66818
DUAKLIR GENUAIR
aclidinium bromide 400 mcg / act , formoterol fumarate dihydrate 12 mcg / act;
Number of active ingredients: 2.00;
2015-07-09;
Inhalation;
Powder (Metered Dose);
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02439530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92396
XERESE
acyclovir 5 % / w/w , hydrocortisone 1 % / w/w;
Number of active ingredients: 2.00;
2013-07-26;
Topical;
Cream;
84:04.06 – ANTIVIRALS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02404044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88879
TACTUPUMP
adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2011-05-13;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
DIN: 02365871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85075
TARO-ADAPALENE/BENZOYL PEROXIDE
adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2019-10-01;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02456923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94404
SANDOZ ADAPALENE / BENZOYL PEROXIDE
adapalene 0.1 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2019-09-27;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02489007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97906
TACTUPUMP FORTE
adapalene 0.3 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2016-01-04;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
DIN: 02446235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93152
FOSAVANCE
alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 2800 unit;
Number of active ingredients: 2.00;
2006-03-13;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ORGANON CANADA INC.
DIN: 02276429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76210
FOSAVANCE
alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
Number of active ingredients: 2.00;
2008-09-17;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
ORGANON CANADA INC.
DIN: 02314940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80047
SANDOZ ALENDRONATE/CHOLECALCIFEROL
alendronic acid (alendronate sodium trihydrate) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
Number of active ingredients: 2.00;
2014-08-29;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02429160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91361
APO-ALENDRONATE/VITAMIN D3
alendronic acid (alendronate sodium) 70 mg , vitamin d3 (cholecalciferol) 2800 unit;
Number of active ingredients: 2.00;
2016-07-21;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
DIN: 02454467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94104
APO-ALENDRONATE/VITAMIN D3
alendronic acid (alendronate sodium) 70 mg , vitamin d3 (cholecalciferol) 5600 unit;
Number of active ingredients: 2.00;
2016-07-21;
Oral;
Tablet;
88:16.00 – VITAMIN D , 92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
APOTEX INC
DIN: 02454475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94105
KAZANO
alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2014-04-30;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02417235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90187
KAZANO
alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2014-04-30;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02417219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90185
KAZANO
alogliptin (alogliptin benzoate) 12.5 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2014-04-30;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02417227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90186
PIQRAY
alpelisib 50 mg , alpelisib 200 mg;
Number of active ingredients: 2.00;
2020-06-29;
Oral;
Kit , Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02497085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98694
ACTIVASE RT-PA
alteplase 100 mg / kit , water 100 ml / kit;
Number of active ingredients: 2.00;
1996-12-31;
Intravenous;
Liquid , Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02147440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20105
ACTIVASE RT-PA
alteplase 50 mg / kit , water 50 ml / kit;
Number of active ingredients: 2.00;
1998-04-12;
Intravenous;
Liquid , Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02225689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43443
DIOVOL PLUS SUSPENSION
aluminum hydroxide (dried aluminum hydroxide gel) 165 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , simethicone 25 mg / 5 ml;
Number of active ingredients: 3.00;
1963-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 00116815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=187
ALMAGEL PLUS SUS
aluminum hydroxide 200 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , dimethicone 25 mg / 5 ml;
Number of active ingredients: 3.00;
1997-04-09;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
LABORATOIRE ATLAS INC
DIN: 00815527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44552
DIOVOL PLUS TABLETS
aluminum hydroxide-magnesium carbonate-co dried gel 300 mg , magnesium hydroxide 100 mg , simethicone 25 mg;
Number of active ingredients: 3.00;
1963-12-31;
Oral;
Tablet;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 00116882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=188
NOVAMILOR
amiloride hydrochloride 5 mg , hydrochlorothiazide 50 mg;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 01937219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12430
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89592
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89593
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89594
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89595
CADUET
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 10 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75877
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 10 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84779
CADUET
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 20 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75878
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 20 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84780
CADUET
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 40 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75879
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 40 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84781
CADUET
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 80 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75880
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 10 mg , atorvastatin (atorvastatin calcium) 80 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84782
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89588
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89589
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89590
APO-AMLODIPINE-ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
Number of active ingredients: 2.00;
2013-11-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02411296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89591
CADUET
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 10 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75873
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 10 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84775
CADUET
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 20 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75874
CADUET
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 40 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75875
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 40 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84777
CADUET
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 80 mg;
Number of active ingredients: 2.00;
2005-12-23;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02273276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75876
GD-AMLODIPINE/ATORVASTATIN
amlodipine (amlodipine besylate) 5 mg , atorvastatin (atorvastatin calcium) 80 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84778
VIACORAM
amlodipine (amlodipine besylate) 5 mg , perindopril arginine 7 mg;
Number of active ingredients: 2.00;
2016-04-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
SERVIER CANADA INC
DIN: 02451549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93783
TWYNSTA
amlodipine (amlodipine besylate) 5 mg , telmisartan 80 mg;
Number of active ingredients: 2.00;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02371049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85624
CLAVULIN 200
amoxicillin (amoxicillin trihydrate) 200 mg / 5 ml , clavulanic acid (clavulanate potassium) 28.5 mg / 5 ml;
Number of active ingredients: 2.00;
1998-10-29;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02238831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62269
APO-AMOXI CLAV
amoxicillin (amoxicillin trihydrate) 250 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
2001-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
DIN: 02243350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67257
CLAVULIN 250 F ORAL SUS
amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml , clavulanic acid (clavulanate potassium) 62.5 mg / 5 ml;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 01916874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15209
CLAVULIN 500 F TAB
amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 01916858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15903
APO-AMOXI CLAV
amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
2001-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
DIN: 02243351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67258
SANDOZ AMOXI-CLAV TABLET
amoxicillin (amoxicillin trihydrate) 500 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
2019-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02482576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97300
CLAVULIN 875
amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
1998-10-29;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02238829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62267
APO-AMOXI CLAV
amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
2002-10-24;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
APOTEX INC
DIN: 02245623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69723
SANDOZ AMOXI-CLAV TABLET
amoxicillin (amoxicillin trihydrate) 875 mg , clavulanic acid (clavulanate potassium) 125 mg;
Number of active ingredients: 2.00;
2019-03-01;
Oral;
Tablet;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02482584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97301
PANCREASE MT 10
amylase 43750 unit , protease 25000 unit , lipase 10500 unit;
Number of active ingredients: 3.00;
1988-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
VIVUS INC.
DIN: 00789437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9513
CEPACOL SENSATIONS
amylmetacresol 0.6 mg , dichlorobenzyl alcohol 1.2 mg;
Number of active ingredients: 2.00;
2012-07-19;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02382938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86872
CEPACOL CHILDREN’S FRUITY STRAWBERRY
amylmetacresol 0.6 mg , dichlorobenzyl alcohol 1.2 mg;
Number of active ingredients: 2.00;
2013-08-15;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02404982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88981
REFRESH EYE ALLERGY RELIEF
antazoline phosphate 0.51 % , naphazoline hydrochloride 0.051 %;
Number of active ingredients: 2.00;
2009-02-09;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
ALLERGAN INC
DIN: 02315890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80140
WILATE
antihemophilic factor (human) 1000 unit / 10 ml , von willebrand factor (human) 1000 unit / 10 ml , human plasma proteins 15 mg / 10 ml;
Number of active ingredients: 3.00;
2008-04-29;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02286769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77222
HUMATE-P
antihemophilic factor (human) 1200 unit / 15 ml , von willebrand factor (human) 3360 unit / 15 ml;
Number of active ingredients: 2.00;
2004-12-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02261235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74663
HUMATE-P
antihemophilic factor (human) 300 unit / 5 ml , von willebrand factor (human) 840 unit / 5 ml;
Number of active ingredients: 2.00;
2004-12-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02261219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74661
WILATE
antihemophilic factor (human) 500 unit / 5 ml , von willebrand factor (human) 500 unit / 5 ml , human plasma proteins 7.5 mg / 5 ml;
Number of active ingredients: 3.00;
2008-04-29;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02286750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77219
OTEZLA
apremilast 10 mg , apremilast 20 mg , apremilast 30 mg;
Number of active ingredients: 3.00;
2014-11-27;
Oral;
Kit , Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
AMGEN CANADA INC
DIN: 02434318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91864
EMEND TRI-PACK
aprepitant 125 mg , aprepitant 80 mg;
Number of active ingredients: 2.00;
2007-09-24;
Oral;
Kit , Capsule;
56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
DIN: 02298813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78412
TISSEEL
aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 500 unit / ml , calcium chloride 40 mcmol / ml , sealer protein (human) 125 mg / ml;
Number of active ingredients: 4.00;
2011-06-20;
Topical;
Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAXTER CORPORATION
DIN: 02326175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81151
SEPTANEST N
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
Number of active ingredients: 2.00;
1994-12-31;
Block/Infiltration;
Liquid;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02123371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16851
4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
Number of active ingredients: 2.00;
2004-01-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02248489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72841
POSICAINE N
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
Number of active ingredients: 2.00;
2012-04-13;
Block/Infiltration;
Solution;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 02381311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86711
4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML)
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
Number of active ingredients: 2.00;
2004-01-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02248488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72840
POSICAINE SP
articaine hydrochloride 40 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
Number of active ingredients: 2.00;
2012-04-13;
Block/Infiltration;
Solution;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 02381338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86712
ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.009 mg / ml;
Number of active ingredients: 2.00;
2010-04-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
DIN: 02339536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82513
ORABLOC 1:200,000
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.009 mg / ml;
Number of active ingredients: 2.00;
2012-06-14;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
DIN: 02361906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84694
ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.018 mg / ml;
Number of active ingredients: 2.00;
2010-04-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
DIN: 02339544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82514
ORABLOC 1:100,000
articaine hydrochloride 40 mg / ml , epinephrine bitartrate 0.018 mg / ml;
Number of active ingredients: 2.00;
2012-06-14;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PIERREL PHARMA S.R.L.
DIN: 02361914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84695
MULTI-12/K1 PEDIATRIC
ascorbic acid (ascorbic acid) 80 mg / vial , vitamin a 2300 unit / vial , vitamin d 400 unit / vial , vitamin b1 (thiamine hydrochloride) 1.2 mg / vial , vitamin b2 (riboflavin-5-phosphate) 1.4 mg / vial , pyridoxine hydrochloride 1 mg / vial , nicotinamide 17 mg / vial , dexpanthenol 5 mg / vial , vitamin e (dl-alpha tocopheryl acetate) 7 unit / vial , vitamin k1 0.2 mg / vial , biotin 20 mcg / vial , folic acid 140 mcg / vial , vitamin b12 (cyanocobalamin) 1 mcg / vial;
Number of active ingredients: 13.00;
2000-11-07;
Intravenous;
Liquid;
88:28.00 – MULTIVITAMIN PREPARATIONS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02242529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66277
MULTI 12 INJECTION
ascorbic acid 20 mg / ml , vitamin a 660 unit / ml , vitamin d 40 unit / ml , vitamin b1 (thiamine hydrochloride) 0.6 mg / ml , vitamin b2 (riboflavin-5-phosphate) 0.72 mg / ml , nicotinamide 8 mg / ml , pyridoxine hydrochloride 0.8 mg / ml , dexpanthenol 3 mg / ml , vitamin e 2 unit / ml , biotin 12 mcg / ml , folic acid 80 mcg / ml , vitamin b12 (vitamin b12) 1 mcg / ml;
Number of active ingredients: 12.00;
1994-12-31;
Intravenous;
Liquid;
88:28.00 – MULTIVITAMIN PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02100606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16462
AA-ATENIDONE
atenolol 100 mg , chlorthalidone 25 mg;
Number of active ingredients: 2.00;
2004-08-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
AA PHARMA INC
DIN: 02248764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73132
AA-ATENIDONE
atenolol 50 mg , chlorthalidone 25 mg;
Number of active ingredients: 2.00;
2004-08-12;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
AA PHARMA INC
DIN: 02248763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73131
GD-AMLODIPINE/ATORVASTATIN
atorvastatin (atorvastatin calcium) 20 mg , amlodipine (amlodipine besylate) 5 mg;
Number of active ingredients: 2.00;
2011-07-25;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
UPJOHN CANADA ULC
DIN: 02362767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84776
MALARONE
atovaquone 250 mg , proguanil hydrochloride 100 mg;
Number of active ingredients: 2.00;
1998-08-07;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02238151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61542
TEVA-ATOVAQUONE PROGUANIL
atovaquone 250 mg , proguanil hydrochloride 100 mg;
Number of active ingredients: 2.00;
2012-03-01;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
TEVA CANADA LIMITED
DIN: 02380927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86668
MYLAN-ATOVAQUONE/PROGUANIL
atovaquone 250 mg , proguanil hydrochloride 100 mg;
Number of active ingredients: 2.00;
2013-10-16;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02402165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88703
ATOVAQUONE PROGUANIL
atovaquone 250 mg , proguanil hydrochloride 100 mg;
Number of active ingredients: 2.00;
2014-05-22;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
SANIS HEALTH INC
DIN: 02421429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90605
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS
atovaquone 250 mg , proguanil hydrochloride 100 mg;
Number of active ingredients: 2.00;
2017-10-30;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS , 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02466783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95514
MALARONE PEDIATRIC
atovaquone 62.5 mg , proguanil hydrochloride 25 mg;
Number of active ingredients: 2.00;
2005-05-17;
Oral;
Tablet;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02264935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75044
INSTANT BRONZER INSTANTANÉ 4 SPRAY GEL SUNSCREEN
avobenzone 1 % / w/w , octocrylene 1 % / w/w;
Number of active ingredients: 2.00;
2020-10-30;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02502062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99166
SHEER DAILY MOISTURIZER
avobenzone 1.5 % / w/w , octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w;
Number of active ingredients: 4.00;
2018-01-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02462133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94987
REVERSA UV CREME VISAGE ET COU FPS 15
avobenzone 1.8 % , octinoxate 7.5 % , oxybenzone 4 %;
Number of active ingredients: 3.00;
2002-09-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 02244858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68850
PREVENTAGE FIRMING DEFENSE CRÈME NORMAL/DRY BROAD SPECTRUM SPF 15
avobenzone 1.9 % / w/w , octocrylene 9.4 % / w/w;
Number of active ingredients: 2.00;
2013-06-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02403552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88834
PREVENTAGE FIRMING DEFENSE CRÈME NORMAL/OILY BROAD SPECTRUM SPF 15
avobenzone 1.9 % / w/w , octocrylene 9.4 % / w/w;
Number of active ingredients: 2.00;
2013-06-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02403560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88835
SUNSCREEN CONTINUOUS SPRAY NO PUMPING NEEDED
avobenzone 2 % , homosalate 15 % , octisalate 5 % , oxybenzone 4 %;
Number of active ingredients: 4.00;
2016-03-08;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02447525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93311
ABSOLUE HAND SPF 15
avobenzone 2 % , octisalate 5 % , octocrylene 10 %;
Number of active ingredients: 3.00;
2004-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02248071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72392
SPORT SUNSCREEN CONTINUOUS SPRAY SPF 15
avobenzone 2 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2020-03-17;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02491044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98106
SUNSCREEN CONTINUOUS SPRAY SPF/FPS 30
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
Number of active ingredients: 4.00;
2011-03-02;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02359995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84496
30 SPF
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
Number of active ingredients: 4.00;
2017-02-28;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
DIN: 02391155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87652
SUNSCREEN SPORT SPF 30
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
Number of active ingredients: 4.00;
2014-03-05;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
DIN: 02393727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87892
PHARMASAVE SPORT SUNSCREEN CONTINUOUS SPRAY SPF FPS 30
avobenzone 2 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w;
Number of active ingredients: 4.00;
2017-08-21;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02465698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95393
RODAN + FIELDS REDEFINE TRIPLE DEFENSE LOTION
avobenzone 2 % / w/w , homosalate 6.8 % / w/w , octisalate 3.4 % / w/w , octocrylene 4.4 % / w/w;
Number of active ingredients: 4.00;
2020-09-16;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02492830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98283
HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 30
avobenzone 2 % / w/w , homosalate 7 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 3.00;
2017-01-03;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02454602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94131
SPRAYGEL WITH INSTANT BRONZE TINT SPF/FPS 15
avobenzone 2 % / w/w , octisalate 5 % / w/w , octocrylene 2.75 % / w/w , oxybenzone 0.5 % / w/w;
Number of active ingredients: 4.00;
2016-03-23;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02447754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93333
VITAMIN E MOISTURE-PROTECT LIP CARE
avobenzone 2 % / w/w , octisalate 5 % / w/w , octocrylene 3 % / w/w;
Number of active ingredients: 3.00;
2016-08-17;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
DIN: 02423952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90868
SUNSCREEN CONTINUOUS SPRAY
avobenzone 2 % / w/w , octisalate 5 % / w/w , oxybenzone 3 % / w/w , homosalate 10 % / w/w;
Number of active ingredients: 4.00;
2016-03-07;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02447649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93322
LIFE BRAND SPORT SUNSCREEN BROAD SPECTRUM SPRAY
avobenzone 2 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w , homosalate 15 % / w/w;
Number of active ingredients: 4.00;
2016-03-17;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02447509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93309
INSTANT BRONZER INSTANTANÉ 15
avobenzone 2 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2020-10-30;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02497344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98717
INSTANT BRONZER INSTANTANÉ 15 CONTINUOUS SPRAY SUNSCREEN
avobenzone 2 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2020-10-30;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02501066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99071
COOLA PINA COLADA SCENT SUNSCREEN SPRAY
avobenzone 2 % / w/w , octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
Number of active ingredients: 4.00;
2017-07-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02458918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94608
COOLA CITRUS MIMOSA SCENT SUNSCREEN SPRAY
avobenzone 2 % / w/w , octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
Number of active ingredients: 4.00;
2017-07-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02458950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94610
COOLA MAKEUP SETTING SPRAY GREEN TEA SCENT
avobenzone 2.1 % / w/w , homosalate 3.5 % / w/w , octinoxate 3.5 % / w/w , octisalate 2.8 % / w/w;
Number of active ingredients: 4.00;
2017-07-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02458942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94609
DRY BALANCE SUNSCREEN LOTION SPF 30
avobenzone 2.2 % / w/w , homosalate 7 % / w/w , octocrylene 4.2 % / w/w;
Number of active ingredients: 3.00;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02456052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94290
SPF 30 SPRAY-ON ALCOHOL-FREE SUNSCREEN
avobenzone 2.5 % , octinoxate 7.5 % , octocrylene 7.5 % , octisalate 5 %;
Number of active ingredients: 4.00;
2012-01-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
WILC HEALTHCARE INC
DIN: 02375788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86119
RODAN+FIELDS ESSENTIALS LIP SHIELD
avobenzone 2.5 % / w/w , homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 2.2 % / w/w;
Number of active ingredients: 4.00;
2016-04-19;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02407051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89171
MOISTURE SUN PROTECTOR
avobenzone 2.5 % / w/w , homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w;
Number of active ingredients: 4.00;
2018-07-12;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
DIN: 02462931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95082
CLE DE PEAU BEAUTE 30 SOIN PROTECTEUR UV POUR LES LEVRES
avobenzone 2.5 % / w/w , oxybenzone 2 % / w/w , octocrylene 3 % / w/w , octinoxate 4.9 % / w/w;
Number of active ingredients: 4.00;
2017-02-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02450224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93627
ADAPTASUN CRÈME DE SOIN SOLAIRE MER ET TROPIQUES VISAGE FPS/SPF 25
avobenzone 2.54 % / w/w , octinoxate 6 % / w/w;
Number of active ingredients: 2.00;
2016-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02445581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93087
HAWAIIAN TROPIC OIL SPRAY MOISTURIZING SUNSCREEN SPF 4
avobenzone 2.8 % , octocrylene 2.2 % , oxybenzone 2 %;
Number of active ingredients: 3.00;
2017-06-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02446898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93246
RODAN + FIELDS REVERSE BRIGHTENING DEFENSE FLUID LOTION
avobenzone 2.8 % / w/w , homosalate 9.3 % / w/w , octisalate 4.67 % / w/w , octocrylene 6.1 % / w/w;
Number of active ingredients: 4.00;
2021-03-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02498081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98788
RODAN + FIELDS ESSENTIALS FACE + BODY SUNSCREEN
avobenzone 2.8 % / w/w , homosalate 9.6 % / w/w , octisalate 4.8 % / w/w , octocrylene 9.6 % / w/w;
Number of active ingredients: 4.00;
2020-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02491001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98103
SUNSCREEN OIL
avobenzone 2.8 g / 100 g , octocrylene 2.2 g / 100 g , oxybenzone 2 g / 100 g;
Number of active ingredients: 3.00;
2016-04-15;
Topical;
Oil;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02448564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93426
COOLA CLASSIC SPF 50 SUNSCREEN SPRAY FRAGRANCE-FREE
avobenzone 2.9 % / w/w , homosalate 4.3 % / w/w , octisalate 4.9 % / w/w , octocrylene 9.5 % / w/w;
Number of active ingredients: 4.00;
2021-03-31;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02510081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99934
TANNING OIL HUILE BRONZANTE 15
avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 %;
Number of active ingredients: 4.00;
2018-03-07;
Topical;
Oil;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02471795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96099
SMART TONE BROAD-SPECTRUM SUNSCREEN SPF 50
avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 %;
Number of active ingredients: 4.00;
2018-12-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ZO SKIN HEALTH INC
DIN: 02475294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96566
PREMIUM SUNSCREEN SPRAY SUN BUM 30
avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 3.75 %;
Number of active ingredients: 4.00;
2019-04-08;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02483335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97377
PREMIUM SUNSCREEN SPRAY SUN BUM 50
avobenzone 3 % , homosalate 15 % , octisalate 5 % , octocrylene 7 %;
Number of active ingredients: 4.00;
2019-04-08;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02483726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97407
SUNSCREEN CONTINUOUS SPRAY SPF 30 SPORT
avobenzone 3 % , homosalate 7.5 % , octisalate 5 % , octocrylene 5 %;
Number of active ingredients: 4.00;
2020-02-27;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02493772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98377
EXTRA-FIRMING JOUR FPS/SPF 15
avobenzone 3 % , homosalate 9 % , octocrylene 6.5 %;
Number of active ingredients: 3.00;
2018-12-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02481294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97178
BEAUTY BOOSTER CREAM SPF 30
avobenzone 3 % , octinoxate 7.5 % , oxybenzone 6 %;
Number of active ingredients: 3.00;
2017-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TRISH MCEVOY LTD
DIN: 02461854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94959
CETAPHIL DAILY FACIAL MOISTURIZER SPF 15
avobenzone 3 % , octocrylene 10 %;
Number of active ingredients: 2.00;
2001-06-19;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GALDERMA CANADA INC
DIN: 02243329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67232
OMBRELLE-LOTION SPF 15
avobenzone 3 % , octocrylene 10 % , ensulizole 1.5 % , terephthalylidene dicamphor sulfonic acid 1 %;
Number of active ingredients: 4.00;
2003-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02246798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70998
SPORT SUNSCREEN LOTION SPF 50+
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , octocrylene 8 % / w/w;
Number of active ingredients: 4.00;
2020-02-19;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02491036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98105
SPORT SUNSCREEN
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2016-02-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02447630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93321
PREMIUM SUNSCREEN FACE LOTION SUN BUM FACE 50
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2020-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02478986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96970
PREMIUM SUNSCREEN LOTION SUN BUM 50
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2019-04-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02479001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96972
SPORT SUNSCREEN LOTION SPF 30
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2019-11-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02488485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97857
RODAN + FIELDS UNBLEMISH INVISIBLE MATTE DEFENSE
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2020-03-10;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02491761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98178
SENSITIVE SKIN SUNSCREEN CONTINUOUS SPRAY SPF 30
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 4.00;
2020-09-21;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02488469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97855
SPORT SUNSCREEN CONTINUOUS SPRAY SPF 30
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 4.00;
2019-11-04;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02490862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98090
KIDS SUNSCREEN CONTINUOUS SPRAY SPF 50+
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
Number of active ingredients: 4.00;
2020-02-27;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02488663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97876
SUNTHERA3 KIDS SPF 50+ CONTINUOUS SPRAY SUNSCREEN BROAD SPECTRUM UVA/UVB PROTECTION
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
Number of active ingredients: 4.00;
2021-03-02;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02494183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98422
SUNSCREEN CONTINUOUS SPRAY SPF 50 KIDS
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2020-02-27;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02494094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98412
KIDS SUNSCREEN LOTION 50+
avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2020-02-27;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02494833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98481
SUNSCREEN FACE STICK / ÉCRAN SOLAIRE BÂTON
avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2021-03-11;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02500612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99028
SCALP MIST
avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 4 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2020-12-11;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02506068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99541
KIDS SUNSCREEN LOTION SPF 50+
avobenzone 3 % / w/w , homosalate 13 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2020-06-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02490382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98043
SENSITIVE SKIN SUNSCREEN LOTION SPF 50+
avobenzone 3 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2020-01-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02491028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98104
SUNTHERA3 SPF 50+ SUN PROTECTION LOTION
avobenzone 3 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2021-04-16;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02493101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98308
OLAY UV MOISTURIZING CREAM
avobenzone 3 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 2.6 % / w/w;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02442779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92717
OLAY AGE DEFYING ANTI WRINKLE DAY LOTION WITH SPF 15
avobenzone 3 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 2.6 % / w/w;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02444208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92910
HYDRAPHASE UV INTENSE
avobenzone 3 % / w/w , homosalate 4.7 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
Number of active ingredients: 4.00;
2011-08-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02362058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84707
PREMIUM SUNSCREEN LOTION SUN BUM 30
avobenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 3 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2019-04-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02478994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96971
LIFTACTIV SPECIALIST FPS/SPF 30
avobenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
Number of active ingredients: 4.00;
2021-03-24;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
DIN: 02498642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98839
SPORT 30 CONTINUOUS SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2019-11-01;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02492261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98230
SUNSCREEN CONTINUOUS SPRAY SPF 30
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2020-02-27;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02494108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98413
SUNSCREEN LOTION 30 SPF/FPS SPORT
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2020-02-27;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02494825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98480
INSTANT BRONZER INSTANTANÉ 30 CONTINUOUS SPRAY SUNSCREEN
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2020-10-30;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02501058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99070
INSTANT BRONZER INSTANTANÉ 30 SPRAY GEL SUNSCREEN
avobenzone 3 % / w/w , homosalate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2020-10-30;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02502054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99165
OLAY LUMINOUS WHIP
avobenzone 3 % / w/w , homosalate 8 % / w/w , octisalate 4 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02463911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95201
COPPERTONE LOTION SUNSCREEN SPF 30 SPORT
avobenzone 3 % / w/w , homosalate 8 % / w/w , octisalate 4.5 % / w/w , octocrylene 6 % / w/w;
Number of active ingredients: 4.00;
2016-10-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02452804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93921
BANANA BOAT SIMPLY PROTECT SPORT SUNSCREEN LOTION SPF 50+
avobenzone 3 % / w/w , homosalate 9 % / w/w , octocrylene 7.5 % / w/w;
Number of active ingredients: 3.00;
2017-12-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02467445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95582
COPPERTONE CLEAR BLUE SUNSCREEN
avobenzone 3 % / w/w , homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2021-02-03;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02490358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98040
MOISTURE THERAPY LIP BALM SPF 25
avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2013-07-08;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JACK BLACK LLC
DIN: 02381753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86761
OLAY REGENERIST MICRO-SCULPTING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 30
avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2016-07-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02436450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92079
NIVEA MEN SENSITIVE
avobenzone 3 % / w/w , octisalate 4.7 % / w/w , octocrylene 8.4 % / w/w;
Number of active ingredients: 3.00;
2021-03-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02507692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99705
CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER COMBINATION OILY TO OILY
avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 2.00;
2016-01-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02440083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92447
ARTISTRY SKIN NUTRITION BALANCING MATTE DAY LOTION
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
Number of active ingredients: 3.00;
2021-04-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02502968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99248
RODAN + FIELDS REDEFINE TRIPLE DEFENSE CREAM
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
Number of active ingredients: 3.00;
2020-09-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02492849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98284
ARTISTRY SKIN NUTRITION HYDRATING DAY LOTION
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w;
Number of active ingredients: 3.00;
2021-04-16;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02502976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99249
NO7 LIFT & LUMINATE TRIPLE ACTION DAY CREAM
avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 7.5 % / w/w;
Number of active ingredients: 3.00;
2018-03-21;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
DIN: 02460300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94759
ORIGINS VITAZING SPF 15 ENERGY-BOOSTING MOISTURIZER
avobenzone 3 % / 50 ml , octisalate 3 % / 50 ml , octocrylene 2.7 % / 50 ml;
Number of active ingredients: 3.00;
2010-10-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ORIGINS NATURAL RESOURCES DIST
DIN: 02351455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83672
SPF FPS 50 KIDS SUNSCREEN
avobenzone 3 g / 100 g , homosalate 15 g / 100 g , octisalate 5 g / 100 g , oxybenzone 6 g / 100 g;
Number of active ingredients: 4.00;
2016-03-09;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02448556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93424
EDARBYCLOR
azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg , chlorthalidone 12.5 mg;
Number of active ingredients: 2.00;
2013-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
VALEANT CANADA LP / VALEANT CANADA S.E.C.
DIN: 02397749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88267
EDARBYCLOR
azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg , chlorthalidone 25 mg;
Number of active ingredients: 2.00;
2013-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
VALEANT CANADA LP / VALEANT CANADA S.E.C.
DIN: 02397765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88269
OZONOL ANTIBIOTICS PLUS
bacitracin 500 unit / g , lidocaine hydrochloride 40 mg / g , polymyxin b (polymyxin b sulfate) 10000 unit / g;
Number of active ingredients: 3.00;
1998-05-27;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
EXZELL PHARMA INC
DIN: 02236917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60209
JAMPOLYCIN
bacitracin 500 unit / g , polymyxin b sulfate 10000 unit / g;
Number of active ingredients: 2.00;
2013-12-09;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JAMP PHARMA CORPORATION
DIN: 02357569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84267
POLY ANTIBIOTIC OINTMENT
bacitracin 500 unit / g , polymyxin b sulfate 10000 unit / g;
Number of active ingredients: 2.00;
2021-03-03;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02510383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99961
POLYDERM OINTMENT USP
bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
Number of active ingredients: 2.00;
1996-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02181908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20134
ANTIBIOTIC OINTMENT USP
bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
Number of active ingredients: 2.00;
2002-06-10;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02230251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48982
STERISPORIN
bacitracin zinc 500 unit / g , polymyxin b sulfate 10000 unit / g;
Number of active ingredients: 2.00;
2017-05-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Otc;
STERI-MED PHARMA INC.
DIN: 02359928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84489
FOOTWORKS HEALTHY CRACKED HEEL CREAM
benzalkonium chloride 0.13 % / w/w , lidocaine 4 % / w/w;
Number of active ingredients: 2.00;
2013-05-27;
Topical;
Cream;
72:00.00 – LOCAL ANESTHETICS , 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02397587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88252
CETACAINE LIQUID
benzocaine 14 % , butamben 2 % , tetracaine hydrochloride 2 %;
Number of active ingredients: 3.00;
1996-09-19;
Topical;
Liquid;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
CETYLITE INDUSTRIES INC.
DIN: 02028867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26564
AURALGAN
benzocaine 14 mg / ml , antipyrine 54 mg / ml;
Number of active ingredients: 2.00;
2011-02-28;
Otic;
Solution;
52:16.00 – LOCAL ANESTHETICS;
Otc;
PALADIN LABS INC.
DIN: 02332477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81814
ZAP TOPICAL ANESTHETIC GEL
benzocaine 18 % , tetracaine hydrochloride 2 %;
Number of active ingredients: 2.00;
1992-12-31;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
GERMIPHENE CORPORATION
DIN: 01930699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13347
ONE TOUCH TOPICAL ANESTHETIC GEL
benzocaine 18 % , tetracaine hydrochloride 2 %;
Number of active ingredients: 2.00;
1998-04-21;
Buccal;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ABJ CUSTOM PACKAGING
DIN: 02230958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50238
FRIAR’S BALSAM BENZOIN TINCTURE
benzoin 10 g / 100 ml , aloe 2 g / 100 ml , storax 8 g / 100 ml , myroxylon balsamum 4 g / 100 ml;
Number of active ingredients: 4.00;
1982-12-31;
Inhalation , Topical;
Tincture;
92:01.00* – HERBS AND NATURAL PRODUCTS;
Otc;
TEVA CANADA LIMITED
DIN: 00545279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41578
PROACTIV 3-STEP CONVENIENCE PAK
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2013-08-08;
Topical;
Gel , Kit;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
DIN: 02406179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89090
PROACTIV 3 PIECE SET
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2014-06-20;
Topical;
Gel , Kit;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
THE PROACTIV COMPANY, LLC
DIN: 02414422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89901
ACTIVE ANTI-ACNE TREATMENT KIT
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2015-12-10;
Topical;
Kit , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02444054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92884
ADVANTAGE ACNE CONTROL KIT
benzoyl peroxide 2.5 % / w/w , benzoyl peroxide 5 % / w/w;
Number of active ingredients: 2.00;
2017-01-30;
Topical;
Gel , Kit , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02452782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93919
CLINDOXYL ADV GEL
benzoyl peroxide 3 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
Number of active ingredients: 2.00;
2013-08-20;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02382822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86863
STUBBORN ACNE SOLUTION
benzoyl peroxide 3.5 % / w/w , benzoyl peroxide 2.5 % / w/w;
Number of active ingredients: 2.00;
2017-01-30;
Topical;
Gel , Kit , Paste;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02457938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94496
RODAN+FIELDS SPOTLESS
benzoyl peroxide 5 % , benzoyl peroxide 2.5 %;
Number of active ingredients: 2.00;
2019-04-09;
Topical;
Kit , Lotion , Cream;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
RODAN & FIELDS LLC
DIN: 02469707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95852
CLINDOXYL GEL
benzoyl peroxide 5 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
Number of active ingredients: 2.00;
2001-09-04;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02243158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67033
TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL
benzoyl peroxide 5 % / w/w , clindamycin (clindamycin phosphate) 1 % / w/w;
Number of active ingredients: 2.00;
2015-08-05;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02440180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92456
ACNE TREATMENT SYSTEM
benzoyl peroxide 5 % / w/w , salicylic acid 2 % / w/w;
Number of active ingredients: 2.00;
2013-11-15;
Topical;
Kit , Liquid , Lotion;
84:28.00 – KERATOLYTIC AGENTS;
Otc;
VIVIER CANADA INCORPORATED
DIN: 02402149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88701
LOTRIDERM
betamethasone (betamethasone dipropionate) 0.05 % , clotrimazole 1 %;
Number of active ingredients: 2.00;
1990-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.08 – AZOLES;
Prescription;
ORGANON CANADA INC.
DIN: 00611174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10748
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
betamethasone (betamethasone dipropionate) 0.05 % / w/w , clotrimazole 1 % / w/w;
Number of active ingredients: 2.00;
2020-04-06;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.08 – AZOLES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02496410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98629
ENSTILAR
betamethasone (betamethasone dipropionate) 0.5 mg / g , calcipotriol (calcipotriol monohydrate) 50 mcg / g;
Number of active ingredients: 2.00;
2016-11-11;
Topical;
Aerosol, Foam;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02457393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94445
TEVA-BETAMETHASONE/ CALCIPOTRIOL
betamethasone (betamethasone dipropionate) 0.5 mg / g , calcipotriol 50 mcg / g;
Number of active ingredients: 2.00;
2020-08-07;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02427419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91194
RATIO-TOPISALIC
betamethasone (betamethasone dipropionate) 0.5 mg / g , salicylic acid 20 mg / g;
Number of active ingredients: 2.00;
2002-05-03;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02245688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69789
DIPROSALIC
betamethasone (betamethasone dipropionate) 0.5 mg / g , salicylic acid 30 mg / g;
Number of active ingredients: 2.00;
1983-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
ORGANON CANADA INC.
DIN: 00578436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5287
VALISONE-G
betamethasone (betamethasone valerate) 0.1 % / w/w , gentamicin (gentamicin sulfate) 0.1 % / w/w;
Number of active ingredients: 2.00;
1970-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00177016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=816
CELESTONE SOLUSPAN
betamethasone acetate 3 mg / ml , betamethasone (betamethasone sodium phosphate) 3 mg / ml;
Number of active ingredients: 2.00;
1965-12-31;
Intra-Articular , Intrabursal , Intradermal , Intramuscular;
Suspension;
68:04.00 – ADRENALS;
Prescription;
ORGANON CANADA INC.
DIN: 00028096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=354
BIKTARVY
bictegravir (bictegravir sodium) 50 mg , emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
Number of active ingredients: 3.00;
2018-08-08;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02478579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96935
STOMACH RELIEF CHEWABLE TABLETS
bismuth subsalicylate 262 mg , calcium carbonate 350 mg;
Number of active ingredients: 2.00;
2013-11-20;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
GUARDIAN DRUG COMPANY INC
DIN: 02389215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87472
PHOTODERM SPF/FPS 50+ CRÈME
bisoctrizole 6 % , octocrylene 10 % , bemotrizinol 2.5 % , avobenzone 5 %;
Number of active ingredients: 4.00;
2012-02-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
DIN: 02354489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83965
PHOTODERM SPF/FPS 50+ LAIT
bisoctrizole 6 % , octocrylene 10 % , bemotrizinol 2.5 % , avobenzone 5 %;
Number of active ingredients: 4.00;
2012-02-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
DIN: 02354497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83966
PHOTODERM SPF/FPS 40 SPRAY
bisoctrizole 6 % , octocrylene 8 % , avobenzone 4.5 %;
Number of active ingredients: 3.00;
2012-02-08;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
DIN: 02354500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83967
REXULTI
brexpiprazole 0.5 mg , brexpiprazole 1 mg;
Number of active ingredients: 2.00;
2019-06-08;
Oral;
Kit , Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02485923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97617
ALUNBRIG
brigatinib 90 mg , brigatinib 180 mg;
Number of active ingredients: 2.00;
2018-08-31;
Oral;
Kit , Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02479230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96985
COMBIGAN
brimonidine tartrate 0.2 % , timolol (timolol maleate) 0.5 %;
Number of active ingredients: 2.00;
2003-12-11;
Ophthalmic;
Solution;
52:40.04 – ALPHA-ADRENERGIC AGONISTS , 52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
ALLERGAN INC
DIN: 02248347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72692
SIMBRINZA
brinzolamide 1 % / w/v , brimonidine tartrate 0.2 % / w/v;
Number of active ingredients: 2.00;
2015-02-17;
Ophthalmic;
Suspension;
52:40.04 – ALPHA-ADRENERGIC AGONISTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02435411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91973
ROBITUSSIN CHILDREN’S COUGH & COLD BEDTIME
brompheniramine maleate 2 mg / 5 ml , phenylephrine hydrochloride 5 mg / 5 ml , dextromethorphan hydrobromide 10 mg / 5 ml;
Number of active ingredients: 3.00;
2013-07-17;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02394707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87985
SYMBICORT 100 TURBUHALER
budesonide 100 mcg / act , formoterol fumarate dihydrate 6 mcg / act;
Number of active ingredients: 2.00;
2002-02-08;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02245385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69428
ENTOCORT ENEMA
budesonide 2.3 mg , sodium chloride 115 ml;
Number of active ingredients: 2.00;
1994-12-31;
Rectal;
Enema , Kit , Tablet;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TILLOTTS PHARMA GMBH
DIN: 02052431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16264
SYMBICORT 200 TURBUHALER
budesonide 200 mcg / act , formoterol fumarate dihydrate 6 mcg / act;
Number of active ingredients: 2.00;
2002-02-08;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02245386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69429
MARCAINE E
bupivacaine hydrochloride 100 mg / 20 ml , epinephrine bitartrate 0.182 mg / 20 ml;
Number of active ingredients: 2.00;
2001-07-15;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02241916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65586
SENSORCAINE WITH EPINEPHRINE
bupivacaine hydrochloride 5 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
Number of active ingredients: 2.00;
1994-12-31;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 01976206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16163
VIVACAINE
bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
Number of active ingredients: 2.00;
2008-04-11;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT INC
DIN: 02305135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79063
BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION
bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
Number of active ingredients: 2.00;
2012-05-07;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 02381850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86769
MARCAINE
bupivacaine hydrochloride 5 mg / ml , epinephrine bitartrate 0.0091 mg / ml;
Number of active ingredients: 2.00;
2019-04-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT INC
DIN: 02474247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96430
MARCAINE E
bupivacaine hydrochloride 50 mg / 20 ml , epinephrine bitartrate 0.182 mg / 20 ml;
Number of active ingredients: 2.00;
2001-07-15;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02241915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65585
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 12 mg , naloxone (naloxone hydrochloride dihydrate) 3 mg;
Number of active ingredients: 2.00;
2018-02-14;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02468085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95646
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 12 mg , naloxone (naloxone hydrochloride) 3 mg;
Number of active ingredients: 2.00;
2021-01-20;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02502356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99192
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 16 mg , naloxone (naloxone hydrochloride dihydrate) 4 mg;
Number of active ingredients: 2.00;
2018-02-14;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02468093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95647
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
Number of active ingredients: 2.00;
2007-11-26;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02295695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78104
PMS-BUPRENORPHINE-NALOXONE
buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride dihydrate) 0.5 mg;
Number of active ingredients: 2.00;
2014-12-10;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02424851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90952
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 2 mg , naloxone (naloxone hydrochloride) 0.5 mg;
Number of active ingredients: 2.00;
2021-01-20;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02502313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99189
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 4 mg , naloxone (naloxone hydrochloride) 1 mg;
Number of active ingredients: 2.00;
2021-06-17;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02502321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99190
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
Number of active ingredients: 2.00;
2007-11-26;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02295709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78105
PMS-BUPRENORPHINE-NALOXONE
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
Number of active ingredients: 2.00;
2014-12-10;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 02424878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90953
TEVA-BUPRENORPHINE/NALOXONE
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride dihydrate) 2 mg;
Number of active ingredients: 2.00;
2017-09-28;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02453916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94044
SUBOXONE
buprenorphine (buprenorphine hydrochloride) 8 mg , naloxone (naloxone hydrochloride) 2 mg;
Number of active ingredients: 2.00;
2021-01-20;
Buccal , Sublingual;
Film, Soluble;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
INDIVIOR UK LIMITED
DIN: 02502348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99191
FIORINAL
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
Number of active ingredients: 3.00;
1971-12-31;
Oral;
Capsule;
28:24.04 – BARBITURATES , 28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
ARALEZ PHARMACEUTICALS CANADA INC
DIN: 00226327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1233
TEVA-TECNAL
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
Number of active ingredients: 3.00;
1984-12-31;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
TEVA CANADA LIMITED
DIN: 00608211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5779
TEVA-TECNAL
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
Number of active ingredients: 3.00;
1985-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS , 28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
TEVA CANADA LIMITED
DIN: 00608238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6480
TRIANAL TABLET
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg;
Number of active ingredients: 3.00;
1997-02-07;
Oral;
Tablet;
28:08.04.24 – SALICYLATES;
Schedule G (Cdsa Iv);
LABORATOIRE RIVA INC.
DIN: 01971409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23671
TEVA-TECNAL C 1/2
butalbital 50 mg , caffeine 40 mg , acetylsalicylic acid 330 mg , codeine phosphate 30 mg;
Number of active ingredients: 4.00;
1984-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00608181
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6419
CABENUVA
cabotegravir 200 mg / ml , rilpivirine 300 mg / ml;
Number of active ingredients: 2.00;
2020-09-21;
Intramuscular;
Suspension (Extended-Release) , Kit;
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02497220
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98706
TEVA-LENOLTEC NO. 3
caffeine 15 mg , codeine phosphate 30 mg , acetaminophen 300 mg;
Number of active ingredients: 3.00;
1985-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00653276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6346
TEVA-TECNAL C 1/4
caffeine 40 mg , acetylsalicylic acid 330 mg , codeine phosphate 15 mg , butalbital 50 mg;
Number of active ingredients: 4.00;
1984-12-31;
Oral;
Capsule;
28:08.08 – OPIATE AGONISTS , 28:08.04.24 – SALICYLATES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00608203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6479
AVEENO ANTI-ITCH LOTION
calamine 3 % , pramoxine hydrochloride 1 %;
Number of active ingredients: 2.00;
2000-05-01;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02240105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63620
CALAMINE LOTION WITH ANTIHISTAMINE
calamine 8 % , diphenhydramine hydrochloride 1 %;
Number of active ingredients: 2.00;
1981-12-31;
Topical;
Suspension;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
DIN: 00538493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41558
LOTION CALAMINE AVEC ANTIHISTAMINIQUE
calamine 8 % , diphenhydramine hydrochloride 1 %;
Number of active ingredients: 2.00;
2000-10-13;
Topical;
Suspension;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRE ATLAS INC
DIN: 02241462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65100
DOVOBET GEL
calcipotriol (calcipotriol monohydrate) 50 mcg / g , betamethasone (betamethasone dipropionate) 0.5 mg / g;
Number of active ingredients: 2.00;
2009-01-28;
Topical;
Gel;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02319012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80450
DOVOBET OINTMENT
calcipotriol 50 mcg / g , betamethasone (betamethasone dipropionate) 0.5 mg / g;
Number of active ingredients: 2.00;
2001-11-29;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02244126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68084
DIOVOL PLUS ALUMINUM FREE SUSPENSION
calcium carbonate 200 mg / 5 ml , magnesium hydroxide 200 mg / 5 ml , simethicone 25 mg / 5 ml;
Number of active ingredients: 3.00;
1995-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02157616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19082
PEPTO-BISMOL CHEWABLES
calcium carbonate 350 mg , bismuth subsalicylate 262 mg;
Number of active ingredients: 2.00;
2000-02-18;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02237315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60637
INVOKAMET
canagliflozin 150 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
DIN: 02455455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94226
INVOKAMET
canagliflozin 150 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
DIN: 02455439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94224
INVOKAMET
canagliflozin 50 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
DIN: 02455420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94223
INVOKAMET
canagliflozin 50 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2016-06-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
JANSSEN INC
DIN: 02455404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94221
ATACAND PLUS
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2001-06-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02244021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67964
SANDOZ CANDESARTAN PLUS
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-09-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02327902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81340
PMS-CANDESARTAN HCTZ
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-09-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02391295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87664
CANDESARTAN-HCTZ
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-10-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02392275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87755
CANDESARTAN/HCTZ
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-11-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02394804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87995
CANDESARTAN HCT
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02394812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87997
TEVA-CANDESARTAN/HCTZ
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-09-23;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88063
AURO-CANDESARTAN HCT
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2015-03-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02421038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90562
JAMP CANDESARTAN-HCT
candesartan cilexetil 16 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2020-02-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02473240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96264
ATACAND PLUS
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2009-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02332922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81858
TEVA-CANDESARTAN/HCTZ
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88064
SANDOZ CANDESARTAN PLUS
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-02-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02420732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90530
AURO-CANDESARTAN HCT
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2015-03-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02421046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90563
JAMP CANDESARTAN-HCT
candesartan cilexetil 32 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2020-02-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02473259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96265
ATACAND PLUS
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2009-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02332957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81859
SANDOZ CANDESARTAN PLUS
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2014-02-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02420740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90531
AURO-CANDESARTAN HCT
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2015-03-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02421054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90564
JAMP CANDESARTAN-HCT
candesartan cilexetil 32 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2020-02-17;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02473267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96266
DUODOPA
carbidopa (carbidopa monohydrate) 5 mg / ml , levodopa 20 mg / ml;
Number of active ingredients: 2.00;
2008-11-10;
Intraintestinal (Upper);
Gel;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
ABBVIE CORPORATION
DIN: 02292165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77753
APO-LEVOCARB – TAB 10MG/100MG
carbidopa 10 mg , levodopa 100 mg;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
APOTEX INC
DIN: 02195933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20189
TEVA-LEVOCARBIDOPA
carbidopa 10 mg , levodopa 100 mg;
Number of active ingredients: 2.00;
2002-07-05;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02244494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68470
APO-LEVOCARB-TAB 25MG/100MG
carbidopa 25 mg , levodopa 100 mg;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
APOTEX INC
DIN: 02195941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20239
TEVA-LEVOCARBIDOPA
carbidopa 25 mg , levodopa 100 mg;
Number of active ingredients: 2.00;
2002-07-05;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02244495
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68471
PRO-LEVOCARB – 100/25
carbidopa 25 mg , levodopa 100 mg;
Number of active ingredients: 2.00;
2008-07-04;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
PRO DOC LIMITEE
DIN: 02311178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79676
APO-LEVOCARB – TAB 25MG/250MG
carbidopa 25 mg , levodopa 250 mg;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
APOTEX INC
DIN: 02195968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20190
TEVA-LEVOCARBIDOPA
carbidopa 25 mg , levodopa 250 mg;
Number of active ingredients: 2.00;
2002-07-05;
Oral;
Tablet;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02244496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68472
CARBON DIOXIDE 7.1% W OXYGEN
carbon dioxide 12 % , oxygen 88 %;
Number of active ingredients: 2.00;
1990-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 00882755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11058
CARBON DIOXIDE, COMPRESSED AIR MEDICAL G.MIX.
carbon dioxide 15 % , air 85 %;
Number of active ingredients: 2.00;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13896
CARBOGEN
carbon dioxide 50 % , oxygen 50 %;
Number of active ingredients: 2.00;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
DIN: 02154749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19293
CARBON DIOXIDE USP, OXYGEN USP MEDICAL G.M.
carbon dioxide 7 % , oxygen 93 %;
Number of active ingredients: 2.00;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13910
CO-HE-O2-N2 MIXTURE
carbon monoxide 0.3 % , helium 10 % , oxygen 21 % , nitrogen 68.7 %;
Number of active ingredients: 4.00;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
DIN: 02154773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19101
CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.
carbon monoxide 0.3 % , helium 10.5 % , oxygen 21.5 % , nitrogen 67.7 %;
Number of active ingredients: 4.00;
1993-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13920
LUNG DIFFUSION TEST MIX NO NE CO
carbon monoxide 0.3 % , neon 0.5 % , oxygen 21 % , nitrogen 78.2 %;
Number of active ingredients: 4.00;
1968-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 00588075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8185
CO-NE-O2-N2 MIXTURE
carbon monoxide 0.3 % / v/v , neon 0.5 % / v/v , oxygen 21 % / v/v , nitrogen 78.2 % / v/v;
Number of active ingredients: 4.00;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
DIN: 02182238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19100
REFRESH OPTIVE FUSION
carboxymethylcellulose sodium 0.5 % , glycerine 0.9 %;
Number of active ingredients: 2.00;
2015-05-15;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 02435578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91991
REFRESH OPTIVE ADVANCED
carboxymethylcellulose sodium 0.5 % , glycerine 1 % , polysorbate 80 0.5 %;
Number of active ingredients: 3.00;
2013-03-06;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 02399148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88404
REFRESH OPTIVE FUSION SENSITIVE
carboxymethylcellulose sodium 0.5 % / w/v , glycerine 1 % / w/v;
Number of active ingredients: 2.00;
2016-04-26;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 02450534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93669
REFRESH OPTIVE ADVANCED SENSITIVE
carboxymethylcellulose sodium 0.5 % / w/v , glycerine 1 % / w/v , polysorbate 80 0.5 % / w/v;
Number of active ingredients: 3.00;
2014-10-14;
Ophthalmic;
Emulsion;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 02425815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91045
REFRESH OPTIVE GEL DROPS
carboxymethylcellulose sodium 1 % / w/v , glycerine 0.9 % / w/v;
Number of active ingredients: 2.00;
2017-07-28;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 02463652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95175
ORABASE PASTE
carboxymethylcellulose sodium 13.3 % , gelatin 13.3 % , pectin 13.3 %;
Number of active ingredients: 3.00;
1995-12-31;
Oral , Topical;
Paste;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
CONVATEC CANADA LTD.
DIN: 02035286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42486
ZERBAXA
ceftolozane (ceftolozane sulfate) 1 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
Number of active ingredients: 2.00;
2016-01-12;
Intravenous;
Powder For Solution;
08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
Prescription;
MERCK CANADA INC
DIN: 02446901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93248
REACTINE COMPLETE
cetirizine hydrochloride 5 mg , pseudoephedrine hydrochloride 120 mg;
Number of active ingredients: 2.00;
2003-03-07;
Oral;
Tablet (Extended-Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02246162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70312
LIBRAX
chlordiazepoxide hydrochloride 5 mg , clidinium bromide 2.5 mg;
Number of active ingredients: 2.00;
1961-12-31;
Oral;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
DIN: 00115630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=728
CHLORAX
chlordiazepoxide hydrochloride 5 mg , clidinium bromide 2.5 mg;
Number of active ingredients: 2.00;
1984-12-31;
Oral;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 00618454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6283
STERIGEL PLUS
chlorhexidine gluconate 0.5 % , alcohol anhydrous 70 %;
Number of active ingredients: 2.00;
1999-11-05;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02240800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64391
SOLUPREP QD WIPE
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
1994-12-31;
Topical (Hospital/Hc Facilities);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02060019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16494
SOLUPREP QD SWAB
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
1996-09-09;
Topical (Hospital/Hc Facilities);
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02119803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=30398
DEXIDIN 0.5 SOLUTION
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
2000-02-02;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LABORATOIRE ATLAS INC
DIN: 02240680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64263
CHLORHEXIDINE AND ISOPROPYL ALCOHOL SWABSTICKS
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
2001-06-14;
Topical;
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROFESSIONAL DISPOSABLES INTERNATIONAL INC.
DIN: 02243002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66842
CHLORHEXIDINE AND ISOPROPYL ALCOHOL PREP PADS
chlorhexidine gluconate 0.5 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
2001-06-14;
Topical;
Pad;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
PROFESSIONAL DISPOSABLES INTERNATIONAL INC.
DIN: 02243003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66843
SOLUPREP QD SOLUTION
chlorhexidine gluconate 0.5 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
1995-12-31;
Topical (Hospital/Hc Facilities);
Solution , Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02116472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19626
AVAGARD CHG
chlorhexidine gluconate 1 % , alcohol anhydrous 61 %;
Number of active ingredients: 2.00;
2003-07-02;
Topical (Hospital/Hc Facilities);
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02246888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71113
STANHEXIDINE 2% WITH ISOPROPYL ALCOHOL 4%
chlorhexidine gluconate 2 % , isopropyl alcohol 4 %;
Number of active ingredients: 2.00;
1992-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
DIN: 01938991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13289
STANHEXIDINE AQUEOUS 2% WITH 4% ISOPROPYL ALCOHOL
chlorhexidine gluconate 2 % , isopropyl alcohol 4 %;
Number of active ingredients: 2.00;
2002-12-04;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
DIN: 02246950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71177
BAXEDIN 2% – 70%
chlorhexidine gluconate 2 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
2004-07-07;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
DIN: 02251477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73640
LORIS – I.V.
chlorhexidine gluconate 2 % , isopropyl alcohol 70 %;
Number of active ingredients: 2.00;
2009-02-24;
Topical;
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LERNAPHARM (LORIS) INC.
DIN: 02297442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78280
CHLORAPREP ONE-STEP
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
1998-08-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CAREFUSION CANADA ULC
DIN: 02160757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34222
SOLUPREP
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
2002-08-02;
Topical (Hospital/Hc Facilities);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02240356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63898
SOLUPREP SWAB
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
2012-12-05;
Topical (Hospital/Hc Facilities);
Swab;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02382040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86791
SOLUPREP APPLICATOR
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
2013-01-17;
Topical (Hospital/Hc Facilities);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02382113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86799
SOLUPREP WIPE
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
2013-01-16;
Topical (Hospital/Hc Facilities);
Wipe;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02385708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87132
3M SOLUPREP SPONGE
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
2013-09-11;
Topical (Hospital/Hc Facilities);
Sponge;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
3M CANADA COMPANY
DIN: 02404125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88890
CHLORAPREP
chlorhexidine gluconate 2 % / w/v , isopropyl alcohol 70 % / v/v;
Number of active ingredients: 2.00;
2019-11-18;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BECTON DICKINSON CANADA INC.
DIN: 02484374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97469
STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%
chlorhexidine gluconate 4 % , isopropyl alcohol 4 %;
Number of active ingredients: 2.00;
1992-12-31;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
OMEGA LABORATORIES LTD
DIN: 01938983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13290
CHILDREN’S TYLENOL COLD AND COUGH
chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 4.00;
1997-08-12;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02039990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26864
BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER
chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 4.00;
2008-09-01;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02305496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79105
CHILDREN’S TYLENOL COMPLETE COLD, COUGH & FEVER
chlorpheniramine maleate 1 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml , acetaminophen 160 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 4.00;
2012-08-31;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02376474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86193
EXTRA STRENGTH COLD MEDICATION NIGHTTIME RELIEF
chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
Number of active ingredients: 4.00;
1995-12-31;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02039842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17887
BUCKLEY’S COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT
chlorpheniramine maleate 2 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
Number of active ingredients: 4.00;
2000-08-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02241592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65249
VICKS CHILDREN’S NYQUIL COLD & COUGH MULTI-SYMPTOM RELIEF
chlorpheniramine maleate 2 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml;
Number of active ingredients: 2.00;
2006-07-21;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02273330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75882
COLDASIDE COUGH & COLD
chlorpheniramine maleate 4 mg , dextromethorphan hydrobromide 30 mg;
Number of active ingredients: 2.00;
2009-01-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
DIN: 02309440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79504
ACETAZONE FORTE
chlorzoxazone 250 mg , acetaminophen 300 mg;
Number of active ingredients: 2.00;
1991-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
TEVA CANADA LIMITED
DIN: 00834300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11427
ACETAZONE FORTE C8
chlorzoxazone 250 mg , acetaminophen 300 mg , codeine phosphate 8 mg;
Number of active ingredients: 3.00;
1991-12-31;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00834319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11339
MICRO PLUS 4 REGULAR STRENGTH
chromium (chromic chloride) 4 mcg / ml , zinc (zinc sulfate) 1 mg / ml , copper (cupric sulfate) 0.4 mg / ml , manganese (manganese sulfate) 0.1 mg / ml;
Number of active ingredients: 4.00;
1996-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02091135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19923
INHIBACE PLUS
cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
1999-04-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 02181479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44252
APO-CILAZAPRIL/HCTZ
cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2006-08-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02284987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77051
TEVA-CILAZAPRIL/HCTZ
cilazapril (cilazapril monohydrate) 5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2009-03-30;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02313731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79924
CIPRODEX
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
Number of active ingredients: 2.00;
2004-05-13;
Otic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02252716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73758
TARO-CIPROFLOXACIN/DEXAMETHASONE
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
Number of active ingredients: 2.00;
2020-11-23;
Otic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02481901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97239
SANDOZ CIPROFLOXACIN / DEXAMETHASONE
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , dexamethasone 0.1 % / w/v;
Number of active ingredients: 2.00;
2021-01-26;
Otic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02506882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99623
OTIXAL
ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v , fluocinolone acetonide 0.025 % / w/v;
Number of active ingredients: 2.00;
2017-05-08;
Otic;
Solution;
52:04.04 – ANTIBACTERIALS , 08:12.18 – QUINOLONES , 52:08.08 – CORTICOSTEROIDS;
Prescription;
MEDEXUS PHARMACEUTICALS INC
DIN: 02459655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94696
PICO-SALAX
citric acid 12 g / sachet , magnesium oxide 3.5 g / sachet , sodium picosulfate 10 mg / sachet;
Number of active ingredients: 3.00;
2004-11-25;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Ethical;
FERRING INC
DIN: 02254794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73995
PURG-ODAN
citric acid 12 g / sachet , magnesium oxide 3.5 g / sachet , sodium picosulfate 10 mg / sachet;
Number of active ingredients: 3.00;
2009-02-16;
Oral;
Powder For Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Ethical;
ODAN LABORATORIES LTD
DIN: 02317966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80347
ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD)
citric acid 3.27 g / l , sodium citrate dihydrate 26.3 g / l , sodium phosphate monobasic 2.51 g / l , dextrose 25.5 g / l;
Number of active ingredients: 4.00;
2016-08-22;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
MACO PHARMA
DIN: 02444100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92893
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
citric acid monohydrate 0.8 g / 100 ml , dextrose 2.45 g / 100 ml , sodium citrate dihydrate 2.2 g / 100 ml;
Number of active ingredients: 3.00;
2018-06-20;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
TERUMO BCT, INC.
DIN: 02469731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95858
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
clavulanic acid (clavulanate potassium) 100 mg / vial , amoxicillin (amoxicillin sodium) 500 mg / vial;
Number of active ingredients: 2.00;
2020-07-03;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02495910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98581
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
clavulanic acid (clavulanate potassium) 200 mg / vial , amoxicillin (amoxicillin sodium) 1000 mg / vial;
Number of active ingredients: 2.00;
2020-07-03;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02495929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98582
AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
clavulanic acid (clavulanate potassium) 200 mg / vial , amoxicillin (amoxicillin sodium) 2000 mg / vial;
Number of active ingredients: 2.00;
2020-07-03;
Intravenous;
Powder For Solution;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02495937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98583
CLAVULIN 125 F ORAL SUS
clavulanic acid (clavulanate potassium) 31.25 mg / 5 ml , amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 01916882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15208
CLAVULIN 400
clavulanic acid (clavulanate potassium) 57 mg / 5 ml , amoxicillin (amoxicillin trihydrate) 400 mg / 5 ml;
Number of active ingredients: 2.00;
1998-10-29;
Oral;
Powder For Suspension;
08:12.16.08 – AMINOPENICILLINS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02238830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62268
BENZACLIN
clindamycin (clindamycin phosphate) 1 % / w/w , benzoyl peroxide 5 % / w/w;
Number of active ingredients: 2.00;
2004-05-04;
Topical;
Gel;
84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02248472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72824
TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT
clindamycin (clindamycin phosphate) 1 % / w/w , benzoyl peroxide 5 % / w/w;
Number of active ingredients: 2.00;
2017-07-24;
Topical;
Gel;
84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02464519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95265
BIACNA TOPICAL GEL
clindamycin phosphate 1.2 % / w/w , tretinoin 0.025 % / w/w;
Number of active ingredients: 2.00;
2011-05-16;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02359685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84468
LOCACORTEN VIOFORM
clioquinol 3 % , flumethasone pivalate 0.02 %;
Number of active ingredients: 2.00;
1968-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.92 – MISCELLANEOUS ANTIFUNGALS;
Prescription;
PALADIN LABS INC.
DIN: 00074462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=631
VIOFORM HYDROCORTISONE
clioquinol 3 % / w/w , hydrocortisone 1 % / w/w;
Number of active ingredients: 2.00;
1957-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:04.08.92 – MISCELLANEOUS ANTIFUNGALS;
Otc;
PALADIN LABS INC.
DIN: 00074500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=810
CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS
clotrimazole 1 % / w/w , clotrimazole 10 % / w/w;
Number of active ingredients: 2.00;
1997-06-11;
Topical , Vaginal;
Kit , Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
DIN: 02230509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49563
CANESTEN COMBI 3 DAY COMFORTAB + EXTERNAL CREAM
clotrimazole 200 mg / vtab , clotrimazole 1 % / w/w;
Number of active ingredients: 2.00;
2006-06-02;
Topical , Vaginal;
Vaginal Tablet , Kit , Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
DIN: 02264099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74951
CANESTEN COMBI 1 DAY COMFORTAB + EXTERNAL CREAM
clotrimazole 500 mg / vtab , clotrimazole 1 % / w/w;
Number of active ingredients: 2.00;
2006-05-12;
Topical , Vaginal;
Vaginal Tablet , Kit , Cream;
84:04.08.08 – AZOLES;
Otc;
BAYER INC
DIN: 02264102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74952
TARGEL SA
coal tar 10 % , salicylic acid 3 %;
Number of active ingredients: 2.00;
1980-12-31;
Topical;
Gel;
84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
DIN: 00510335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4037
DENOREX EXTRA STRENGTH MEDICATED SHAMPOO
coal tar 2.4 % / w/w , menthol 1.5 % / w/w , chloroxylenol 0.5 % / w/w;
Number of active ingredients: 3.00;
2007-04-20;
Topical;
Shampoo;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
NEOTERIC COSMETICS INC.
DIN: 02285703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77120
DENOREX EXTRA STRENGTH MEDICATED SHAMPOO WITH CONDITIONERS
coal tar 2.4 % / w/w , menthol 1.5 % / w/w , chloroxylenol 0.5 % / w/w;
Number of active ingredients: 3.00;
2007-04-20;
Topical;
Shampoo;
84:32.00 – KERATOPLASTIC AGENTS;
Otc;
NEOTERIC COSMETICS INC.
DIN: 02285711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77121
ROBAXISAL C 1/4
codeine phosphate 16.2 mg , methocarbamol 400 mg , acetylsalicylic acid 325 mg;
Number of active ingredients: 3.00;
1992-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01934783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12944
DAMYLIN WITH CODEINE SYRUP
codeine phosphate 3.3 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
Number of active ingredients: 3.00;
2002-09-13;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
DIN: 02245592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69689
COUGH AND ALLERGY SYRUP WITH CODEINE
codeine phosphate 3.3 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
Number of active ingredients: 3.00;
2019-10-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
DIN: 02486903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97706
COUGH SYRUP WITH CODEINE
codeine phosphate 3.3 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 3.00;
1995-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02099748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19625
CALMYLIN PSE WITH CODEINE
codeine phosphate 3.3 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 3.00;
1996-08-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02172917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34650
CALMYLIN
codeine phosphate 3.33 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
Number of active ingredients: 3.00;
1981-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00535230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4469
COUGH SYRUP
codeine phosphate 3.33 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
Number of active ingredients: 3.00;
1986-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00690074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6844
PMS-ACETAMINOPHEN WITH CODEINE ELIXIR
codeine phosphate 8 mg / 5 ml , acetaminophen 160 mg / 5 ml;
Number of active ingredients: 2.00;
1991-12-31;
Oral;
Elixir;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 00816027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11384
CYESTRA-35
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
2007-04-03;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PALADIN LABS INC.
DIN: 02290308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77558
TEVA-CYPROTERONE / ETHINYL ESTRADIOL
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
2008-09-26;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02309556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79517
TARO-CYPROTERONE/ETHINYL ESTRADIOL
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
2015-03-26;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02425017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90968
CLÉO -35
cyproterone acetate 2 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
2015-10-30;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ALTIUS HEALTHCARE INC
DIN: 02436736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92104
DIANE-35
cyproterone acetate 2 mg , ethinyl estradiol 35 mcg;
Number of active ingredients: 2.00;
1998-04-08;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BAYER INC
DIN: 02233542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=53444
XIGDUO
dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2016-02-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02449943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93581
XIGDUO
dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2016-02-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02449935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93580
PREZCOBIX
darunavir (darunavir ethanolate) 800 mg , cobicistat 150 mg;
Number of active ingredients: 2.00;
2014-08-28;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS , 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JANSSEN INC
DIN: 02426501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91108
SYMTUZA
darunavir (darunavir ethanolate) 800 mg , cobicistat 150 mg , emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg;
Number of active ingredients: 4.00;
2018-04-25;
Oral;
Tablet;
08:18.08 – ANTIRETROVIRALS;
Prescription;
JANSSEN INC
DIN: 02473720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96312
INQOVI
decitabine 35 mg , cedazuridine 100 mg;
Number of active ingredients: 2.00;
2020-11-11;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02501600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99121
SATIVEX
delta-9-tetrahydrocannabinol (cannabis sativa extract) 2.7 mg / act , cannabidiol (cannabis sativa extract) 2.5 mg / act;
Number of active ingredients: 2.00;
2005-06-22;
Buccal;
Spray;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
GW PHARMA LIMITED
DIN: 02266121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75157
ALLERGENIC EXTRACT, STANDARDIZED MITE MIXED
dermatophagoides farinae 5000 unit / ml , dermatophagoides pteronyssinus 5000 unit / ml;
Number of active ingredients: 2.00;
2006-02-28;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02270919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75630
ALLERGENIC EXTRACT – STANDARDIZED MITE MIX
dermatophagoides pteronyssinus 5000 unit / ml , dermatophagoides farinae 5000 unit / ml;
Number of active ingredients: 2.00;
2002-08-20;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02231325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50632
ACARIZAX
dermatophagoides pteronyssinus 6 unit , dermatophagoides farinae 6 unit;
Number of active ingredients: 2.00;
2017-11-06;
Sublingual;
Tablet;
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
DIN: 02463644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95174
AERIUS DOUBLE ACTION 12 HOUR
desloratadine 2.5 mg , pseudoephedrine sulfate 120 mg;
Number of active ingredients: 2.00;
2010-02-01;
Oral;
Tablet (Extended-Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
BAYER INC
DIN: 02309300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79491
MARVELON 21
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
1993-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
DIN: 02042487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14354
APRI 21
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2008-09-29;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02317192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80270
APRI 28
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2008-09-29;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02317206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80272
FREYA 21
desogestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2012-11-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02396491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88154
MIRVALA 21
desogestrel 0.15 mg / tab , ethinyl estradiol 0.03 mg / tab;
Number of active ingredients: 2.00;
2014-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02410249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89490
MIRVALA 28
desogestrel 0.15 mg / tab , ethinyl estradiol 0.03 mg / tab;
Number of active ingredients: 2.00;
2014-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02410257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89491
MAXITROL
dexamethasone 0.1 % / w/v , neomycin (neomycin sulfate) 3.5 mg / ml , polymyxin b sulfate 6000 unit / ml;
Number of active ingredients: 3.00;
1963-12-31;
Ophthalmic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00042676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=259
MAXITROL
dexamethasone 0.1 % / w/w , neomycin (neomycin sulfate) 3.5 mg / g , polymyxin b sulfate 6000 unit / g;
Number of active ingredients: 3.00;
1970-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00358177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2423
LMD 10% IN DEXTROSE 5%
dextran 10 % , dextrose 5 %;
Number of active ingredients: 2.00;
1968-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
DIN: 00224235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1744
LMD 10% IN 0.9% SODIUM CHLORIDE
dextran 10 % , sodium chloride 0.9 %;
Number of active ingredients: 2.00;
1968-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
DIN: 00224227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1743
TEARS NATURALE FORTE
dextran 70 0.1 % , glycerine 0.2 % , hypromellose 0.3 %;
Number of active ingredients: 3.00;
2003-01-02;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 02246397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70567
TEARS NATURALE II
dextran 70 0.1 % / w/v , hypromellose 0.3 % / w/v;
Number of active ingredients: 2.00;
1989-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 00743445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10032
VISINE FOR RED EYE TRIPLE ACTION
dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
Number of active ingredients: 4.00;
2005-03-08;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02248657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73019
ADVANCED RELIEF EYE DROPS
dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
Number of active ingredients: 4.00;
2010-08-30;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02344319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82979
VISINE FOR RED EYE WORKPLACE
dextran 70 0.1 % / w/v , polyethylene glycol 400 1 % / w/v , povidone 1 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
Number of active ingredients: 4.00;
2016-06-03;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02436086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92041
COLD & SINUS LIQUID FASTGELS
dextromethorphan hydrobromide 10 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2009-01-22;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02305356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79088
NYQUIL COMPLETE + VICKS VAPOCOOL
dextromethorphan hydrobromide 10 mg , doxylamine succinate 6.25 mg , phenylephrine hydrochloride 5 mg , acetaminophen 325 mg;
Number of active ingredients: 4.00;
2020-07-20;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02481928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97241
TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF
dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 4.00;
2009-08-18;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02295326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78062
BENYLIN ALL-IN-ONE COLD, FLU & COUGH LIQUID GELS
dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg , acetaminophen 250 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 4.00;
2010-08-11;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02345110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83056
ROBITUSSIN SUGAR FREE COUGH CONTROL
dextromethorphan hydrobromide 10 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 2.00;
2006-08-07;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02248568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72923
DAYTIME COLD & FLU LIQUID CAPSULES
dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 3.00;
2005-01-10;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02258919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74414
VICKS NYQUIL LIQUICAPS COLD & FLU MULTI-SYMPTOM RELIEF
dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
Number of active ingredients: 3.00;
2006-06-26;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02272792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75829
COMPLETE LIQUID CAPSULES NIGHTTIME RELIEF
dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 4.00;
2017-05-25;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02427923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91242
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
Number of active ingredients: 4.00;
2010-08-11;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02347652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83303
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
Number of active ingredients: 4.00;
2010-08-11;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02347660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83304
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU DAYTIME
dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , guaifenesin 100 mg , acetaminophen 500 mg;
Number of active ingredients: 4.00;
2011-08-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02365731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85062
VICKS NYQUIL COUGH
dextromethorphan hydrobromide 15 mg / 15 ml , doxylamine succinate 6.25 mg / 15 ml;
Number of active ingredients: 2.00;
2010-08-19;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
DIN: 02244662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68650
BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
Number of active ingredients: 4.00;
2003-07-03;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02245710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69814
EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
Number of active ingredients: 4.00;
2011-08-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02365774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85065
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF
dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , guaifenesin 100 mg / 15 ml , acetaminophen 500 mg / 15 ml;
Number of active ingredients: 4.00;
2011-08-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02366207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85106
BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 01944762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12449
BALMINIL DM + EXPECTORANT
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 2.00;
1997-02-04;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
DIN: 02201712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36293
DM-EXPECTORANT SYRUP
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 2.00;
2000-02-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02241491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65131
COUGH & CHEST CONGESTION
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 2.00;
2013-07-26;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02405938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89068
BALMINIL DM + EXPECTORANT EXTRA STRENGTH
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 2.00;
1998-03-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
DIN: 02233027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52514
DM EXPECTORANT (EXTRA STRENGTH) SYRUP
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 2.00;
2001-01-08;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02243010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66851
MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 2.00;
2013-09-20;
Oral;
Syrup;
48:16.00 – EXPECTORANTS , 48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02405857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89062
COUGH & CHEST CONGESTION EXTRA STRENGTH
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 2.00;
2013-08-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02405911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89067
BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
Number of active ingredients: 3.00;
2005-03-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02265419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75088
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL
dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
Number of active ingredients: 3.00;
2009-07-21;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02320959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80637
BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES
dextromethorphan hydrobromide 15 mg / 5 ml , menthol 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 3.00;
2015-07-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02436485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92082
BALMINIL DM + DECONGESTANT + EXPECTORANT
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 3.00;
1998-05-22;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
DIN: 02236915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60207
BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 3.00;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02003317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13440
ROBITUSSIN EXTRA STRENGTH COUGH & COLD
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 3.00;
1995-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02172380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19060
BALMINIL DM + DECONGESTANT + EXPECTORANT EXTRA STRENGTH
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 3.00;
1998-04-22;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
DIN: 02233026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52513
BENYLIN EXTRA STRENGTH COUGH COMPLETE
dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
Number of active ingredients: 4.00;
2005-09-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02265400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75087
ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION
dextromethorphan hydrobromide 20 mg / 20 ml , guaifenesin 400 mg / 20 ml;
Number of active ingredients: 2.00;
2019-08-01;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02485524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97576
NIGHTTIME COMPLETE
dextromethorphan hydrobromide 20 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , phenylephrine hydrochloride 10 mg / 30 ml;
Number of active ingredients: 4.00;
2018-12-20;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 52:24.00 – MYDRIATICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02458462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94559
DIMETAPP EXTRA STRENGTH DM COUGH & COLD
dextromethorphan hydrobromide 20 mg / 5 ml , brompheniramine maleate 4 mg / 5 ml , phenylephrine hydrochloride 10 mg / 5 ml;
Number of active ingredients: 3.00;
2002-08-01;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02245076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69080
ROBITUSSIN HONEY COUGH & COLD NIGHTTIME
dextromethorphan hydrobromide 30 mg / 20 ml , doxylamine succinate 12.5 mg / 20 ml;
Number of active ingredients: 2.00;
2019-08-01;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02485443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97569
NIGHTTIME COLD AND FLU RELIEF
dextromethorphan hydrobromide 30 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
Number of active ingredients: 3.00;
2013-02-06;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02378655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86446
NIGHTTIME COLD & FLU RELIEF
dextromethorphan hydrobromide 30 mg / 30 ml , acetaminophen 650 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml;
Number of active ingredients: 3.00;
2021-05-19;
Oral;
Solution;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
DIN: 02492857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98285
COLD FLU RELIEF
dextromethorphan hydrobromide 30 mg / 30 ml , doxylamine succinate 12.5 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , acetaminophen 1 g / 30 ml;
Number of active ingredients: 4.00;
1997-01-09;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02218836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37183
TOTAL COLD AND FLU EXTRA STRENGTH
dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , guaifenesin 200 mg / 30 ml , acetaminophen 1000 mg / 30 ml;
Number of active ingredients: 4.00;
2007-07-11;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02289385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77475
CHILDREN’S TYLENOL COLD AND COUGH NIGHTTIME
dextromethorphan hydrobromide 5 mg / 5 ml , acetaminophen 160 mg / 5 ml , diphenhydramine hydrochloride 6.25 mg / 5 ml;
Number of active ingredients: 3.00;
2006-08-31;
Oral;
Suspension;
48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02279150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76469
JACK & JILL COUGH & COLD
dextromethorphan hydrobromide 5 mg / 5 ml , phenylephrine hydrochloride 2.5 mg / 5 ml;
Number of active ingredients: 2.00;
2014-08-05;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02412357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89697
BENYLIN FOR CHILDREN COUGH & COLD
dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 01944746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12504
DM-DECONGESTANT CHILDREN’S SYRUP
dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 2.00;
2000-03-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02241492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65132
CHILDREN’S COUGH & COLD RELIEF
dextromethorphan hydrobromide 7.5 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 2.00;
2013-08-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02405903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89066
DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ
dextrose 10 g / 100 ml , sodium chloride 900 mg / 100 ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00060755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10441
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
dextrose 2.45 g / 100 ml , sodium citrate 2.2 g / 100 ml , citric acid 730 mg / 100 ml;
Number of active ingredients: 3.00;
1991-12-31;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
FRESENIUS KABI AG
DIN: 00788139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11376
DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION
dextrose 200 mg / 100 ml , sodium chloride 900 mg / 100 ml;
Number of active ingredients: 2.00;
1991-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00783641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12171
SCLERODEX
dextrose 250 mg / ml , sodium chloride 100 mg / ml;
Number of active ingredients: 2.00;
1977-12-31;
Intravenous;
Liquid;
24:16.00 – SCLEROSING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02020939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14183
POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE
dextrose 3.3 g / 100 ml , sodium chloride 0.3 g / 100 ml , potassium chloride 0.149 g / 100 ml;
Number of active ingredients: 3.00;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00472085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3538
DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ
dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00060712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10515
(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP
dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 3.00;
1978-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00438014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3132
(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP
dextrose 3.3 g / 100 ml , sodium chloride 300 mg / 100 ml , potassium chloride 300 mg / 100 ml;
Number of active ingredients: 3.00;
1978-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00438022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3133
3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE
dextrose 33.3 mg / ml , sodium chloride 3 mg / ml;
Number of active ingredients: 2.00;
1976-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2575
HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ
dextrose 5 g / 100 ml , heparin sodium 4000 unit / 100 ml;
Number of active ingredients: 2.00;
1996-09-10;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 02209713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36794
POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE
dextrose 5 g / 100 ml , potassium chloride 0.149 g / 100 ml;
Number of active ingredients: 2.00;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00466697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3536
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE
dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml;
Number of active ingredients: 2.00;
1983-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00606820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6400
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE
dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml , sodium chloride 0.45 g / 100 ml;
Number of active ingredients: 3.00;
1983-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00603244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6228
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE
dextrose 5 g / 100 ml , potassium chloride 0.3 g / 100 ml , sodium chloride 0.9 g / 100 ml;
Number of active ingredients: 3.00;
2008-04-07;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 02299135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78453
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP
dextrose 5 g / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 2.00;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00438049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10041
(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP
dextrose 5 g / 100 ml , potassium chloride 300 mg / 100 ml;
Number of active ingredients: 2.00;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00438030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10042
POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE
dextrose 5 g / 100 ml , sodium chloride 0.45 g / 100 ml , potassium chloride 0.149 g / 100 ml;
Number of active ingredients: 3.00;
1979-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00466670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3534
DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ
dextrose 5 g / 100 ml , sodium chloride 200 mg / 100 ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00060704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10438
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP
dextrose 5 g / 100 ml , sodium chloride 200 mg / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 3.00;
1998-09-03;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01931598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=21753
DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00060739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10439
5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml;
Number of active ingredients: 2.00;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01927531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13033
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 3.00;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00437999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10044
(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
dextrose 5 g / 100 ml , sodium chloride 450 mg / 100 ml , potassium chloride 300 mg / 100 ml;
Number of active ingredients: 3.00;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00438006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10045
DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ
dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00060747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10440
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP
dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 3.00;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00786292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10866
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR
dextrose 5 g / 100 ml , sodium chloride 900 mg / 100 ml , potassium chloride 300 mg / 100 ml;
Number of active ingredients: 3.00;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 00786306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10867
HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML
dextrose 5 g / 100 ml , sodium phosphate dibasic 410 mg / 100 ml , citric acid 93 mg / 100 ml , heparin sodium 5000 unit / 100 ml;
Number of active ingredients: 4.00;
1993-12-31;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01935941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16794
5% DEXTROSE AND 0.225% SODIUM CHLORIDE
dextrose 50 mg / ml , sodium chloride 2.25 mg / ml;
Number of active ingredients: 2.00;
1955-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1751
5% DEXTROSE AND 0.45% SODIUM CHLORIDE
dextrose 50 mg / ml , sodium chloride 4.5 mg / ml;
Number of active ingredients: 2.00;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1750
5% DEXTROSE AND 0.9% SODIUM CHLORIDE
dextrose 50 mg / ml , sodium chloride 9 mg / ml;
Number of active ingredients: 2.00;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1747
5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP
dextrose 50 mg / ml , sodium chloride 9 mg / ml;
Number of active ingredients: 2.00;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01924435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13288
GASTROGRAFIN – LIQ ORL
diatrizoate meglumine 66 % , diatrizoate sodium 10 %;
Number of active ingredients: 2.00;
1978-12-30;
Oral;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
DIN: 02228564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37570
ODAN PROCTOMYXIN HC SUPPOSITORIES
dibucaine hydrochloride 5 mg , esculin 10 mg , hydrocortisone 5 mg , framycetin sulfate 10 mg;
Number of active ingredients: 4.00;
2001-01-05;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02242528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66276
TEVA-PROCTOSONE
dibucaine hydrochloride 5 mg , framycetin sulfate 10 mg , hydrocortisone (hydrocortisone acetate) 5 mg , esculin 10 mg;
Number of active ingredients: 4.00;
1996-12-30;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02226391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37455
CERUMOL
dichlorobenzene 2 % , oil of turpentine 10 % , peanut oil 57 % , chlorobutanol 5 %;
Number of active ingredients: 4.00;
1971-12-31;
Otic;
Drops;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
THORNTON & ROSS LTD
DIN: 00221570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1103
ANTIBACTERIAL THROAT LOZENGES
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg;
Number of active ingredients: 2.00;
2013-03-07;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
QUIMICA CANADA LIMITED
DIN: 02375567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86098
CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg , levomenthol 8 mg;
Number of active ingredients: 3.00;
2012-07-19;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02382881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86869
CEPACOL SENSATIONS SORE THROAT & COUGH
dichlorobenzyl alcohol 1.2 mg , amylmetacresol 0.6 mg , menthol 8 mg;
Number of active ingredients: 3.00;
2012-09-04;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02388642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87415
ARTHROTEC 50
diclofenac sodium 50 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
1993-12-31;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PFIZER CANADA ULC
DIN: 01917056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13636
GD-DICLOFENAC/MISOPROSTOL 50
diclofenac sodium 50 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
2014-07-22;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
GENMED A DIVISION OF PFIZER CANADA ULC
DIN: 02341689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82718
PMS-DICLOFENAC-MISOPROSTOL
diclofenac sodium 50 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
2018-12-11;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PHARMASCIENCE INC
DIN: 02413469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89812
ARTHROTEC 75
diclofenac sodium 75 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
1996-11-11;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PFIZER CANADA ULC
DIN: 02229837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48191
GD-DICLOFENAC/MISOPROSTOL 75
diclofenac sodium 75 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
2014-07-22;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
GENMED A DIVISION OF PFIZER CANADA ULC
DIN: 02341697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82719
PMS-DICLOFENAC-MISOPROSTOL
diclofenac sodium 75 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
2018-12-11;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.28 – PROSTAGLANDINS;
Prescription;
PHARMASCIENCE INC
DIN: 02413477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89813
HUMATROPE
diluent 3.15 ml , somatropin 12 mg;
Number of active ingredients: 2.00;
2001-08-28;
Intramuscular , Subcutaneous;
Liquid , Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02243078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66944
HUMATROPE
diluent 3.15 ml , somatropin 24 mg;
Number of active ingredients: 2.00;
2003-12-08;
Intramuscular , Subcutaneous;
Liquid , Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02243079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66945
HUMATROPE
diluent 3.15 ml , somatropin 6 mg;
Number of active ingredients: 2.00;
2001-09-25;
Intramuscular , Subcutaneous;
Liquid , Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02243077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66943
BAZA PROTECT II
dimethicone 1 % / w/w , zinc oxide 12 % / w/w;
Number of active ingredients: 2.00;
2009-05-20;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
COLOPLAST A/S
DIN: 02315793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80131
ABC ARBONNE BABY CARE DIAPER RASH CREAM
dimethicone 1 % / w/w , zinc oxide 12 % / w/w;
Number of active ingredients: 2.00;
2014-09-25;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ARBONNE INTERNATIONAL LLC
DIN: 02417693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90232
ADVIL COLD & FLU
diphenhydramine citrate 38 mg , ibuprofen 200 mg;
Number of active ingredients: 2.00;
2011-10-27;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02362643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84765
BALMINIL NIGHT-TIME
diphenhydramine hydrochloride 12.5 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , ammonium chloride 125 mg / 5 ml;
Number of active ingredients: 3.00;
2001-03-20;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
DIN: 02242999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66839
BENADRYL SPRAY
diphenhydramine hydrochloride 2 % , zinc acetate 0.1 %;
Number of active ingredients: 2.00;
2007-03-09;
Topical;
Spray;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02280876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76655
BENADRYL ITCH STOPPING CREAM
diphenhydramine hydrochloride 2 % , zinc acetate 0.1 %;
Number of active ingredients: 2.00;
2020-01-13;
Topical;
Cream;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02484838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97511
BENADRYL BUG BITE RELIEF
diphenhydramine hydrochloride 2 % / w/v , zinc acetate 0.1 % / w/v;
Number of active ingredients: 2.00;
2007-03-09;
Topical;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02280868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76653
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME
diphenhydramine hydrochloride 25 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2018-02-23;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRES TRIANON INC.
DIN: 02238183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61574
EXTRA STRENGTH FLU RELIEF NIGHTIME
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2004-01-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02248700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73064
BENADRYL ALLERGY, SINUS & PAIN TOTAL
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2004-10-15;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02250993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73592
EXTRA STRENGTH ALLERGY TOTAL
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2008-03-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02303833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78913
NIGHTTIME TOTAL COLD AND FLU
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2009-03-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02305305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79084
NIGHTTIME FLU, COUGH & COLD COMPLETE RELIEF EXTRA STRENGTH
diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2014-07-16;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02404974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88980
NEOCITRAN EXTRA STRENGTH TOTAL COLD NIGHT
diphenhydramine hydrochloride 25 mg / sachet , phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet;
Number of active ingredients: 3.00;
2015-08-04;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02409178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89389
JACK & JILL BEDTIME COUGH & COLD
diphenhydramine hydrochloride 6.25 mg / 5 ml , phenylephrine hydrochloride 2.5 mg / 5 ml;
Number of active ingredients: 2.00;
2014-08-05;
Oral;
Syrup;
04:04.04 – ETHANOLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02412349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89696
LOMOTIL
diphenoxylate hydrochloride 2.5 mg , atropine sulfate 0.025 mg;
Number of active ingredients: 2.00;
1960-12-31;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Narcotic (Cdsa I);
PFIZER CANADA ULC
DIN: 00036323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=937
TD ADSORBED
diphtheria toxoid adsorbed 2 lf / 0.5 ml , tetanus toxoid adsorbed 5 lf / 0.5 ml;
Number of active ingredients: 2.00;
1980-12-31;
Intramuscular;
Suspension;
80:08.00 – TOXOIDS;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 00514462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4109
TARO-DIPYRIDAMOLE/ ASA
dipyridamole 200 mg , acetylsalicylic acid 25 mg;
Number of active ingredients: 2.00;
2018-11-27;
Oral;
Capsule (Immediate And Extended Release);
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS , 28:08.04.24 – SALICYLATES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02471051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96015
SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS
docusate sodium 50 mg , sennosides 8.6 mg;
Number of active ingredients: 2.00;
2003-03-07;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02247134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71374
TRIUMEQ
dolutegravir (dolutegravir sodium) 50 mg , abacavir (abacavir sulfate) 600 mg , lamivudine 300 mg;
Number of active ingredients: 3.00;
2014-10-22;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02430932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91536
DOVATO
dolutegravir (dolutegravir sodium) 50 mg , lamivudine 300 mg;
Number of active ingredients: 2.00;
2019-09-09;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02491753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98173
JULUCA
dolutegravir (dolutegravir sodium) 50 mg , rilpivirine (rilpivirine hydrochloride) 25 mg;
Number of active ingredients: 2.00;
2018-06-04;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02475774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96645
DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP
dopamine hydrochloride 0.8 mg / ml , dextrose 50 mg / ml;
Number of active ingredients: 2.00;
1992-12-31;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
BAXTER CORPORATION
DIN: 00761850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12256
DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP
dopamine hydrochloride 1.6 mg / ml , dextrose 50 mg / ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
BAXTER CORPORATION
DIN: 00761826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11625
DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP
dopamine hydrochloride 3.2 mg / ml , dextrose 50 mg / ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
BAXTER CORPORATION
DIN: 00761834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11624
DELSTRIGO
doravirine 100 mg , lamivudine 300 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2018-12-10;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02482592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97302
COSOPT
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
1999-05-27;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 02240113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63627
COSOPT
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2005-11-02;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 02258692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74388
APO-DORZO-TIMOP
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2010-12-15;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02299615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78499
SANDOZ DORZOLAMIDE/TIMOLOL
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2010-10-25;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02344351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82984
ACT DORZOTIMOLOL
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2013-05-01;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02404389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88915
MED-DORZOLAMIDE-TIMOLOL
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2016-05-17;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02437686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92207
RIVA-DORZOLAMIDE/TIMOLOL
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2015-07-22;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02441659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92604
JAMP DORZOLAMIDE-TIMOLOL
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2019-12-13;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02457539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94459
DORZOLAMIDE AND TIMOLOL EYE DROPS BP
dorzolamide (dorzolamide hydrochloride) 20 mg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2020-05-01;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
TELIGENT CANADA INC
DIN: 02489635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97971
DICLECTIN
doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
Number of active ingredients: 2.00;
1983-12-31;
Oral;
Tablet (Delayed-Release);
56:22.08 – ANTIHISTAMINES;
Prescription;
DUCHESNAY INC
DIN: 00609129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5509
PMS-DOXYLAMINE-PYRIDOXINE
doxylamine succinate 10 mg , pyridoxine hydrochloride 10 mg;
Number of active ingredients: 2.00;
2017-07-10;
Oral;
Tablet (Delayed-Release);
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02406187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89091
SINUS MEDICATION
doxylamine succinate 6.25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2003-03-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02245016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69017
ANGELIQ
drospirenone 1 mg , estradiol 1 mg;
Number of active ingredients: 2.00;
2008-10-20;
Oral;
Tablet;
68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
Prescription;
BAYER INC
DIN: 02268825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75422
YAZ
drospirenone 3 mg , ethinyl estradiol 0.02 mg;
Number of active ingredients: 2.00;
2009-01-06;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
DIN: 02321157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80656
MYA
drospirenone 3 mg , ethinyl estradiol 0.02 mg;
Number of active ingredients: 2.00;
2014-05-20;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02415380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89999
YAZ PLUS
drospirenone 3 mg , ethinyl estradiol 0.02 mg , levomefolate calcium 0.451 mg , levomefolate calcium 0.451 mg;
Number of active ingredients: 4.00;
2013-03-01;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
DIN: 02387433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87302
YASMIN 21
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2004-12-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
DIN: 02261723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74710
YASMIN 28
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2004-12-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
DIN: 02261731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74711
ZAMINE 21
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2014-01-30;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02410788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89544
ZAMINE 28
drospirenone 3 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2014-01-30;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02410796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89545
JALYN
dutasteride 0.5 mg , tamsulosin hydrochloride 0.4 mg;
Number of active ingredients: 2.00;
2011-11-17;
Oral;
Capsule (Immediate And Extended Release);
92:08.00 – 5 ALFA REDUCTASE INHIBITORS , 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02372010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85714
ATRIPLA
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2007-10-23;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES, LLC
DIN: 02300699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78602
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2017-07-26;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02393549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87876
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2017-07-31;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02461412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94902
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2018-09-04;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02468247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95665
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2020-03-18;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02478404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96916
SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2019-09-30;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02484676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97496
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
efavirenz 600 mg , emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2019-10-29;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02487284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97744
ZEPATIER
elbasvir 50 mg , grazoprevir 100 mg;
Number of active ingredients: 2.00;
2016-01-25;
Oral;
Tablet;
08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
MERCK CANADA INC
DIN: 02451131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93740
GLYXAMBI
empagliflozin 10 mg , linagliptin 5 mg;
Number of active ingredients: 2.00;
2016-12-21;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02459752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94707
SYNJARDY
empagliflozin 12.5 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02456621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94362
SYNJARDY
empagliflozin 12.5 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02456605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94360
SYNJARDY
empagliflozin 12.5 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02456613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94361
GLYXAMBI
empagliflozin 25 mg , linagliptin 5 mg;
Number of active ingredients: 2.00;
2016-12-21;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS , 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02459760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94709
SYNJARDY
empagliflozin 5 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02456591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94359
SYNJARDY
empagliflozin 5 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02456575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94357
SYNJARDY
empagliflozin 5 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2016-08-03;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02456583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94358
GENVOYA
emtricitabine 200 mg , elvitegravir 150 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg , cobicistat 150 mg;
Number of active ingredients: 4.00;
2016-02-03;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02449498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93532
ODEFSEY
emtricitabine 200 mg , rilpivirine (rilpivirine hydrochloride) 25 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
Number of active ingredients: 3.00;
2017-03-20;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02461463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94909
COMPLERA
emtricitabine 200 mg , rilpivirine (rilpivirine hydrochloride) 25 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 3.00;
2011-10-20;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02374129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85932
DESCOVY
emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg;
Number of active ingredients: 2.00;
2016-06-03;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02454416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94099
DESCOVY
emtricitabine 200 mg , tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
Number of active ingredients: 2.00;
2016-06-03;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02454424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94100
TEVA-EMTRICITABINE/TENOFOVIR
emtricitabine 200 mg , tenofovir disoproxil fumarate 300 mg;
Number of active ingredients: 2.00;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02399059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88396
ENALAPRIL MALEATE/HCTZ
enalapril maleate 10 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-02-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AA PHARMA INC
DIN: 02352931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83817
ENALAPRIL MALEATE/HCTZ
enalapril maleate 5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-02-24;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AA PHARMA INC
DIN: 02352923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83816
VASERETIC
enalapril sodium (enalapril maleate) 8 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
1990-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 00657298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10913
MARCELLE/MULTI-DEFENSE CREAM/CRÈME MULTI-DÉFENSE/SPF 15 FPS
ensulizole 2 % , meradimate 4 % , octinoxate 7.5 %;
Number of active ingredients: 3.00;
1994-12-31;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02093014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42377
MARCELLE/ OIL FREE MULTI-DÉFENSE LOTION SPF 15 FPS/ FLUIDE MULTI-DÉFENSE SANS HUILE
ensulizole 2 % , octinoxate 7.5 % , meradimate 4 %;
Number of active ingredients: 3.00;
1994-12-31;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02093006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42376
ARTISTRY EXACT FIT BEAUTY BALM PERFECTING PRIMER
ensulizole 2 % / w/w , octinoxate 5 % / w/w , zinc oxide 5.49 % / w/w;
Number of active ingredients: 3.00;
2015-09-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02434865
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91916
SOOTHING DAY CREAM
ensulizole 2.25 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02466600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95494
SEPTANEST SP
epinephrine (epinephrine bitartrate) 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
Number of active ingredients: 2.00;
1994-12-31;
Block/Infiltration;
Solution;
52:32.00 – VASOCONSTRICTORS , 72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02123398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16850
ZORCAINE
epinephrine (epinephrine bitartrate) 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
Number of active ingredients: 2.00;
2019-07-24;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02474239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96424
LIDOCAINE 2% AND EPINEPHRINE 1:100,000
epinephrine (epinephrine bitartrate) 0.01 mg / ml , lidocaine hydrochloride 20 mg / ml;
Number of active ingredients: 2.00;
2019-04-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02473518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96290
LIDOCAINE 2% AND EPINEPHRINE 1:50,000
epinephrine (epinephrine bitartrate) 0.02 mg / ml , lidocaine hydrochloride 20 mg / ml;
Number of active ingredients: 2.00;
2019-05-10;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02473526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96291
SENSORCAINE WITH EPINEPHRINE
epinephrine (epinephrine bitartrate) 5 mcg / ml , bupivacaine hydrochloride 2.5 mg / ml;
Number of active ingredients: 2.00;
1994-12-31;
Block/Infiltration , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 01976184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16162
ULTRACAINE D-S FORTE INJECTION
epinephrine 0.01 mg / ml , articaine hydrochloride 40 mg / ml;
Number of active ingredients: 2.00;
1993-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
HANSAMED LIMITED
DIN: 01988557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16511
ULTRACAINE D-S INJECTION
epinephrine 5 mcg / ml , articaine hydrochloride 40 mg / ml;
Number of active ingredients: 2.00;
1994-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
HANSAMED LIMITED
DIN: 01988530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16508
TEVETEN PLUS
eprosartan (eprosartan mesylate) 600 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2004-07-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BGP PHARMA ULC
DIN: 02253631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73859
BENZAMYCIN
erythromycin 3 % / w/w , benzoyl peroxide 5 % / w/w;
Number of active ingredients: 2.00;
1996-11-05;
Topical;
Gel;
84:04.04 – ANTIBIOTICS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02225271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43428
NEXTSTELLIS
estetrol monohydrate 15 mg , drospirenone 3 mg;
Number of active ingredients: 2.00;
2021-06-15;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
SEARCHLIGHT PHARMA INC
DIN: 02513218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100241
ACTIVELLE LD
estradiol 0.5 mg , norethindrone acetate 0.1 mg;
Number of active ingredients: 2.00;
2008-05-16;
Oral;
Tablet;
68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
Prescription;
NOVO NORDISK CANADA INC
DIN: 02309009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79461
ACTIVELLE
estradiol 1 mg , norethindrone acetate 0.5 mg;
Number of active ingredients: 2.00;
2008-05-16;
Oral;
Tablet;
68:32.00 – PROGESTINS , 68:16.04 – ESTROGENS;
Prescription;
NOVO NORDISK CANADA INC
DIN: 02249405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73420
ESTALIS 140/50 MCG
estradiol 50 mcg / 24 hour , norethindrone acetate 140 mcg / 24 hour;
Number of active ingredients: 2.00;
2000-05-25;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02241835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65502
ESTALIS 250/50 MCG
estradiol 50 mcg / 24 hour , norethindrone acetate 250 mcg / 24 hour;
Number of active ingredients: 2.00;
2000-05-25;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02241837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65503
ENBREL
etanercept 25 mg / kit , water 1 ml / kit;
Number of active ingredients: 2.00;
2001-03-14;
Subcutaneous;
Kit , Liquid , Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
IMMUNEX CORPORATION
DIN: 02242903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66735
SEASONIQUE
ethinyl estradiol 0.01 mg , levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 3.00;
2011-04-18;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02346176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83160
MARVELON 28
ethinyl estradiol 0.03 mg , desogestrel 0.15 mg;
Number of active ingredients: 2.00;
1993-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
DIN: 02042479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14355
FREYA 28
ethinyl estradiol 0.03 mg , desogestrel 0.15 mg;
Number of active ingredients: 2.00;
2012-11-22;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02396610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88165
BREVICON 0.5/35 TABLETS (21-DAY PACK)
ethinyl estradiol 0.035 mg , norethindrone 0.5 mg;
Number of active ingredients: 2.00;
1976-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02187086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20162
BREVICON 0.5/35 TABLETS (28-DAY PACK)
ethinyl estradiol 0.035 mg , norethindrone 0.5 mg;
Number of active ingredients: 2.00;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02187094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42888
SYNPHASIC 28 TABLETS
ethinyl estradiol 0.035 mg , norethindrone 0.5 mg , ethinyl estradiol 0.035 mg , norethindrone 1 mg;
Number of active ingredients: 4.00;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02187116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42890
SELECT 1/35 (28-DAY)
ethinyl estradiol 0.035 mg , norethindrone 1 mg;
Number of active ingredients: 2.00;
1997-05-08;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02199297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42960
NUVARING
etonogestrel 11.4 mg , ethinyl estradiol 2.6 mg;
Number of active ingredients: 2.00;
2004-12-02;
Vaginal;
Ring (Slow-Release);
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
DIN: 02253186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73815
DEMO-CINEOL ENFANTS/CHILDREN
eucalyptol 185 mg , guaiacol 90 mg , camphor 20 mg , guaiacol carbonate 100 mg;
Number of active ingredients: 4.00;
1977-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
DIN: 00319724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2787
PEPCID COMPLETE
famotidine 10 mg , calcium carbonate 800 mg , magnesium hydroxide 165 mg;
Number of active ingredients: 3.00;
2001-05-14;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS , 56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02243053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66915
ALLEGRA-D
fexofenadine hydrochloride 60 mg , pseudoephedrine hydrochloride 120 mg;
Number of active ingredients: 2.00;
1999-04-29;
Oral;
Tablet (Immediate And Extended Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02239853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63341
EVICEL
fibrinogen (human) 90 mg / ml , thrombin (human) 1200 unit / ml;
Number of active ingredients: 2.00;
2011-03-01;
Topical;
Solution , Kit;
20:28.16 – HEMOSTATICS;
Schedule D;
OMRIX BIOPHARMACEUTICALS LTD
DIN: 02348497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83385
CANESORAL COMBI 1 DAY
fluconazole 150 mg , clotrimazole 2 % / w/w;
Number of active ingredients: 2.00;
2020-02-14;
Oral , Topical;
Capsule , Cream;
#N/A;
Otc;
BAYER INC
DIN: 02490935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98097
MONICURE COMBO
fluconazole 150 mg , miconazole nitrate 2 %;
Number of active ingredients: 2.00;
2012-10-25;
Oral , Topical;
Kit , Capsule , Cream;
84:04.08.08 – AZOLES , 08:14.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02382628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86844
CANESORAL COMBI
fluconazole 150 mg / cap , clotrimazole 1 %;
Number of active ingredients: 2.00;
2010-03-10;
Oral , Topical , Vaginal;
Capsule , Cream;
08:14.08 – AZOLES;
Otc;
BAYER INC
DIN: 02311739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79728
CLOTRIMADERM-FLUCONAZOLE COMBI-PACK
fluconazole 150 mg / cap , clotrimazole 1 % / w/w;
Number of active ingredients: 2.00;
2017-02-14;
Oral , Topical;
Kit , Capsule , Cream;
08:14.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02445131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93036
CLOTRIMAZOLE-FLUCONAZOLE COMBI
fluconazole 150 mg / cap , clotrimazole 1 % / w/w;
Number of active ingredients: 2.00;
2017-02-03;
Oral , Topical;
Kit , Capsule , Cream;
08:14.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02451727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93803
LOCACORTEN VIOFORM EARDROPS
flumethasone pivalate 0.02 % , clioquinol 1 %;
Number of active ingredients: 2.00;
1969-12-31;
Otic;
Drops;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
PALADIN LABS INC.
DIN: 00074454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=868
ACTIKERALL
fluorouracil 0.5 % / w/w , salicylic acid 10 % / w/w;
Number of active ingredients: 2.00;
2016-02-19;
Topical;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02428946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91338
TRELEGY ELLIPTA
fluticasone furoate 100 mcg / act , umeclidinium (umeclidinium bromide) 62.5 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
Number of active ingredients: 3.00;
2018-05-30;
Inhalation;
Powder;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02474522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96469
BREO ELLIPTA
fluticasone furoate 200 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
Number of active ingredients: 2.00;
2015-10-02;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02444186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92906
PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI
fluticasone propionate 100 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
Number of active ingredients: 2.00;
2020-03-05;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02494507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98451
WIXELA INHUB
fluticasone propionate 100 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
Number of active ingredients: 2.00;
2020-02-13;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02495597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98549
PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI
fluticasone propionate 250 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
Number of active ingredients: 2.00;
2020-03-05;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02494515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98452
WIXELA INHUB
fluticasone propionate 250 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
Number of active ingredients: 2.00;
2020-02-13;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02495600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98550
DYMISTA
fluticasone propionate 50 mcg / act , azelastine hydrochloride 137 mcg / act;
Number of active ingredients: 2.00;
2015-03-31;
Nasal;
Spray, Metered Dose;
52:02.00 – ANTIALLERGIC AGENTS , 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Prescription;
BGP PHARMA ULC
DIN: 02432889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91729
PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI
fluticasone propionate 500 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
Number of active ingredients: 2.00;
2020-03-05;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02494523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98453
WIXELA INHUB
fluticasone propionate 500 mcg / act , salmeterol (salmeterol xinafoate) 50 mcg / act;
Number of active ingredients: 2.00;
2020-02-13;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02495619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98551
SOFRAMYCIN NASAL SPRAY
framycetin sulfate 12.5 mg / ml , gramicidin 0.05 mg / ml , phenylephrine hydrochloride 2.5 mg / ml;
Number of active ingredients: 3.00;
2001-05-04;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Prescription;
ERFA CANADA 2012 INC
DIN: 02224860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37384
SOFRACORT
framycetin sulfate 5 mg / ml , dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg / ml , gramicidin 0.05 mg / ml;
Number of active ingredients: 3.00;
2002-07-26;
Ophthalmic , Otic;
Drops;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02224623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37363
FUCIDIN H
fusidic acid 2 % , hydrocortisone acetate 1 %;
Number of active ingredients: 2.00;
1998-11-11;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02238578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62005
FUCIBET
fusidic acid 2 % / w/w , betamethasone (betamethasone valerate) 0.1 % / w/w;
Number of active ingredients: 2.00;
2018-10-03;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02474883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96510
VALISONE-G
gentamicin (gentamicin sulfate) 0.1 % / w/w , betamethasone (betamethasone valerate) 0.1 % / w/w;
Number of active ingredients: 2.00;
1972-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00232351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1285
ARTIFICIAL TEARS
glycerine 0.2 % / w/v , hypromellose 0.2 % / w/v;
Number of active ingredients: 2.00;
2011-04-19;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
TEVA CANADA LIMITED
DIN: 02354535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83970
DRY EYE TEARS
glycerine 0.2 % / w/v , hypromellose 0.2 % / w/v;
Number of active ingredients: 2.00;
2014-02-12;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
TEVA CANADA LIMITED
DIN: 02389886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87535
SOOTHE DRY EYES
glycerine 0.3 % / w/v , propylene glycol 1 % / w/v;
Number of active ingredients: 2.00;
2004-12-01;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
DIN: 02242370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66081
LUBRICANT EYE DROPS/ ARTIFICIAL TEARS
glycerine 0.3 % / w/v , propylene glycol 1 % / w/v;
Number of active ingredients: 2.00;
2009-08-25;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
DIN: 02321696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80709
PH 12 STERILE DILUENT FOR FLOLAN
glycine 94 mg / vial , sodium chloride 73.3 mg / vial , water 50 ml / vial;
Number of active ingredients: 3.00;
2016-08-04;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
GLAXOSMITHKLINE INC
DIN: 02443651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92834
OPTIMYXIN
gramicidin 0.025 mg / ml , polymyxin b (polymyxin b sulfate) 10000 unit / ml;
Number of active ingredients: 2.00;
1989-12-31;
Ophthalmic , Otic;
Drops;
52:04.04 – ANTIBACTERIALS;
Otc;
EURO-PHARM INTERNATIONAL CANADA INC
DIN: 00701785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10025
DEMO-CINEOL ADULTES/ADULTS
guaiacol 180 mg , eucalyptol 370 mg , camphor 40 mg , guaiacol carbonate 200 mg;
Number of active ingredients: 4.00;
1986-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
DIN: 00319716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6645
CREO-RECTAL ENFANTS/CHILDREN
guaiacol carbonate 200 mg , diphenylpyraline hydrochloride 0.5 mg , camphor 2 mg;
Number of active ingredients: 3.00;
1951-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
DIN: 00299596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2150
CREO-RECTAL ADULTES/ADULTS
guaiacol carbonate 600 mg , diphenylpyraline hydrochloride 1.5 mg , camphor 5 mg;
Number of active ingredients: 3.00;
1951-12-31;
Rectal;
Suppository;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRES CONFAB INC
DIN: 00299561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2148
ROBITUSSIN COUGH CONTROL
guaifenesin 100 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
Number of active ingredients: 2.00;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01931024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13296
ROBITUSSIN COUGH AND COLD
guaifenesin 100 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml;
Number of active ingredients: 3.00;
1994-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02068419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16698
BUCKLEY’S CHEST CONGESTION
guaifenesin 100 mg / 5 ml , menthol 10 mg / 5 ml;
Number of active ingredients: 2.00;
2007-08-07;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02289164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77454
BUCKLEY’S MUCUS & PHLEGM
guaifenesin 100 mg / 5 ml , menthol 10 mg / 5 ml;
Number of active ingredients: 2.00;
2010-08-02;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02346451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83190
CALMYLIN ACE
guaifenesin 100 mg / 5 ml , pheniramine maleate 7.5 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
Number of active ingredients: 3.00;
1996-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02198630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19690
VICKS DAYQUIL COUGH COUGH & CONGESTION
guaifenesin 200 mg / 15 ml , dextromethorphan hydrobromide 10 mg / 15 ml;
Number of active ingredients: 2.00;
2009-09-18;
Oral;
Liquid;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02323907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80938
ROBITUSSIN EXTRA STRENGTH COUGH CONTROL
guaifenesin 200 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02142775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19026
BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD
guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
Number of active ingredients: 2.00;
2005-09-30;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02265427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75089
BENYLIN EXTRA STRENGTH SORE THROAT & COUGH
guaifenesin 200 mg / 5 ml , menthol 15 mg / 5 ml;
Number of active ingredients: 2.00;
2019-07-02;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02479869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97024
EXTRA STRENGTH MUCOUS RELIEF COUGH
guaifenesin 400 mg , dextromethorphan hydrobromide 20 mg;
Number of active ingredients: 2.00;
2011-05-17;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES , 48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
DIN: 02353563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83878
FLUZONE QUADRIVALENT
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2014-10-15;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02420643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90522
FLULAVAL TETRA
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2015-10-14;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
ID BIOMEDICAL CORPORATION OF QUEBEC
DIN: 02420783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90535
AFLURIA TETRA
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2019-10-25;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS PTY LTD
DIN: 02473283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96268
AFLURIA TETRA
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2020-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS PTY LTD
DIN: 02473313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96272
INFLUVAC TETRA
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2019-10-17;
Intramuscular , Subcutaneous;
Suspension;
80:12.00 – VACCINES;
Schedule D;
BGP PHARMA ULC
DIN: 02484854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97512
FLUAD
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b 15 mcg / 0.5 ml;
Number of active ingredients: 3.00;
2011-09-10;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS UK LIMITED
DIN: 02362384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84739
FLUVIRAL
haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml , haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b 15 mcg / 0.5 ml;
Number of active ingredients: 3.00;
2015-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
ID BIOMEDICAL CORPORATION OF QUEBEC
DIN: 02420686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90524
FLUZONE QUADRIVALENT
haemagglutinin-strain a (h1n1) 30 mcg / ml , haemagglutinin-strain a (h3n2) 30 mcg / ml , haemagglutinin-strain b (victoria) 30 mcg / ml , haemagglutinin-strain b (yamagata) 30 mcg / ml;
Number of active ingredients: 4.00;
2015-09-14;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02432730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91717
FLUAD PEDIATRIC
haemagglutinin-strain a (h1n1) 7.5 mcg / 0.25 ml , haemagglutinin-strain a (h3n2) 7.5 mcg / 0.25 ml , haemagglutinin-strain b 7.5 mcg / 0.25 ml;
Number of active ingredients: 3.00;
2015-11-05;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS UK LIMITED
DIN: 02434881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91919
FLUCELVAX QUAD
haemagglutinin-strain a (h3n2) 15 mcg / 0.5 ml , haemagglutinin-strain b (victoria) 15 mcg / 0.5 ml , haemagglutinin-strain b (yamagata) 15 mcg / 0.5 ml , haemagglutinin-strain a (h1n1) 15 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2020-09-21;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SEQIRUS UK LIMITED
DIN: 02494248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98427
ACT-HIB
haemophilus influenzae type b-prp 10 mcg / 0.5 ml , tetanus protein 30 mcg / 0.5 ml;
Number of active ingredients: 2.00;
1992-12-31;
Intramuscular;
Kit , Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 01959034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13140
DUOBRII
halobetasol propionate 0.01 % / w/w , tazarotene 0.045 % / w/w;
Number of active ingredients: 2.00;
2020-08-04;
Topical;
Lotion;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 84:06.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02499967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98967
HELIOX 70/30
helium 70 % , oxygen 30 %;
Number of active ingredients: 2.00;
2014-12-22;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
VITALAIRE CANADA INC
DIN: 02416468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90106
HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
heparin sodium 10000 unit / 100 ml , dextrose 5 g / 100 ml;
Number of active ingredients: 2.00;
1996-09-10;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 02209721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36795
TWINRIX
hepatitis a vaccine – inactivated 720 unit / 1 ml , hepatitis b surface antigen (recombinant) 20 mcg / 1 ml;
Number of active ingredients: 2.00;
1997-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02230578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49687
TWINRIX JUNIOR
hepatitis b surface antigen (recombinant) 10 mcg / 0.5 ml , hepatitis a vaccine – inactivated 360 unit / 0.5 ml;
Number of active ingredients: 2.00;
1998-11-06;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02237548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60885
STREPSILS EXTRA BLACK CHERRY
hexylresorcinol 2.4 mg , levomenthol 4 mg;
Number of active ingredients: 2.00;
2007-03-23;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02263998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74940
ULTRA-LIGHT MOISTURIZING LOTION SPF 30
homosalate 10 % , octisalate 5 % , avobenzone 3 % , octocrylene 2.7 %;
Number of active ingredients: 4.00;
2019-08-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CERAVE CANADA
DIN: 02481944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97242
OIL AND PORE CONTROL MATTIFIER BROAD SPECTRUM SPF 45
homosalate 10 % , octisalate 5 % , octocrylene 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2019-07-28;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
DIN: 02483866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97422
BROAD SPECTRUM SPF/FPS 30
homosalate 10 % , octocrylene 10 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2017-06-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02444232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92916
ULTRA SHEER BODY MIST SUNSCREEN SPF 45
homosalate 10 % , octocrylene 10 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02487942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97806
BANANA BOAT KIDS FREE CONTINUOUS SPRAY SUNSCREEN SPF 50+
homosalate 10 % , octocrylene 6 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02440849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92520
CLEAR SUNSCREEN STICK 50+
homosalate 10 % / w/w , avobenzone 2.5 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2021-04-12;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02501384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99101
SENSITIVE SKIN SUNSCREEN LOTION SPF 30
homosalate 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2020-01-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02490390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98044
LOTION SOLAIRE CORPS FPS 30
homosalate 10 % / w/w , bisoctrizole 5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-12-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02504871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99426
CLINIQUE SPF 30 SHEER BODY MIST
homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2017-05-15;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02455048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94184
SUNSCREEN LIP BALM
homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 8 % / w/w;
Number of active ingredients: 4.00;
2020-10-13;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02501406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99103
ULTRA SHEER FACE MIST SUNSCREEN
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02486458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97665
PRISMA PROTECT SPF 30
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-07-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMALOGICA, LLC
DIN: 02486687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97685
ÉMULSION HYDRATANTE VISAGE FPS 30
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 2.7 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-12-02;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02494205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98424
DREAM URBAN COVER
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w;
Number of active ingredients: 3.00;
2019-07-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAYBELLINE CANADA
DIN: 02486784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97695
ULTRA SUN PROTECTOR LOTION LAIT SOLAIRE ULTRA PROTECTION 50+
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 2.3 % / w/w;
Number of active ingredients: 4.00;
2020-12-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02497050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98691
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN SPRAY SPF 50+
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2014-12-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02422360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90705
SKIN TONE CORRECTING & BEAUTIFYING BB CREAM
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , titanium dioxide 4.5 % / w/w;
Number of active ingredients: 4.00;
2013-06-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
DIN: 02406195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89092
PLAY EVERYDAY LOTION
homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 7.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-06-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
DIN: 02494949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98492
EQUATE SPORT SUNSCREEN CONTINOUS SPRAY SPF/FPS 15
homosalate 10 % / w/w , octisalate 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2011-03-02;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02359871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84486
NATURE REPUBLIC CALIFORNIA MOISTURIZING ALOE DAILY SUN CREAM SPF 50+
homosalate 10 % / w/w , octisalate 5 % / w/w , titanium dioxide 4.315 % / w/w;
Number of active ingredients: 3.00;
2019-12-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NATURE REPUBLIC CO LTD.
DIN: 02493136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98310
SPF/FPS 30
homosalate 10 % / w/w , octocrylene 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2014-07-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02404338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88910
SPF 30 FPS SUNSCREEN LOTION LOTION ÉCRAN SOLAIRE
homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2014-05-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
DIN: 02415321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89994
NEUTROGENA CLEAR FACE SUNSCREEN LOTION
homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02496240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98611
SPF 50 FACE CREAM
homosalate 10 % / w/w , octocrylene 10 % / w/w , zinc oxide 7 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2020-12-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SUN BUM LLC
DIN: 02494965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98493
SPF/FPS 15
homosalate 10 % / w/w , octocrylene 5 % / w/w , avobenzone 2 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2014-07-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02404362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88913
COPPERTONE SPRAY SUNSCREEN SPF 50 DEFEND & CARE
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02488892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97894
COPPERTONE SPRAY SUNSCREEN SPF 50 KIDS
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-12-16;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02487705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97785
COPPERTONE SPRAY SUNSCREEN SPF 50 SPORT
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-04-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02487934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97805
SPORT 50 CONTINUOUS SPRAY SUNSCREEN ECRAN SOLAIRE EN VAPORISATEUR
homosalate 10 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-11-01;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02491567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98155
BANANA BOAT BABY SUNSCREEN LOTION SPF/FPS 60
homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2015-03-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02430207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91469
BANANA BOAT KIDS SUNSCREEN LOTION SPF/FPS 60
homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2015-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02430215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91470
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN LOTION SPF/FPS 60
homosalate 10 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2015-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02432455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91693
SUN SILK DROPS
homosalate 10 % / w/w , octocrylene 6 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2020-07-09;
Topical;
Solution;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02490854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98089
BANANA BOAT KIDS TEAR-FREE SUNSCREEN SPRAY SPF 50+
homosalate 10 % / w/w , octocrylene 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02464977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95318
CRÈME SOLAIRE VISAGE TOUCHER SEC FPS 30
homosalate 10 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2020-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02494450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98446
CRÈME SOLAIRE CORPS FPS 30
homosalate 10 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2020-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02494655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98465
COPPERTONE LOTION SUNSCREEN SPF 50 KIDS
homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96902
COPPERTONE LOTION SUNSCREEN SPF 50 SUN GUARD
homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96903
COPPERTONE LOTION SUNSCREEN SPF 50 DEFEND & CARE
homosalate 10 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02489791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97987
OLAY REGENERIST WHIP SUN PROTECTION FACTOR 40
homosalate 10 % / w/w , octocrylene 9 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-05-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02493098
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98307
PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 50
homosalate 13.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02496801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98665
PROTECT + HYDRATE FACE
homosalate 13.5 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02497336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98716
SUNTHERA3 KIDS/ENFANTS SPF/FPS 50 CONTINUOUS SPRAY
homosalate 15 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w , oxybenzone 6 % / w/w;
Number of active ingredients: 4.00;
2008-04-03;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02301741
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78709
EQUATE SPORT SUNSCREEN CONTINUOUS SPRAY SPF/FPS30
homosalate 15 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2011-03-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02359898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84487
HYDRO BOOST WATER GEL LOTION SUNSCREEN
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02496585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98644
LIFE BRAND SUNSCREEN LOTION SPF 50+
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-03-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02497123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98696
ULTRA SHEER BODY MIST SUNSCREEN
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02502526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99209
ULTRA SHEER DRY-TOUCH SUNSCREEN
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02502534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99210
ULTRA SHEER FACE SUNSCREEN
homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02502542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99211
OLAY COMPLETE ALL DAY MOISTURE CREAM
homosalate 3 % / w/w , avobenzone 3 % / w/w , octocrylene 2.6 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2009-05-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02314800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80034
OLAY COMPLETE UV365* DAILY MOISTURIZING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 15 NORMAL
homosalate 4 % , avobenzone 3 % , octisalate 4.5 % , octocrylene 2.6 %;
Number of active ingredients: 4.00;
2017-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02461196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94870
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 NORMAL
homosalate 4 % , avobenzone 3 % , octisalate 4.5 % , octocrylene 2.6 %;
Number of active ingredients: 4.00;
2017-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02461234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94874
CRÈME HYDRA FINISH CREAM CRÈME HYDRATATION RÉVÉLATRICE DE TEINT FPS 15 LARGE SPECTRE VISAGE MOISTURIZING COMPLEXION ENHACING CREAM SPF 15 BROAD SPECTRUM FACE
homosalate 4 % , octinoxate 6 %;
Number of active ingredients: 2.00;
2019-04-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUINOT
DIN: 02480441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97097
OLAY REGENERIST ENHANCING UV LOTION WITH SPF 15
homosalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 2.6 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2014-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02376466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86192
INVISIBLUR PERFECTING SHIELD BROAD SPECTRUM SPF 30 PA+++
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 4.00;
2015-05-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
DIN: 02433710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91807
HYDRO BOOST GEL CREAM SPF 15
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 4.00;
2016-01-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02438240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92261
AGE BALANCING MOISTURE BROAD SPECTRUM SPF 30 | PA+++
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 4.00;
2017-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
DIN: 02445743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93102
HYDRO BOOST GEL CREAM SPF 25
homosalate 4 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 4.00;
2020-01-06;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02484285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97460
RAPID WRINKLE REPAIR MOISTURIZER
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2012-01-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02368382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85335
RAPID TONE REPAIR MOISTURIZER
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2013-01-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02384159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86990
TRIPLE AGE REPAIR MOISTURIZER
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2015-01-12;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02387557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87316
DEEP MOISTURE
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2015-06-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02405342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89014
ABSOLUTELY AGELESS DAILY MOISTURIZER
homosalate 4 % / w/w , octisalate 4 % / w/w , octocrylene 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2016-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02440873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92523
ORIGINS PLANTSCRIPTION SPF 25 POWER ANTI-AGING CREAM
homosalate 5 % , octisalate 4.5 % , avobenzone 3 % , octocrylene 2.8 %;
Number of active ingredients: 4.00;
2016-05-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ORIGINS NATURAL RESOURCES DIST
DIN: 02444216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92912
ORIGINS PLANTSCRIPTION SPF 25 POWER ANTI-AGING OIL-FREE CREAM
homosalate 5 % , octisalate 4.5 % , avobenzone 3 % , octocrylene 2.8 %;
Number of active ingredients: 4.00;
2016-05-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ORIGINS NATURAL RESOURCES DIST
DIN: 02444828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93002
BANANA BOAT SUNCOMFORT SUNSCREEN LOTION SPF 30
homosalate 5 % , octocrylene 4 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2017-01-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02440822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92518
STOKODERM SUNSCREEN PURE
homosalate 5 % / w/w , avobenzone 3 % / w/w , octisalate 3 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 4.00;
2021-05-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SC JOHNSON PROFESSIONAL CA INC
DIN: 02497093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98695
LAB SERIES DAY RESCUE DEFENSE LOTION SPF 35
homosalate 5 % / w/w , octisalate 4.5 % / w/w , octocrylene 3.3 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2018-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LAB SERIES DIST.
DIN: 02462648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95043
SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L’ÂGE VERY DRY TO DRY COMBINATION / TRÈS SÈCHE À MIXTE SPF 25 FPS
homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2020-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02492083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98208
EVEN TONE DAILY MOISTURIZER
homosalate 5 % / w/w , octisalate 5 % / w/w , octocrylene 7 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2016-02-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02448394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93408
KIDS SUNSCREEN STICK SPF 50+
homosalate 5 % / w/w , octocrylene 10 % / w/w , zinc oxide 15 % / w/w;
Number of active ingredients: 3.00;
2019-11-11;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02488825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97890
COPPERTONE LOTION SUNSCREEN SPF 15 SUN GUARD
homosalate 5 % / w/w , octocrylene 3 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96948
HAWAIIAN TROPIC PROTECTIVE ARGAN DRY OIL SUNSCREEN SPRAY SPF 15
homosalate 5 % / w/w , octocrylene 3.5 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 3.00;
2019-02-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02477874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96872
HAWAIIAN TROPIC SILK HYDRATION WEGHTLESS FACE
homosalate 5.5 % , octisalate 4.5 % , octocrylene 4 % , avobenzone 2 %;
Number of active ingredients: 4.00;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02458160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94521
SILK HYDRATION WEIGHTLESS CLEAR SUNSCREEN SPRAY SPF 30
homosalate 5.5 % , octocrylene 4 % , avobenzone 2 % , octisalate 4.5 %;
Number of active ingredients: 4.00;
2017-01-03;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02455315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94213
SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 30
homosalate 5.5 % / w/w , octisalate 4.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2014-02-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02409488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89418
HAWAIIAN TROPIC SHEER TOUCH CLEAR SUNSCREEN SPRAY SPF 30 ULTRA RADIANCE
homosalate 5.5 % / w/w , octisalate 4.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2015-02-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02425831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91047
BB CREAM SUNSCREEN SPF 30
homosalate 5.9 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.4 % / w/w , avobenzone 2.2 % / w/w;
Number of active ingredients: 4.00;
2017-01-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02456281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94317
DUO DEFENCE SUNSCREEN LOTION SPF 30
homosalate 6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02464934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95314
BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 30
homosalate 6 % / w/w , octocrylene 4.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2021-01-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02505304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99467
BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 30
homosalate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2021-01-25;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02505959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99531
HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS DAILY USE SUNSCREEN MIST SPRAY SPF 30
homosalate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 3.00;
2019-12-02;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02490919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98095
COPPERTONE LOTION SUNSCREEN SPF 15 GLOW
homosalate 6 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02487969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97808
HAWAIIAN TROPIC MATTE EFFECT MINERAL ENRICHED SUNSCREEN LOTION SPF 30
homosalate 6 % / w/w , zinc oxide 5.6 % / w/w , octisalate 4.5 % / w/w , octocrylene 4.5 % / w/w;
Number of active ingredients: 4.00;
2019-12-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02488310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97841
ANEW REVERSALIST COMPLETE RENEWAL DAY CREAM
homosalate 7 % / w/w , octinoxate 7 % / w/w , oxybenzone 4 % / w/w , avobenzone 2.85 % / w/w;
Number of active ingredients: 4.00;
2014-03-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02414031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89871
ULTRA FACIAL MOISTURIZER SPF 30
homosalate 7 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2013-07-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
DIN: 02401908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88678
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN SPRAY SPF 30
homosalate 7 % / w/w , octocrylene 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2014-12-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02422352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90704
BANANA BOAT SUNCOMFORT SUNSCREEN SPRAY SPF 30
homosalate 7 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w , octocrylene 1.5 % / w/w;
Number of active ingredients: 4.00;
2015-02-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02426722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91129
SPORT 30 LOTION SUNSCREEN LOTION ÉCRAN SOLAIRE
homosalate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 4.00;
2020-10-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PRIME ENTERPRISES INC
DIN: 02502070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99167
ANEW ULTIMATE DAY MULTI-PERFORMANCE CREAM
homosalate 8 % / w/w , avobenzone 2.9 % / w/w , octinoxate 5 % / w/w , oxybenzone 4 % / w/w;
Number of active ingredients: 4.00;
2015-05-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02431432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91585
ANEW REVERSALIST COMPLETE RENEWAL DAY LOTION
homosalate 8 % / w/w , octinoxate 5 % / w/w , oxybenzone 4 % / w/w , avobenzone 2.85 % / w/w;
Number of active ingredients: 4.00;
2014-03-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02414023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89870
ANEW VITALE DAY LOTION
homosalate 8 % / w/w , octinoxate 5 % / w/w , oxybenzone 4 % / w/w , avobenzone 2.85 % / w/w;
Number of active ingredients: 4.00;
2015-06-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02424363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90907
DAILYSCREEN
homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 3.00;
2020-05-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
DIN: 02494957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98488
ANTI-AGING MOISTURIZER BROAD SPECTRUM SPF 30 | PA+++
homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 4.00;
2016-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MURAD LLC
DIN: 02445751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93103
UNSEEN SUNSCREEN
homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 4 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-05-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
DIN: 02495481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98540
MATTE DEFENSE SPF 30
homosalate 8 % / w/w , octisalate 5 % / w/w , octocrylene 8 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-11-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMALOGICA, LLC
DIN: 02490455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98050
SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 45 ULTRA RADIANCE/ULTRA-RADIEUX
homosalate 8 % / w/w , octocrylene 5 % / w/w , avobenzone 2.7 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2014-02-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02409496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89419
COPPERTONE LOTION SUNSCREEN SPF 30 SUN GUARD
homosalate 8 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96949
COPPERTONE SPRAY SUNSCREEN SPF 30 SPORT
homosalate 8 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2019-12-16;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96901
ULTRA SHEER BODY MIST SUNSCREEN SPF 30
homosalate 8 % / w/w , octocrylene 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02486474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97667
HAWAIIAN TROPIC MATTE EFFECT MINERAL ENRICHED SUNSCREEN LOTION SPF 50
homosalate 8 % / w/w , zinc oxide 7.3 % / w/w , octocrylene 5.7 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2019-12-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02488329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97842
COMPLETE DRY MIST SPRAY HYPOALLERGENIC UVA + UVB SPF 30
homosalate 8.78 % / w/w , octocrylene 5.92 % / w/w , octisalate 4.88 % / w/w , avobenzone 2.96 % / w/w;
Number of active ingredients: 4.00;
2014-03-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02415313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89993
HAUTE EXIGENCE JOUR SPF 20 MULTI-INTENSIVE
homosalate 9 % , avobenzone 3 % , octocrylene 2.7 %;
Number of active ingredients: 3.00;
2015-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02425289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90992
DENTEC LOTION
homosalate 9 % , octinoxate 7.5 % , octisalate 5 % , oxybenzone 4 %;
Number of active ingredients: 4.00;
2019-06-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DENTEC SAFETY SPECIALISTS INC
DIN: 02440792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92515
BANANA BOAT SUNCOMFORT SUNSCREEN LOTION SPF 50+
homosalate 9 % , octocrylene 5 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2017-01-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02440830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92519
HYDRA-ESSENTIEL FLUIDE FONDANT DÉSALTÉRANT PEAUX NORMALES À MIXTES FPS/SPF 15
homosalate 9 % , octocrylene 5 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2018-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02471043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96014
DUO DEFENCE SUNSCREEN LOTION SPF 50+
homosalate 9 % / w/w , octisalate 4 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02464926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95312
INTO REPAIR DRY SKIN / PEAUX SÈCHES
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 3.00;
2020-06-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02489104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97916
SUN ULTIMATE FACE CREAM / CRÈME VISAGE
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 3.00;
2020-05-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02489112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97917
HYDRA VIZOR
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2020-12-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KENDO HOLDINGS, INC
DIN: 02496577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98643
SUNSCREEN OIL SPRAY
homosalate 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.4 % / w/w;
Number of active ingredients: 4.00;
2013-01-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02388154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87370
BANANA BOAT SIMPLY PROTECT SPORT SUNSCREEN SPRAY SPF 50+
homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 7 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02465051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95329
BANANA BOAT SPORT FOR KIDS SUNSCREEN STICK SPF 50+
homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02464861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95306
BANANA BOAT ULTRA SPORT SUNSCREEN STICK SPF 50+
homosalate 9 % / w/w , octisalate 4.5 % / w/w , octocrylene 9 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02464969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95317
MARY KAY FOUNDATION PRIMER SPF 15
homosalate 9 % / w/w , octisalate 5 % / w/w , octocrylene 3 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 4.00;
2012-03-16;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MARY KAY COSMETICS LTD
DIN: 02353695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83890
BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 50+
homosalate 9 % / w/w , octocrylene 6 % / w/w , avobenzone 2.7 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2021-01-25;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02505967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99532
HAWAIIAN TROPIC SHEER TOUCH CLEAR SUNSCREEN SPRAY SPF 50+ ULTRA RADIANCE
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2015-02-01;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02425998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91061
BANANA BOAT SIMPLY PROTECT KIDS SUNSCREEN LOTION SPRAY SPF 50+
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2017-12-10;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02466627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95496
OLAY REGENERIST MICRO-SCULPTING CREAM WITH SUNSCREEN
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02482177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97264
BANANA BOAT SIMPLY PROTECT SENSITIVE FACES VISAGES SUNCREEN LOTION SPF 50 PLUS
homosalate 9 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w , zinc oxide 7.3 % / w/w;
Number of active ingredients: 4.00;
2019-01-24;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02478056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96878
BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 50+
homosalate 9 % / w/w , octocrylene 6.5 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2021-01-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02505290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99466
HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 50
homosalate 9 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2021-01-31;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02495031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98499
COPPERTONE LOTION SUNSCREEN SPF 30 GLOW
homosalate 9 % / w/w , octocrylene 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02488124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97823
COPPERTONE LOTION SUNSCREEN SPF 50 WATERBABIES
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02487799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97795
COPPERTONE LOTION SUNSCREEN SPF 50 GLOW
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02487950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97807
COPPERTONE CLEAR SUNSCREEN SPF 50 SPORT
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02489538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97961
COPPERTONE CLEAR ORANGE SUNSCREEN
homosalate 9 % / w/w , octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-02-02;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02490293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98035
BANANA BOAT SIMPLY PROTECT SENSITIVE SUNSCREEN LOTION SPF 50 PLUS
homosalate 9 % / w/w , zinc oxide 7.3 % / w/w , octocrylene 6 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2019-01-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02478064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96879
FIVE STAR LIP PROTECTION
homosalate 9.6 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , oxybenzone 5 % / w/w;
Number of active ingredients: 4.00;
2010-09-29;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
DIN: 02353822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83903
IRBESARTAN-HCTZ
hydrochlorothiazide 12.5 mg , irbesartan 150 mg;
Number of active ingredients: 2.00;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02365162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85001
TEVA-IRBESARTAN HCTZ
hydrochlorothiazide 12.5 mg , irbesartan 300 mg;
Number of active ingredients: 2.00;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02330520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81625
ACH-OLMESARTAN HCTZ
hydrochlorothiazide 12.5 mg , olmesartan medoxomil 20 mg;
Number of active ingredients: 2.00;
2019-06-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02468948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95759
OLMESARTAN/HCTZ
hydrochlorothiazide 12.5 mg , olmesartan medoxomil 20 mg;
Number of active ingredients: 2.00;
2021-06-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02509601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99889
ACH-OLMESARTAN HCTZ
hydrochlorothiazide 12.5 mg , olmesartan medoxomil 40 mg;
Number of active ingredients: 2.00;
2019-06-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02468956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95760
OLMESARTAN/HCTZ
hydrochlorothiazide 12.5 mg , olmesartan medoxomil 40 mg;
Number of active ingredients: 2.00;
2021-06-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02509636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99891
TEVA-IRBESARTAN HCTZ
hydrochlorothiazide 25 mg , irbesartan 300 mg;
Number of active ingredients: 2.00;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02330539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81626
ACH-OLMESARTAN HCTZ
hydrochlorothiazide 25 mg , olmesartan medoxomil 40 mg;
Number of active ingredients: 2.00;
2019-06-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02468964
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95761
OLMESARTAN/HCTZ
hydrochlorothiazide 25 mg , olmesartan medoxomil 40 mg;
Number of active ingredients: 2.00;
2021-06-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02509628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99890
AA-AMILZIDE
hydrochlorothiazide 50 mg , amiloride hydrochloride 5 mg;
Number of active ingredients: 2.00;
1989-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AA PHARMA INC
DIN: 00784400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10494
TEVA-PROCTOSONE
hydrocortisone (hydrocortisone acetate) 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
Number of active ingredients: 4.00;
1997-02-03;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02226383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37454
PRAMOX HC CREAM
hydrocortisone (hydrocortisone acetate) 1 % , pramoxine hydrochloride 1 %;
Number of active ingredients: 2.00;
1989-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
DERMTEK PHARMA INC
DIN: 00770957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10052
PRAMOX HC LOTION
hydrocortisone (hydrocortisone acetate) 1 % , pramoxine hydrochloride 1 %;
Number of active ingredients: 2.00;
1994-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
DERMTEK PHARMA INC
DIN: 01954210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15948
PROCTOSEDYL
hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
Number of active ingredients: 4.00;
2003-04-01;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02223252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37334
ODAN PROCTOMYXIN HC
hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
Number of active ingredients: 4.00;
2001-03-09;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02242527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66275
PROCTOL OINTMENT
hydrocortisone 0.5 % , dibucaine hydrochloride 0.5 % , framycetin sulfate 1 % , esculin 1 %;
Number of active ingredients: 4.00;
2003-08-06;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02247322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71565
PROCTOL SUPPOSITORIES
hydrocortisone 5 mg , dibucaine hydrochloride 5 mg , framycetin sulfate 10 mg , esculin 10 mg;
Number of active ingredients: 4.00;
2004-03-15;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02247882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72190
ANUSOL-HC OINTMENT
hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
Number of active ingredients: 2.00;
1981-12-31;
Rectal;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
CHURCH & DWIGHT CANADA CORP
DIN: 00505773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4389
ANODAN-HC OINTMENT
hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
Number of active ingredients: 2.00;
1995-12-31;
Rectal , Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02128446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18240
JAMPZINC-HC
hydrocortisone acetate 0.5 % / w/w , zinc sulfate monohydrate 0.5 % / w/w;
Number of active ingredients: 2.00;
2012-07-23;
Rectal , Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02387239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87281
PROCTOFOAM HC
hydrocortisone acetate 1 % , pramoxine hydrochloride 1 %;
Number of active ingredients: 2.00;
1979-12-31;
Rectal;
Aerosol;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
DUCHESNAY INC
DIN: 00363014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3492
ANUSOL-HC SUPPOSITORIES
hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
Number of active ingredients: 2.00;
1975-12-31;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
CHURCH & DWIGHT CANADA CORP
DIN: 00476285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4630
ANODAN-HC 10MG SUPPOSITORIES
hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
Number of active ingredients: 2.00;
1998-08-13;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02236399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59873
VISINE FOR DRY EYE EYE REVIVAL
hypromellose 0.2 % / w/v , glycerine 0.2 % / v/v;
Number of active ingredients: 2.00;
2016-05-19;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02436132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92046
VISINE FOR DRY EYE TIRED EYE RELIEF
hypromellose 0.2 % / w/v , glycerine 0.2 % / w/v;
Number of active ingredients: 2.00;
2016-06-07;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02438585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92296
TEARS NATURALE FREE
hypromellose 0.3 % / w/v , dextran 70 0.1 % / w/v;
Number of active ingredients: 2.00;
1992-12-31;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 01943308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13167
NIGHTTIME PAIN RELIEF
ibuprofen (ibuprofen – ibuprofen potassium) 200 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 2.00;
2017-10-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
APOTEX INC
DIN: 02424630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90931
CHILDREN’S ADVIL COLD
ibuprofen 100 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml;
Number of active ingredients: 2.00;
2004-08-09;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02248435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72786
CHILDREN’S ADVIL COLD & FLU MULTI-SYMPTOM
ibuprofen 100 mg / 5 ml , pseudoephedrine hydrochloride 15 mg / 5 ml , chlorpheniramine maleate 1 mg / 5 ml;
Number of active ingredients: 3.00;
2010-01-26;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02268701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75412
ADVIL NIGHTTIME
ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 2.00;
2011-01-03;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02355841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84104
ADVIL COLD, COUGH & FLU NIGHTTIME
ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 2.00;
2013-08-06;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02401193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88592
ADVIL DAY/NIGHT CONVENIENCE PACK
ibuprofen 200 mg , ibuprofen 200 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 3.00;
2014-06-02;
Oral;
Kit , Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02410583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89525
ROBAX PLATINUM
ibuprofen 200 mg , methocarbamol 500 mg;
Number of active ingredients: 2.00;
2003-07-02;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02247147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71388
MOTRIN PLATINUM MUSCLE & BODY
ibuprofen 200 mg , methocarbamol 500 mg;
Number of active ingredients: 2.00;
2014-06-18;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02418967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90351
ADVIL COLD AND SINUS
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
1993-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02036312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14492
SUDAFED SINUS ADVANCE
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2000-08-01;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02242217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65897
ADVIL COLD & SINUS LIQUI-GELS
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2005-07-09;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02250705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73565
ADVIL COLD AND SINUS DAYTIME
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2006-08-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02267616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75302
COLD + SINUS
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2010-10-12;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02352281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83757
COLD & SINUS RELIEF CAPSULES
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg;
Number of active ingredients: 2.00;
2014-03-20;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
APOTEX INC
DIN: 02407779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89248
ADVIL COLD & SINUS PLUS
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2004-08-02;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02248645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73002
ADVIL COLD AND SINUS NIGHTTIME
ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2006-08-04;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02267632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75304
ADVIL COLD, SINUS & FLU EXTRA STRENGTH
ibuprofen 400 mg , pseudoephedrine hydrochloride 60 mg , chlorpheniramine maleate 4 mg;
Number of active ingredients: 3.00;
2018-08-17;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02471604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96076
TARO-IMIPENEM-CILASTATIN
imipenem 250 mg / vial , cilastatin (cilastatin sodium) 250 mg / vial;
Number of active ingredients: 2.00;
2010-08-25;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02351692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83695
IMIPENEM AND CILASTATIN FOR INJECTION USP
imipenem 250 mg / vial , cilastatin (cilastatin sodium) 250 mg / vial;
Number of active ingredients: 2.00;
2010-12-21;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02358336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84339
PRIMAXIN 500
imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
Number of active ingredients: 2.00;
1987-12-31;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
MERCK CANADA INC
DIN: 00717282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8054
TARO-IMIPENEM-CILASTATIN
imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
Number of active ingredients: 2.00;
2010-08-25;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02351706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83696
IMIPENEM AND CILASTATIN FOR INJECTION USP
imipenem 500 mg / vial , cilastatin (cilastatin sodium) 500 mg / vial;
Number of active ingredients: 2.00;
2010-12-21;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02358344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84340
IMOVAX POLIO
inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 40 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 8 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 32 unit / 0.5 ml;
Number of active ingredients: 3.00;
2007-03-22;
Subcutaneous;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 01959042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44019
ENERZAIR BREEZHALER
indacaterol (indacaterol acetate) 150 mcg , glycopyrronium (glycopyrronium bromide) 50 mcg , mometasone furoate 160 mcg;
Number of active ingredients: 3.00;
2020-11-05;
Inhalation;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02501244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99087
ATECTURA BREEZHALER
indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 160 mcg;
Number of active ingredients: 2.00;
2020-08-19;
Inhalation;
Capsule;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02498707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98849
ATECTURA BREEZHALER
indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 320 mcg;
Number of active ingredients: 2.00;
2020-08-19;
Inhalation;
Capsule;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02498693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98848
ATECTURA BREEZHALER
indacaterol (indacaterol acetate) 150 mcg , mometasone furoate 80 mcg;
Number of active ingredients: 2.00;
2020-08-19;
Inhalation;
Capsule;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02498685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98847
ULTIBRO BREEZHALER
indacaterol (indacaterol maleate) 110 mcg , glycopyrronium (glycopyrronium bromide) 50 mcg;
Number of active ingredients: 2.00;
2014-03-05;
Inhalation;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02418282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90285
APO-PERINDOPRIL-INDAPAMIDE
indapamide 2.5 mg , perindopril erbumine 8 mg;
Number of active ingredients: 2.00;
2021-02-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
APOTEX INC
DIN: 02453061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93947
FLUMIST QUADRIVALENT
influenza virus type a (h1n1) 32000000 ffu / 0.2 ml , influenza virus type a (h3n2) 32000000 ffu / 0.2 ml , influenza virus type b (victoria) 32000000 ffu / 0.2 ml , influenza virus type b (yamagata) 32000000 ffu / 0.2 ml;
Number of active ingredients: 4.00;
2014-10-10;
Nasal;
Spray;
80:12.00 – VACCINES;
Schedule D;
ASTRAZENECA CANADA INC
DIN: 02426544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91111
HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)
insulin 30 unit / ml , insulin isophane (nph) 70 unit / ml;
Number of active ingredients: 2.00;
1989-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 00795879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9788
NOVOMIX 30
insulin aspart 30 unit / ml , insulin aspart protamine 70 unit / ml;
Number of active ingredients: 2.00;
2005-09-12;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02265435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75090
XULTOPHY
insulin degludec 100 unit / ml , liraglutide 3.6 mg / ml;
Number of active ingredients: 2.00;
2018-06-06;
Subcutaneous;
Solution;
68:20.08 – INSULINS , 68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02474875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96506
SOLIQUA
insulin glargine 100 unit / ml , lixisenatide 33 mcg / ml;
Number of active ingredients: 2.00;
2018-09-12;
Subcutaneous;
Solution;
68:20.08 – INSULINS , 68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02478293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96906
HUMULIN 30/70 CARTRIDGE
insulin injection human biosynthetic 30 unit / ml , insulin isophane human biosynthetic 70 unit / ml;
Number of active ingredients: 2.00;
1992-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 01959212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12568
NOVOLIN GE 30/70
insulin injection human biosynthetic 30 unit / ml , insulin isophane human biosynthetic 70 unit / ml;
Number of active ingredients: 2.00;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14269
NOVOLIN GE 40/60 PENFILL
insulin injection human biosynthetic 40 unit / ml , insulin isophane human biosynthetic 60 unit / ml;
Number of active ingredients: 2.00;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14262
NOVOLIN GE 50/50 PENFILL
insulin injection human biosynthetic 50 unit / ml , insulin isophane human biosynthetic 50 unit / ml;
Number of active ingredients: 2.00;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14270
NOVOLIN GE 30/70 PENFILL
insulin isophane human biosynthetic 70 unit / ml , insulin injection human biosynthetic 30 unit / ml;
Number of active ingredients: 2.00;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02025248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14265
HUMALOG MIX 25 (CARTRIDGE)
insulin lispro 25 unit / ml , insulin lispro protamine suspension 75 unit / ml;
Number of active ingredients: 2.00;
1999-07-05;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02240294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63832
HUMALOG MIX 25 (KWIKPEN)
insulin lispro 25 unit / ml , insulin lispro protamine suspension 75 unit / ml;
Number of active ingredients: 2.00;
2013-09-30;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02403420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88823
HUMALOG MIX 50 (CARTRIDGE)
insulin lispro 50 unit / ml , insulin lispro protamine suspension 50 unit / ml;
Number of active ingredients: 2.00;
2007-01-12;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02240297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63835
HUMALOG MIX 50 (KWIKPEN)
insulin lispro 50 unit / ml , insulin lispro protamine suspension 50 unit / ml;
Number of active ingredients: 2.00;
2014-01-23;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02403439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88824
INTRON A
interferon alfa-2b 10000000 unit / vial , water 1 ml / vial;
Number of active ingredients: 2.00;
1997-03-12;
Intralesional , Intramuscular , Intravenous , Subcutaneous;
Liquid , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 08:18.20 – INTERFERONS;
Prescription , Schedule D;
MERCK CANADA INC
DIN: 02223406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43361
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg / 2.5 ml , salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml;
Number of active ingredients: 2.00;
2019-08-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
DIN: 02483394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97384
COMBIVENT RESPIMAT
ipratropium bromide (ipratropium bromide monohydrate) 20 mcg / act , salbutamol (salbutamol sulfate) 100 mcg / act;
Number of active ingredients: 2.00;
2014-09-16;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02419106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90364
AVALIDE
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2000-03-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02241818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65483
PMS-IRBESARTAN-HCTZ
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02328518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81403
TEVA-IRBESARTAN HCTZ
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02330512
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81624
SANDOZ IRBESARTAN HCT
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02337428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82301
IRBESARTAN/HCTZ
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02372886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85799
IRBESARTAN HCT
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87095
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
irbesartan 150 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02418223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90280
AVALIDE
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2000-03-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02241819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65484
PMS-IRBESARTAN-HCTZ
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02328526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81404
SANDOZ IRBESARTAN HCT
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02337436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82302
IRBESARTAN-HCTZ
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02365170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85002
IRBESARTAN/HCTZ
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02372894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85800
IRBESARTAN HCT
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-06-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87096
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
irbesartan 300 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02418231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90281
PMS-IRBESARTAN-HCTZ
irbesartan 300 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02328534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81405
SANDOZ IRBESARTAN HCT
irbesartan 300 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02337444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82303
IRBESARTAN-HCTZ
irbesartan 300 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02365189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85003
IRBESARTAN/HCTZ
irbesartan 300 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02372908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85801
IRBESARTAN HCT
irbesartan 300 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87097
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
irbesartan 300 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02418258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90282
GERMI-STAT PREP GEL
isopropyl alcohol 70 % , chlorhexidine gluconate 0.5 %;
Number of active ingredients: 2.00;
2002-05-17;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
DIN: 02241528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65180
ORKAMBI
ivacaftor 125 mg , lumacaftor 100 mg;
Number of active ingredients: 2.00;
2017-05-03;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02463040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95094
ORKAMBI
ivacaftor 125 mg , lumacaftor 200 mg;
Number of active ingredients: 2.00;
2016-01-27;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02451379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93762
COMBIVIR
lamivudine 150 mg , zidovudine 300 mg;
Number of active ingredients: 2.00;
1998-12-08;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02239213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62673
APO-LAMIVUDINE-ZIDOVUDINE
lamivudine 150 mg , zidovudine 300 mg;
Number of active ingredients: 2.00;
2012-06-04;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02375540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86096
TEVA-LAMIVUDINE/ZIDOVUDINE
lamivudine 150 mg , zidovudine 300 mg;
Number of active ingredients: 2.00;
2012-06-06;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02387247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87285
AURO-LAMIVUDINE/ZIDOVUDINE
lamivudine 150 mg , zidovudine 300 mg;
Number of active ingredients: 2.00;
2014-03-03;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02414414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89907
APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
lansoprazole 30 mg / cap , amoxicillin 500 mg / cap , clarithromycin 500 mg / tab;
Number of active ingredients: 3.00;
2018-08-03;
Oral;
Capsule (Delayed Release) , Kit , Capsule , Tablet;
08:12.12.92 – OTHER MACROLIDES , 08:12.16.08 – AMINOPENICILLINS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
DIN: 02470780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95983
ACT LATANOPROST/TIMOLOL
latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2015-09-29;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
TEVA CANADA LIMITED
DIN: 02436256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92058
MED-LATANOPROST-TIMOLOL
latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2019-08-22;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02454505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94108
LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION
latanoprost 50 mcg / ml , timolol (timolol maleate) 5 mg / ml;
Number of active ingredients: 2.00;
2020-07-03;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
TELIGENT CANADA INC
DIN: 02489368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97945
PROLOPA CAP 100-25
levodopa 100 mg , benserazide (benserazide hydrochloride) 25 mg;
Number of active ingredients: 2.00;
1977-12-31;
Oral;
Capsule;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 00386464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2723
AA-LEVOCARB CR
levodopa 100 mg , carbidopa 25 mg;
Number of active ingredients: 2.00;
2009-02-04;
Oral;
Tablet (Extended-Release);
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
AA PHARMA INC
DIN: 02272873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75839
STALEVO
levodopa 100 mg , carbidopa 25 mg , entacapone 200 mg;
Number of active ingredients: 3.00;
2008-04-28;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02305941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79151
STALEVO
levodopa 125 mg , carbidopa 31.25 mg , entacapone 200 mg;
Number of active ingredients: 3.00;
2010-01-20;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02337835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82348
STALEVO
levodopa 150 mg , carbidopa 37.5 mg , entacapone 200 mg;
Number of active ingredients: 3.00;
2008-04-28;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02305968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79152
PROLOPA CAP 200-50
levodopa 200 mg , benserazide (benserazide hydrochloride) 50 mg;
Number of active ingredients: 2.00;
1977-12-31;
Oral;
Capsule;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 00386472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2724
AA-LEVOCARB CR
levodopa 200 mg , carbidopa 50 mg;
Number of active ingredients: 2.00;
2003-11-13;
Oral;
Tablet (Extended-Release);
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
AA PHARMA INC
DIN: 02245211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69226
PROLOPA CAP 50-12.5
levodopa 50 mg , benserazide (benserazide hydrochloride) 12.5 mg;
Number of active ingredients: 2.00;
1981-12-31;
Oral;
Capsule;
28:36.16 – DOPAMINE PRECURSORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 00522597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4459
STALEVO
levodopa 50 mg , carbidopa 12.5 mg , entacapone 200 mg;
Number of active ingredients: 3.00;
2008-04-28;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02305933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79150
STALEVO
levodopa 75 mg , carbidopa 18.75 mg , entacapone 200 mg;
Number of active ingredients: 3.00;
2010-01-20;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS , 28:36.16 – DOPAMINE PRECURSORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02337827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82347
PORTIA 21
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2007-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02295946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78129
PORTIA 28
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2007-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02295954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78130
SEASONALE
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2008-01-03;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02296659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78201
INDAYO
levonorgestrel 0.15 mg , ethinyl estradiol 0.03 mg;
Number of active ingredients: 2.00;
2016-09-01;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02398869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88378
ALESSE 21
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
1998-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02236974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60269
ALESSE 28
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
1998-01-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02236975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60270
AVIANE 21
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
2007-11-05;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02298538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78383
AVIANE 28
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
2007-11-05;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02298546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78384
ALYSENA 21
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
2012-11-19;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02387875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87345
ALYSENA 28
levonorgestrel 100 mcg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
2012-11-19;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02387883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87346
MIN-OVRAL 21
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02042320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18754
MIN-OVRAL 28
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02042339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18755
OVIMA 21
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
Number of active ingredients: 2.00;
2013-08-27;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02387085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87265
OVIMA 28
levonorgestrel 150 mcg , ethinyl estradiol 30 mcg;
Number of active ingredients: 2.00;
2013-08-27;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
APOTEX INC
DIN: 02387093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87266
XYLONOR
lidocaine 15 g / 100 g , cetrimide 150 mg / 100 g;
Number of active ingredients: 2.00;
1997-03-26;
Buccal;
Spray, Metered Dose;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02218607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37164
EMLA CREAM
lidocaine 2.5 % , prilocaine 2.5 %;
Number of active ingredients: 2.00;
1991-12-31;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00886858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11440
EMLA PATCH
lidocaine 2.5 % , prilocaine 2.5 %;
Number of active ingredients: 2.00;
1994-12-31;
Topical;
Patch;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02057794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16733
XYLONOR GEL
lidocaine 5 g / 100 g , cetrimonium bromide 150 mg / 100 g;
Number of active ingredients: 2.00;
1981-12-31;
Topical;
Gel;
52:16.00 – LOCAL ANESTHETICS;
Otc;
SEPTODONT
DIN: 00479896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4410
PLIAGLIS
lidocaine 7 % , tetracaine 7 %;
Number of active ingredients: 2.00;
2015-09-28;
Topical;
Cream;
72:00.00 – LOCAL ANESTHETICS;
Prescription;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02398028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88297
INSTILLAGEL
lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % / w/w , chlorhexidine gluconate 0.05 % / w/w;
Number of active ingredients: 2.00;
2007-12-06;
Urethral;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02294990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78032
XYLOCAINE 1% W EPINEPHRINE 1:100000
lidocaine hydrochloride 10 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
Number of active ingredients: 2.00;
1954-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00001791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=589
XYLOCAINE 1% W EPINEPHRINE 1:200000
lidocaine hydrochloride 10 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
Number of active ingredients: 2.00;
1954-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00001805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=590
BACTINE FIRST AID SPRAY
lidocaine hydrochloride 2.5 % / w/w , benzalkonium chloride 0.13 % / w/w;
Number of active ingredients: 2.00;
1995-12-31;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
WELLSPRING PHARMACEUTICAL CANADA CORP
DIN: 02150379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19488
XYLOCAINE 2% WITH EPINEPHRINE 1:200000
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.005 mg / ml;
Number of active ingredients: 2.00;
2012-04-25;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02373130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85829
OCTOCAINE HCL 2% EPINEPHRINE 1:100000
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
Number of active ingredients: 2.00;
1964-12-31;
Subcutaneous;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 00151866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=636
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.01 mg / ml;
Number of active ingredients: 2.00;
2016-01-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02436221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92056
OCTOCAINE HCL 2% EPINEPHRINE 1:50000
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.02 mg / ml;
Number of active ingredients: 2.00;
1964-12-31;
Subcutaneous;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 00151874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=635
XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 0.02 mg / ml;
Number of active ingredients: 2.00;
2010-07-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02345072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83052
XYLOCAINE 2% W EPINEPHRINE 1:200000
lidocaine hydrochloride 20 mg / ml , epinephrine (epinephrine bitartrate) 5 mcg / ml;
Number of active ingredients: 2.00;
1965-12-31;
Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00284106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1830
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
lidocaine hydrochloride 20 mg / ml , epinephrine 0.01 mg / ml;
Number of active ingredients: 2.00;
1989-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 01901915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12648
XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000
lidocaine hydrochloride 20 mg / ml , epinephrine 0.01 mg / ml;
Number of active ingredients: 2.00;
2009-10-19;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02331640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81732
LIGNOSPAN FORTE
lidocaine hydrochloride 36 mg / 1.8 ml , epinephrine (epinephrine bitartrate) 36 mcg / 1.8 ml;
Number of active ingredients: 2.00;
1976-12-31;
Block/Infiltration;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 00375799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2506
LIGNOSPAN STANDARD
lidocaine hydrochloride 36 mg / 1.8 ml , epinephrine 18 mcg / 1.8 ml;
Number of active ingredients: 2.00;
1976-12-31;
Block/Infiltration;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 00375780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2541
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
lidocaine hydrochloride 4 mg / ml , dextrose 50 mg / ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Solution;
24:04.04.08 – CLASS IB ANTIARRYTHMICS;
Ethical;
BAXTER CORPORATION
DIN: 00828602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10519
ANTIBIOTIC CREAM PLUS PAIN RELIEF
lidocaine hydrochloride 40 mg / g , polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 3.00;
2012-04-09;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02372045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85717
TPR20
lidocaine hydrochloride 5 % / w/w , menthol 1 % / w/w;
Number of active ingredients: 2.00;
2009-05-05;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
HUMN PHARMACEUTICALS INC
DIN: 02309076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79467
JENTADUETO
linagliptin 2.5 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2013-04-17;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02403277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88809
JENTADUETO
linagliptin 2.5 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2013-04-17;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02403250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88807
JENTADUETO
linagliptin 2.5 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2013-04-17;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02403269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88808
CREON MINIMICROSPHERES 10
lipase 10000 unit , amylase 11200 unit , protease 730 unit;
Number of active ingredients: 3.00;
1996-10-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
DIN: 02200104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36179
COTAZYM
lipase 10000 unit , amylase 40000 unit , protease 35000 unit;
Number of active ingredients: 3.00;
1973-12-31;
Oral;
Capsule (Immediate Release);
56:16.00 – DIGESTANTS;
Prescription;
ORGANON CANADA INC.
DIN: 00263818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1649
COTAZYM ECS 8
lipase 10800 unit , amylase 42000 unit , protease 45000 unit;
Number of active ingredients: 3.00;
1980-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
ORGANON CANADA INC.
DIN: 00502790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3891
PANCREASE MT 16
lipase 16800 unit , amylase 70000 unit , protease 40000 unit;
Number of active ingredients: 3.00;
1988-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
VIVUS INC.
DIN: 00789429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9512
VIOKACE
lipase 20880 unit , protease 112500 unit , amylase 113400 unit;
Number of active ingredients: 3.00;
2000-06-02;
Oral;
Tablet;
56:16.00 – DIGESTANTS;
Prescription;
NESTLE ENTERPRISES S.A.
DIN: 02241933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65603
PANCREASE MT 20
lipase 21000 unit , amylase 61000 unit , protease 37000 unit;
Number of active ingredients: 3.00;
2020-12-21;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription , Schedule D;
VIVUS INC.
DIN: 02503441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99292
COTAZYM ECS 20
lipase 25000 unit , amylase 100000 unit , protease 100000 unit;
Number of active ingredients: 3.00;
1989-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
ORGANON CANADA INC.
DIN: 00821373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9892
CREON MINIMICROSPHERES 25
lipase 25000 unit , amylase 25500 unit , protease 1600 unit;
Number of active ingredients: 3.00;
1992-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
DIN: 01985205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13302
PANCREASE MT 2
lipase 2600 unit , amylase 10850 unit , protease 6200 unit;
Number of active ingredients: 3.00;
2020-12-21;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription , Schedule D;
VIVUS INC.
DIN: 02503433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99291
CREON MINIMICROSPHERES 35
lipase 35000 unit , amylase 35700 unit , protease 2240 unit;
Number of active ingredients: 3.00;
2021-01-26;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
DIN: 02494639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98463
PANCREASE MT 4
lipase 4200 unit , amylase 17500 unit , protease 10000 unit;
Number of active ingredients: 3.00;
1988-12-31;
Oral;
Capsule (Delayed Release);
56:16.00 – DIGESTANTS;
Prescription;
VIVUS INC.
DIN: 00789445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9514
CREON MINIMICROSPHERES MICRO
lipase 5000 unit / 100 mg , amylase 5100 unit / 100 mg , protease 320 unit / 100 mg;
Number of active ingredients: 3.00;
2015-11-18;
Oral;
Granules For Suspension, Delayed Release;
56:16.00 – DIGESTANTS;
Prescription;
BGP PHARMA ULC
DIN: 02445158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93037
TEVA-LISINOPRIL/HCTZ (TYPE Z)
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02301768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78710
TEVA-LISINOPRIL/HCTZ (TYPE P)
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-11-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02302136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78744
SANDOZ LISINOPRIL HCT
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02302365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78769
LISINOPRIL/HCTZ (TYPE Z)
lisinopril (lisinopril dihydrate) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-06-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02362945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84793
TEVA-LISINOPRIL/HCTZ (TYPE Z)
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02301776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78711
TEVA-LISINOPRIL/HCTZ (TYPE P)
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-11-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02302144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78745
SANDOZ LISINOPRIL HCT
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02302373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78770
LISINOPRIL/HCTZ (TYPE Z)
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-06-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02362953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84794
TEVA-LISINOPRIL/HCTZ (TYPE Z)
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02301784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78712
TEVA-LISINOPRIL/HCTZ (TYPE P)
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2007-11-22;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02302152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78746
SANDOZ LISINOPRIL HCT
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2007-11-21;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02302381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78771
LISINOPRIL/HCTZ (TYPE Z)
lisinopril (lisinopril dihydrate) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-06-10;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS , 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02362961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84795
ZESTORETIC
lisinopril 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02103729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16636
ZESTORETIC
lisinopril 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02045737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16903
ZESTORETIC
lisinopril 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02045729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17903
IMODIUM COMPLETE
loperamide hydrochloride 2 mg , simethicone 125 mg;
Number of active ingredients: 2.00;
2002-06-20;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02245185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69200
KALETRA
lopinavir 100 mg , ritonavir 25 mg;
Number of active ingredients: 2.00;
2008-08-11;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
DIN: 02312301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79781
KALETRA
lopinavir 200 mg , ritonavir 50 mg;
Number of active ingredients: 2.00;
2006-09-08;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
DIN: 02285533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77104
KALETRA
lopinavir 400 mg / 5 ml , ritonavir 100 mg / 5 ml;
Number of active ingredients: 2.00;
2001-03-09;
Oral;
Solution;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
ABBVIE CORPORATION
DIN: 02243644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67570
CLARITIN ALLERGY + SINUS
loratadine 5 mg , pseudoephedrine sulfate 120 mg;
Number of active ingredients: 2.00;
1991-12-31;
Oral;
Tablet (Immediate And Extended Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
BAYER INC
DIN: 01945157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11974
HYZAAR
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2007-09-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 02297841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78318
SANDOZ LOSARTAN HCT
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02362449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84745
TEVA-LOSARTAN/HCTZ
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02377144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86273
LOSARTAN HCT
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87450
MINT-LOSARTAN/HCTZ
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02389665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87516
PMS-LOSARTAN-HCTZ
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-09-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02392232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87751
AURO-LOSARTAN HCT
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02423650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90836
LOSARTAN/HCTZ
losartan potassium 100 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-07-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02427656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91216
HYZAAR DS
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2000-01-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 02241007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64599
SANDOZ LOSARTAN HCT DS
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79891
TEVA-LOSARTAN/HCTZ
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02377152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86274
LOSARTAN HCT
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-07-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87451
MINT-LOSARTAN/HCTZ DS
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-07-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02389673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87517
PMS-LOSARTAN-HCTZ
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-09-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02392240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87752
JAMP-LOSARTAN HCTZ
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02408252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89298
AURO-LOSARTAN HCT
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02423669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90837
LOSARTAN/HCTZ
losartan potassium 100 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2014-07-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02427664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91217
HYZAAR
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
1996-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 02230047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48580
SANDOZ LOSARTAN HCT
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79890
TEVA-LOSARTAN/HCTZ
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-04-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02358263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84332
LOSARTAN HCT
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87449
MINT-LOSARTAN/HCTZ
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02389657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87515
PMS-LOSARTAN-HCTZ
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-09-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02392224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87750
JAMP-LOSARTAN HCTZ
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02408244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89297
AURO-LOSARTAN HCT
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-04-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02423642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90835
LOSARTAN/HCTZ
losartan potassium 50 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-07-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02427648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91215
ORKAMBI
lumacaftor 100 mg / sachet , ivacaftor 125 mg / sachet;
Number of active ingredients: 2.00;
2018-12-14;
Oral;
Granules;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02483831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97420
ORKAMBI
lumacaftor 150 mg / sachet , ivacaftor 188 mg / sachet;
Number of active ingredients: 2.00;
2018-12-14;
Oral;
Granules;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02483858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97421
LUBRICATING NASAL GEL
macrogol 15 % , propylene glycol 20 %;
Number of active ingredients: 2.00;
1997-01-17;
Nasal;
Gel;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PHARMASCIENCE INC
DIN: 02220806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37257
RHINARIS NASAL GEL
macrogol 15 % , propylene glycol 20 %;
Number of active ingredients: 2.00;
2011-11-24;
Nasal;
Gel;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02352699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83795
EYE STREAM
magnesium chloride 0.03 % / w/v , sodium chloride 0.64 % / w/v , potassium chloride 0.075 % / w/v , calcium chloride 0.048 % / w/v;
Number of active ingredients: 4.00;
1987-12-31;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
ALCON CANADA INC
DIN: 00707937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7474
PRISM0CAL
magnesium chloride 0.108 g / 1000 ml , sodium chloride 6.449 g / 1000 ml , lactic acid 0.284 g / 1000 ml , sodium bicarbonate 58.8 g / 1000 ml;
Number of active ingredients: 4.00;
2005-12-24;
Intravenous , Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02274876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76040
PRISM0CAL B22K0/0
magnesium chloride 3.05 g / l , sodium chloride 7.14 g / l , sodium bicarbonate 2.12 g / l;
Number of active ingredients: 3.00;
2016-06-18;
Intravenous , Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02441691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92609
GELUSIL ANTACID AND ANTI-GAS
magnesium hydroxide 200 mg , aluminum hydroxide-sucrose dried gel 200 mg , simethicone 25 mg;
Number of active ingredients: 3.00;
2014-01-14;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
BOYD PHARMACEUTICALS INC.
DIN: 02409836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89449
DIOVOL PLUS ALUMINUM FREE
magnesium hydroxide 200 mg , simethicone 25 mg , calcium carbonate 200 mg;
Number of active ingredients: 3.00;
1995-12-31;
Oral;
Tablet (Chewable);
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02157624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19075
STOMAAX PLUS
magnesium hydroxide 200 mg / 5 ml , aluminum hydroxide 200 mg / 5 ml , dimethicone 25 mg / 5 ml;
Number of active ingredients: 3.00;
1989-12-31;
Oral;
Suspension;
56:04.00 – ANTACIDS AND ADSORBENTS;
Otc;
LABORATOIRE ATLAS INC
DIN: 00623709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10217
ARIDOL
mannitol 5 mg / cap , mannitol 10 mg / cap , mannitol 20 mg / cap , mannitol 40 mg / cap;
Number of active ingredients: 4.00;
2020-06-15;
Inhalation;
Kit , Powder;
36:00.00 – DIAGNOSTIC AGENTS;
Prescription Recommended;
PHARMAXIS LTD
DIN: 02489562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97957
CYSTOSOL W 3% HEXITOLS
mannitol 500 mg / 100 ml , sorbitol 2.5 g / 100 ml;
Number of active ingredients: 2.00;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00799963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9829
M-M-R II
measles virus vaccine live attenuated 1000 unit / 0.5 ml , mumps virus vaccine live attenuated (jeryl lynn strain) 5000 unit / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 unit / 0.5 ml;
Number of active ingredients: 3.00;
1979-12-31;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 00466085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3569
TELEBRIX 38 ORAL
meglumine ioxitalamate 513 mg / ml , sodium ioxitalamate 255 mg / ml;
Number of active ingredients: 2.00;
1995-12-31;
Oral;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
LIEBEL-FLARSHEIM CANADA INC
DIN: 02131684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17800
ALKERAN
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
Number of active ingredients: 2.00;
1995-12-31;
Intra-Arterial , Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02087286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18786
MELPHALAN FOR INJECTION
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
Number of active ingredients: 2.00;
2018-11-20;
Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 02468921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95758
MELPHALAN FOR INJECTION
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
Number of active ingredients: 2.00;
2018-06-18;
Intra-Arterial , Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02473348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96274
TARO-MELPHALAN
melphalan (melphalan hydrochloride) 50 mg / vial , buffer solution 10 ml / vial;
Number of active ingredients: 2.00;
2021-01-25;
Intra-Arterial , Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02480026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97057
MENJUGATE LIQUID
meningococcal group c oligosaccharide 10 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 25 mcg / 0.5 ml;
Number of active ingredients: 2.00;
2015-10-07;
Intramuscular;
Suspension;
80:08.00 – TOXOIDS , 80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02440709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92507
NEISVAC-C
meningococcal polysaccharide vaccine grp c 10 mcg / 0.5 ml , tetanus toxoid 20 mcg / 0.5 ml;
Number of active ingredients: 2.00;
2002-01-21;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
PFIZER CANADA ULC
DIN: 02245057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69061
MENACTRA
meningococcal polysaccharide-diphtheria toxoid conjugate – group a 4 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group c 4 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group y 4 mcg / 0.5 ml , meningococcal polysaccharide-diphtheria toxoid conjugate – group w 135 4 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2006-10-20;
Intramuscular;
Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02279924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76550
GOLD BOND ANTI-ITCH LOTION
menthol 0.5 % / w/w , pramoxine hydrochloride 1 % / w/w , dimethicone 5 % / w/w;
Number of active ingredients: 3.00;
2009-03-05;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02318482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80397
GOLD BOND MEDICATED ANTI-ITCH CREAM
menthol 1 % / w/w , pramoxine hydrochloride 1 % / w/w;
Number of active ingredients: 2.00;
1999-01-11;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02236991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60289
ABSORBINE JR LINIMENT
menthol 1.25 % , chloroxylenol 0.5 %;
Number of active ingredients: 2.00;
1993-12-31;
Topical;
Liquid;
84:24.04 – BASIC LOTIONS AND LINIMENTS;
Otc;
CLARION BRANDS LLC
DIN: 01942301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42113
BENYLIN EXTRA STRENGTH MUCUS & PHLEGM
menthol 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 2.00;
2009-07-21;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02320940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80636
BUCKLEY’S NIGHTTIME COUGH & CONGESTION
menthol 22 mg / 5 ml , diphenhydramine hydrochloride 12.5 mg / 5 ml;
Number of active ingredients: 2.00;
1997-06-23;
Oral;
Syrup;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02230939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50217
ABSORBINE JR EXTRA STRENGTH LINIMENT
menthol 4 % , chloroxylenol 0.5 %;
Number of active ingredients: 2.00;
1992-12-31;
Topical;
Liquid;
84:24.04 – BASIC LOTIONS AND LINIMENTS;
Otc;
CLARION BRANDS LLC
DIN: 01942271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41939
ISOCAINE HCL INJ 2%
mepivacaine hydrochloride 20 mg / ml , corbadrine 0.05 mg / ml;
Number of active ingredients: 2.00;
1977-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 00393711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2744
CARBOCAINE 2% WITH NEO-COBEFRIN
mepivacaine hydrochloride 20 mg / ml , corbadrine 0.05 mg / ml;
Number of active ingredients: 2.00;
2019-07-30;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 02474182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96421
MUSCLE & BACK PAIN RELIEF CAPLETS
methocarbamol 400 mg , acetaminophen 325 mg;
Number of active ingredients: 2.00;
1997-04-08;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02230790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50062
MUSCLE AND BACK PAIN RELIEF REGULAR STRENGTH TABLETS
methocarbamol 400 mg , acetaminophen 325 mg;
Number of active ingredients: 2.00;
2005-11-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02251876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73677
ROBAXACET-8
methocarbamol 400 mg , acetaminophen 325 mg , codeine phosphate 8 mg;
Number of active ingredients: 3.00;
1992-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01934767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12942
ROBAXACET EXTRA STRENGTH
methocarbamol 400 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
1997-07-07;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02231176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50484
EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF
methocarbamol 400 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
1999-06-04;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02239141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62597
EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF
methocarbamol 400 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2005-09-19;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02251884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73678
EXTRA STRENGTH TYLENOL BODY PAIN NIGHT
methocarbamol 400 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2011-03-30;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02357356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84247
MUSCLE AND BACK PAIN RELIEF
methocarbamol 400 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2018-04-03;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02451298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93755
ROBAXISAL C 1/2
methocarbamol 400 mg , acetylsalicylic acid 325 mg , codeine phosphate 32.4 mg;
Number of active ingredients: 3.00;
1992-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01934791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12946
ROBAXISAL EXTRA STRENGTH
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
Number of active ingredients: 2.00;
1997-07-07;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02230949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50227
MUSCLE RELAXANT AND BACK PAIN RELIEF EXTRA STRENGTH TABLETS
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
Number of active ingredients: 2.00;
2009-02-23;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02251906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73680
EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
Number of active ingredients: 2.00;
2005-05-01;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02252228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73710
EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA
methocarbamol 400 mg , acetylsalicylic acid 500 mg;
Number of active ingredients: 2.00;
2014-09-04;
Oral;
Tablet;
28:08.04.24 – SALICYLATES , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02426625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91119
MUSCLE AND BACK PAIN PLATINUM RELIEF
methocarbamol 500 mg , ibuprofen 200 mg;
Number of active ingredients: 2.00;
2014-06-17;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02422042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90673
ANALGESIC AND MUSCLE RELAXANT
methocarbamol 500 mg , ibuprofen 400 mg;
Number of active ingredients: 2.00;
2012-03-20;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
PHARMASCIENCE INC
DIN: 02377462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86317
DEPO-MEDROL WITH LIDOCAINE
methylprednisolone acetate 40 mg / ml , lidocaine hydrochloride 10 mg / ml;
Number of active ingredients: 2.00;
1973-12-31;
Intra-Articular , Intrabursal;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00260428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1619
FLAGYSTATIN
metronidazole 500 mg , nystatin 100000 unit;
Number of active ingredients: 2.00;
1979-12-31;
Vaginal;
Suppository;
84:04.04 – ANTIBIOTICS , 84:04.08.28 – POLYENES;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 01926829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12654
MONISTAT 7 DUAL-PAK
miconazole nitrate 100 mg / sup , miconazole nitrate 2 %;
Number of active ingredients: 2.00;
1994-12-31;
Topical , Vaginal;
Suppository , Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02126257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16611
MONISTAT 1 COMBINATION PACK
miconazole nitrate 1200 mg / sup , miconazole nitrate 2 %;
Number of active ingredients: 2.00;
1999-02-26;
Topical , Vaginal;
Suppository , Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02239600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63070
MONISTAT 3 DUAL-PAK
miconazole nitrate 400 mg / sup , miconazole nitrate 2 %;
Number of active ingredients: 2.00;
1986-12-31;
Topical , Vaginal;
Ovule , Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02126249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16610
MIFEGYMISO
mifepristone 200 mg , misoprostol 200 mcg;
Number of active ingredients: 2.00;
2017-01-10;
Buccal , Oral;
Kit , Tablet;
76:00.00 – OXYTOCICS , 56:28.28 – PROSTAGLANDINS;
Prescription;
LINEPHARMA INTERNATIONAL LIMITED
DIN: 02444038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92881
MAGNOLAX
mineral oil 0.25 ml / ml , magnesium hydroxide 60 mg / ml;
Number of active ingredients: 2.00;
1972-12-31;
Oral;
Emulsion;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00202045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1281
SYSTANE OINTMENT
mineral oil 3 % , lanolin 3 % , white petrolatum 94 %;
Number of active ingredients: 3.00;
2016-03-01;
Ophthalmic;
Ointment;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 02444062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92885
SOOTHE RESTORE
mineral oil 4.5 % , mineral oil light 1 %;
Number of active ingredients: 2.00;
2018-05-03;
Ophthalmic;
Drops;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
DIN: 02465302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95350
REFRESH LACRI-LUBE
mineral oil 42.5 % , white petrolatum 57.3 %;
Number of active ingredients: 2.00;
1989-12-31;
Ophthalmic;
Ointment;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALLERGAN INC
DIN: 00210889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9820
HUILE DE BAIN THERAPEUTIQUE
mineral oil 91.7 % , lanolin 3 %;
Number of active ingredients: 2.00;
1992-12-31;
Topical;
Solution;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LABORATOIRE ATLAS INC
DIN: 01939068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12947
POLLINEX R
modified ragweed tyrosine adsorbate 210 unit / ml , modified ragweed tyrosine adsorbate 500 unit / ml , modified ragweed tyrosine adsorbate 1400 unit / ml , modified ragweed tyrosine adsorbate 4300 unit / ml;
Number of active ingredients: 4.00;
1979-12-31;
Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALLERGY THERAPEUTICS (UK) LTD
DIN: 00464988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3409
ZENHALE
mometasone furoate 100 mcg / act , formoterol fumarate dihydrate 5 mcg / act;
Number of active ingredients: 2.00;
2011-03-10;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS;
Prescription;
ORGANON CANADA INC.
DIN: 02361752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84680
ZENHALE
mometasone furoate 200 mcg / act , formoterol fumarate dihydrate 5 mcg / act;
Number of active ingredients: 2.00;
2011-06-17;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS;
Prescription;
ORGANON CANADA INC.
DIN: 02361760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84681
PRIORIX
mumps virus vaccine live attenuated (jeryl lynn strain) 10000 ccid50 / 0.5 ml , measles virus vaccine live attenuated 1000 ccid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 ccid50 / 0.5 ml , water 0.5 ml;
Number of active ingredients: 4.00;
1998-12-04;
Intramuscular , Subcutaneous;
Kit , Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02239208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62666
PRIORIX-TETRA
mumps virus vaccine live attenuated (jeryl lynn strain) 25118.9 ccid50 / 0.5 ml , measles virus vaccine live attenuated 1000 ccid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000 ccid50 / 0.5 ml , varicella-zoster virus vaccine live attenuated (oka/merck strain) 1995.2623 ccid50 / 0.5 ml;
Number of active ingredients: 4.00;
2008-06-04;
Intramuscular , Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02297884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78322
TEVA-BUPRENORPHINE/NALOXONE
naloxone (naloxone hydrochloride dihydrate) 0.5 mg , buprenorphine (buprenorphine hydrochloride) 2 mg;
Number of active ingredients: 2.00;
2017-09-28;
Sublingual;
Tablet;
28:08.12 – OPIATE PARTIAL AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02453908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94043
CONTRAVE
naltrexone hydrochloride 8 mg , bupropion hydrochloride 90 mg;
Number of active ingredients: 2.00;
2018-03-16;
Oral;
Tablet (Extended-Release);
28:20.08.92 – Anorexigenic Agents, Miscellaneous;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02472945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96230
CLEAR EYES ALLERGY
naphazoline hydrochloride 0.012 % , glycerine 0.26 % , zinc sulfate 0.25 %;
Number of active ingredients: 3.00;
2004-03-24;
Ophthalmic;
Liquid;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
DIN: 02248059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72379
NAPHCON A
naphazoline hydrochloride 0.025 % , pheniramine maleate 0.3 %;
Number of active ingredients: 2.00;
1980-12-31;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
ALCON CANADA INC
DIN: 00481408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3743
OPTI-TEARS ALLERGY
naphazoline hydrochloride 0.025 % , pheniramine maleate 0.3 %;
Number of active ingredients: 2.00;
2017-04-04;
Ophthalmic;
Solution;
04:04.20 – PROPYLAMINE DERIVATIVES , 52:32.00 – VASOCONSTRICTORS;
Otc;
ALCON CANADA INC
DIN: 02445573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93086
SOOTHE ALLERGY
naphazoline hydrochloride 0.02675 % / w/v , pheniramine maleate 0.315 % / w/v;
Number of active ingredients: 2.00;
1987-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
BAUSCH & LOMB INC
DIN: 00750794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8155
CLEAR EYES EXTRA STRENGTH REDNESS RELIEF
naphazoline hydrochloride 0.03 % / w/v , glycerine 0.5 % / w/v;
Number of active ingredients: 2.00;
2011-04-27;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
DIN: 02360837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84583
VIMOVO
naproxen 375 mg , esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
Number of active ingredients: 2.00;
2011-02-04;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02361701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84676
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
naproxen 375 mg , esomeprazole (esomeprazole magnesium) 20 mg;
Number of active ingredients: 2.00;
2017-02-27;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02458608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94575
VIMOVO
naproxen 500 mg , esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
Number of active ingredients: 2.00;
2011-02-04;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02361728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84677
MYLAN-NAPROXEN/ESOMEPRAZOLE MR
naproxen 500 mg , esomeprazole (esomeprazole magnesium) 20 mg;
Number of active ingredients: 2.00;
2017-02-10;
Oral;
Tablet (Immediate And Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02443449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92813
ALEVE NIGHTTIME
naproxen sodium 220 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 2.00;
2016-02-24;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BAYER INC
DIN: 02444593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92965
TRUMENBA
neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a 60 mcg / 0.5 ml , neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b 60 mcg / 0.5 ml;
Number of active ingredients: 2.00;
2018-01-31;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
PFIZER CANADA ULC
DIN: 02468751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95723
OXYGEN USP, NITROGEN NF, MEDICAL GAS MIXTURE
nitrogen 50 % , oxygen 50 %;
Number of active ingredients: 2.00;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13894
NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML
nitroglycerin 20 mg / 100 ml , dextrose 5 g / 100 ml;
Number of active ingredients: 2.00;
1995-12-31;
Intravenous;
Solution;
24:12.08 – NITRATES AND NITRITES;
Ethical;
BAXTER CORPORATION
DIN: 02145308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18086
NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML
nitroglycerin 40 mg / 100 ml , dextrose 5 g / 100 ml;
Number of active ingredients: 2.00;
1995-12-31;
Intravenous;
Solution;
24:12.08 – NITRATES AND NITRITES;
Ethical;
BAXTER CORPORATION
DIN: 02145316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18085
LIQUI-MED ANALGESIC GAS
nitrous oxide 50 % , oxygen 50 %;
Number of active ingredients: 2.00;
1983-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
PRAXAIR CANADA INC
DIN: 00693596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6850
ALNOX GAS
nitrous oxide 50 % , oxygen 50 %;
Number of active ingredients: 2.00;
1995-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 02071010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18513
EVRA
norelgestromin 200 mcg / 24 hour , ethinyl estradiol 35 mcg / 24 hour;
Number of active ingredients: 2.00;
2003-12-24;
Transdermal;
Patch (Extended Release);
68:12.00 – CONTRACEPTIVES;
Prescription;
JANSSEN INC
DIN: 02248297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72637
SYNPHASIC 21 TABLETS
norethindrone 0.5 mg , ethinyl estradiol 0.035 mg , norethindrone 1 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 4.00;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02187108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42889
BREVICON 1/35 TABLETS (21-DAY PACK)
norethindrone 1 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
1996-08-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02189054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42921
BREVICON 1/35 TABLETS (28-DAY PACK)
norethindrone 1 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
1996-09-16;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02189062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42922
SELECT 1/35 (21-DAY)
norethindrone 1 mg , ethinyl estradiol 0.035 mg;
Number of active ingredients: 2.00;
1997-05-08;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
PFIZER CANADA ULC
DIN: 02197502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42952
LOLO
norethindrone acetate 1 mg , ethinyl estradiol 10 mcg , ethinyl estradiol 10 mcg;
Number of active ingredients: 3.00;
2014-03-24;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
DIN: 02417456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90215
MINESTRIN 1/20
norethindrone acetate 1 mg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
1975-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
DIN: 00343838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2254
MINESTRIN 1/20
norethindrone acetate 1 mg , ethinyl estradiol 20 mcg;
Number of active ingredients: 2.00;
1975-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
DIN: 00315966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2255
LOESTRIN 1.5/30
norethindrone acetate 1.5 mg , ethinyl estradiol 30 mcg;
Number of active ingredients: 2.00;
1974-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
DIN: 00297143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1922
LOESTRIN 1.5/30
norethindrone acetate 1.5 mg , ethinyl estradiol 30 mcg;
Number of active ingredients: 2.00;
1976-12-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
ALLERGAN INC
DIN: 00353027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2386
BANANA BOAT SUNSCREEN OIL SPRAY HUILE ÉCRAN SOLAIRE EN VAPORISATEUR SPF FPS 4
octinoxate 2 % / w/w , padimate o 1.4 % / w/w;
Number of active ingredients: 2.00;
2001-03-15;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02242583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66357
ALMOST POWDER MAKEUP TEINT POUDRE NATUREL SPF 18 / FPS 18
octinoxate 2 % / w/w , titanium dioxide 1.2 % / w/w;
Number of active ingredients: 2.00;
2019-06-01;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02482991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97339
AGE RENEWAL SPF 25
octinoxate 2.5 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 2.00;
2013-05-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02393093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87834
CC CREAM BROAD SPECTRUM SPF 30
octinoxate 2.5 % / w/w , homosalate 7 % / w/w , oxybenzone 2 % / w/w , titanium dioxide 4.1 % / w/w;
Number of active ingredients: 4.00;
2014-09-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02426145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91075
M.A.C STUDIO FIX FLUID SPF 15
octinoxate 2.5 % / w/w , titanium dioxide 1 % / w/w;
Number of active ingredients: 2.00;
2010-03-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
DIN: 02328259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81378
LE FOND DE TEINT
octinoxate 3.9 % / w/w , titanium dioxide 3.3 % / w/w;
Number of active ingredients: 2.00;
2017-09-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02458284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94538
ELIZABETH ARDEN NOURISHING LIP BALM SPF 20
octinoxate 4 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2013-02-11;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
DIN: 02392895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87816
ARTISTRY HYDRA-V SHEER WEIGHTLESS FOUNDATION
octinoxate 4 % / w/w , zinc oxide 2.74 % / w/w;
Number of active ingredients: 2.00;
2018-05-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02463490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95157
CERAMIDE LIFT AND FIRM EYE CREAM SPF 15
octinoxate 4.09 % / w/w , oxybenzone 1.4 % / w/w;
Number of active ingredients: 2.00;
2011-03-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
DIN: 02354470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83964
PREVAGE ANTI-AGING EYE CREAM SPF 15
octinoxate 4.09 % / w/w , oxybenzone 1.4 % / w/w;
Number of active ingredients: 2.00;
2010-10-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
DIN: 02355302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84055
CLÉ DE PEAU BEAUTÉ RADIANT CREAM FOUNDATION
octinoxate 4.4 % / w/w , titanium dioxide 1.2 % / w/w;
Number of active ingredients: 2.00;
2016-07-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02446952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93252
PHELITYL DAY LOTION SPF 15
octinoxate 5 % , avobenzone 2 %;
Number of active ingredients: 2.00;
2012-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ERNO LASZLO
DIN: 02383314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86907
MAC STUDIO FINISH CONCEALER SPF 35
octinoxate 5 % , titanium dioxide 2 %;
Number of active ingredients: 2.00;
2004-01-05;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
DIN: 02248338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72680
TEINT LUMIÈRE
octinoxate 5 % / w/w , titanium dioxide 1.52 % / w/w;
Number of active ingredients: 2.00;
2015-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02434016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91835
M.A.C. STUDIO WATERWEIGHT SPF 30 FOUNDATION
octinoxate 5 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 2.1 % / w/w;
Number of active ingredients: 3.00;
2015-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
DIN: 02437376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92171
ESTEE LAUDER DOUBLE WEAR NUDE WATER FRESH MAKEUP SPF 30
octinoxate 5 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 2.2 % / w/w;
Number of active ingredients: 3.00;
2017-07-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02459868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94717
SUPERDEFENSE CITY BLOCK DAILY ENERGY + FACE PROTECTOR SPF 50
octinoxate 5 % / w/w , zinc oxide 3.6 % / w/w , titanium dioxide 3.2 % / w/w;
Number of active ingredients: 3.00;
2020-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02492970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98295
CLINIQUE EVEN BETTER MAKEUP SPF 15
octinoxate 5.9 % / w/w , titanium dioxide 3.5 % / w/w , zinc oxide 2.8 % / w/w;
Number of active ingredients: 3.00;
2012-03-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02367998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85281
CLINIQUE REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY
octinoxate 5.9 % / w/w , titanium dioxide 3.7 % / w/w , zinc oxide 2.9 % / w/w;
Number of active ingredients: 3.00;
2012-03-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02370425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85558
BRONZ REPAIR SEA AND TROPICS FACE
octinoxate 6 % , avobenzone 2.6 %;
Number of active ingredients: 2.00;
2016-09-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02455250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94207
BRIGHT SKIN MOISTURIZER SPF 30
octinoxate 6 % , zinc oxide 4.5 %;
Number of active ingredients: 2.00;
2012-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
DIN: 02392704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87795
RED CURRANT PROTECTIVE MOISTURIZER SPF 30
octinoxate 6 % , zinc oxide 4.5 %;
Number of active ingredients: 2.00;
2013-09-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
DIN: 02410281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89494
TROPICAL VANILLA BODY SPF 32
octinoxate 6 % , zinc oxide 5 %;
Number of active ingredients: 2.00;
2009-08-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
DIN: 02330679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81642
TROPICAL VANILLA SUN CREAM
octinoxate 6 % , zinc oxide 5 %;
Number of active ingredients: 2.00;
2009-08-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
DIN: 02330687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81643
SOOTHING CARE
octinoxate 6 % / w/w , avobenzone 2.5 % / w/w , octocrylene 1.85 % / w/w;
Number of active ingredients: 3.00;
2014-06-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02416611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90120
BUTTERSTICK
octinoxate 6 % / w/w , octocrylene 6 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2019-06-05;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
DIN: 02466716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95506
OLAY AGE DEFYING ADVANCED WITH HYALURONIC ACID HYDRATING MOISTURIZER LOTION WITH SUNSCREEN
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
Number of active ingredients: 2.00;
2018-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02460874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94836
OLAY AGE DEFYING CLASSIC DAILY RENEWAL LOTION WITH SUNSCREEN
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
Number of active ingredients: 2.00;
2017-09-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02460882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94837
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 SENSITIVE
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
Number of active ingredients: 2.00;
2018-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02461242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94873
OLAY COMPLETE UV365* DAILY MOISTURIZING CREAM WITH SUNSCREEN BROAD SPECTRUM SPF 15 SENSITIVE
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
Number of active ingredients: 2.00;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02461250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94875
OLAY SENSITIVE
octinoxate 6 % / w/w , zinc oxide 3 % / w/w;
Number of active ingredients: 2.00;
2020-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02492792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98279
SPF 50 CLASSIC FACE SPORT COOLA CLASSIC SUNSCREEN WHITE TEA MOISTURIZER
octinoxate 6.25 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2018-05-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02464543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95268
EXTRA LASTING CREAM-TO-POWDER FOUNDATION
octinoxate 6.34 % / w/w , titanium dioxide 3 % / w/w;
Number of active ingredients: 2.00;
2011-06-22;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02358387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84344
MARY KAY CC CREAM
octinoxate 6.5 % / w/w , homosalate 5 % / w/w , oxybenzone 1.2 % / w/w;
Number of active ingredients: 3.00;
2014-02-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MARY KAY COSMETICS LTD
DIN: 02414430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89908
COMPLETE MOISTURE
octinoxate 6.6 % , octisalate 4.4 %;
Number of active ingredients: 2.00;
2020-04-24;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
DIN: 02475189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96549
SUPERFRUIT SOOTHER
octinoxate 6.6 % , octisalate 4.4 %;
Number of active ingredients: 2.00;
2019-05-28;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
DIN: 02487160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97729
ULTRA-RICH HYDRATION
octinoxate 6.6 % / w/w , octisalate 4.4 % / w/w;
Number of active ingredients: 2.00;
2019-11-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
DIN: 02487926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97804
SHADE AND ILLUMINATE SOFT RADIANCE FOUNDATION SPF 50
octinoxate 6.7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 3.8 % / w/w , ensulizole 2.7 % / w/w;
Number of active ingredients: 4.00;
2020-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TOM FORD BEAUTY DIST.
DIN: 02491494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98149
FUTURIST HYDRA RESCUE MOISTURIZING MAKEUP FOND DE TEINT HYDRATANT SPF/FPS 45
octinoxate 6.7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 3.8 % / w/w , ensulizole 2.7 % / w/w;
Number of active ingredients: 4.00;
2020-02-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02494604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98460
HEALTHY GLOW ALL-IN-ONE TINTED MOISTURIZER BROAD SPECTRUM SPF 25
octinoxate 6.7 % / w/w , titanium dioxide 3.1 % / w/w , zinc oxide 1.3 % / w/w;
Number of active ingredients: 3.00;
2020-09-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SMASHBOX COSMETICS DIST
DIN: 02496909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98678
CC CREAM CORRECTION COMPLETE COMPLETE CORRECTION FPS 50 / SPF 50
octinoxate 6.8 % , titanium dioxide 4 % , zinc oxide 15.2 %;
Number of active ingredients: 3.00;
2019-07-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CHANEL CANADA ULC
DIN: 02486849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97701
RENEWED HOPE IN A JAR SPF 30
octinoxate 7 % / w/w , avobenzone 2.7 % / w/w , octocrylene 2 % / w/w;
Number of active ingredients: 3.00;
2017-10-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
HFC PRESTIGE INTERNATIONAL CANADA INC
DIN: 02461676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94933
ANEW VITALE DAY CREAM
octinoxate 7 % / w/w , octisalate 4.5 % / w/w , oxybenzone 4 % / w/w , avobenzone 2.8 % / w/w;
Number of active ingredients: 4.00;
2014-09-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02419181
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90373
MAC STUDIO SCULPT SPF 15 FOUNDATION
octinoxate 7 % / w/w , titanium dioxide 2 % / w/w;
Number of active ingredients: 2.00;
2009-02-06;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAKE UP ART COSMETICS DIST MAC
DIN: 02311143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79674
AMOREPACIFIC COLOR CONTROL CUSHION COMPACT
octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
Number of active ingredients: 3.00;
2018-02-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
DIN: 02462621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95041
IOPE AIR CUSHION
octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
Number of active ingredients: 3.00;
2019-08-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
DIN: 02488299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97839
SULWHASOO PERFECTING CUSHION
octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w , zinc oxide 9.8 % / w/w;
Number of active ingredients: 3.00;
2019-10-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
DIN: 02491117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98113
FLAWLESS FUTURE
octinoxate 7.14 % / w/w , octisalate 4.75 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2014-07-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
DIN: 02417928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90252
FUTURE SOLUTION LX TOTAL PROTECTIVE EMULSION E
octinoxate 7.4 % , octocrylene 2 % , avobenzone 1.5 % , oxybenzone 1 %;
Number of active ingredients: 4.00;
2017-09-08;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02461951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94971
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E
octinoxate 7.4 % , octocrylene 3 % , avobenzone 2 % , oxybenzone 1.5 %;
Number of active ingredients: 4.00;
2017-09-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02461943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94970
COLOR-SMART DAY MOISTURIZER HYDRATANT JOUR CORRECTEUR DE TEINT BROAD SPECTRUM SPF 30 FPS 30 A LARGE SPECTRE
octinoxate 7.4 % , titanium dioxide 4.5 %;
Number of active ingredients: 2.00;
2019-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02480565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97111
COLOR-SMART DAY MOISTURIZER OIL-FREE HYDRATANT JOUR CORRECTEUR DE TEINT SANS CORPS GRAS BROAD SPECTRUM SPF 30 FPS
octinoxate 7.4 % , titanium dioxide 5.3 %;
Number of active ingredients: 2.00;
2019-05-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02480573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97112
CLINIQUE FOR MEN SPF 21 MOISTURIZER
octinoxate 7.4 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , oxybenzone 2 % / w/w;
Number of active ingredients: 4.00;
2006-11-28;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02271508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75697
UV PROTECTIVE COMPACT FOUNDATION (REFILL)
octinoxate 7.4 % / w/w , octocrylene 5 % / w/w , titanium dioxide 11.8 % / w/w;
Number of active ingredients: 3.00;
2016-03-14;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02424002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90873
ANTI-AGING COMPLEX EYE TREATMENT BROAD SPECTRUM SPF 15
octinoxate 7.4 % / w/w , zinc oxide 6.5 % / w/w;
Number of active ingredients: 2.00;
2013-08-28;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02404842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88967
BEAUTY BOOSTER LIP GLOSS SPF 15
octinoxate 7.5 % , avobenzone 2 %;
Number of active ingredients: 2.00;
2017-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TRISH MCEVOY LTD
DIN: 02461838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94957
DORMER 211 FACE CREAM SPF 15
octinoxate 7.5 % , avobenzone 2 % , oxybenzone 3 %;
Number of active ingredients: 3.00;
1995-12-31;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DORMER LABORATORIES INC.
DIN: 02035472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18554
SUNSCREEN LOTION SPF 30
octinoxate 7.5 % , avobenzone 2.5 % , ensulizole 2 %;
Number of active ingredients: 3.00;
2018-08-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VIVIER CANADA INCORPORATED
DIN: 02473844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96351
DYNAMIC SKIN RECOVERY SPF 50
octinoxate 7.5 % , avobenzone 3 %;
Number of active ingredients: 2.00;
2018-05-31;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMALOGICA, LLC
DIN: 02466007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95427
ULTRA CALMING DAILY MOISTURIZER SPF 15
octinoxate 7.5 % , avobenzone 3 % , octisalate 2 %;
Number of active ingredients: 3.00;
2005-08-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02260255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74548
ADAPTASUN SUN CARE LOTION SEA AND TROPICS BODY / LAIT DE SOIN SOLAIRE MER ET TROPIQUES CORPS SPF/FPS 35
octinoxate 7.5 % , homosalate 3 % , avobenzone 2.5 %;
Number of active ingredients: 3.00;
2016-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02452642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93901
DRY OIL SUNSCREEN
octinoxate 7.5 % , homosalate 5 % , octisalate 5 % , oxybenzone 3 %;
Number of active ingredients: 4.00;
2015-03-09;
Topical;
Spray, Bag-On-Valve;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02431041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91549
POSITIVELY RADIANT DAILY MOISTURIZER SPF 15
octinoxate 7.5 % , octisalate 2 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2004-12-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02250942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73587
SOFTLIPS SLIMS
octinoxate 7.5 % , octisalate 3 % , oxybenzone 3 %;
Number of active ingredients: 3.00;
2001-02-01;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
DIN: 02240701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64289
HYDRATANT DÉFENSE FPS 30
octinoxate 7.5 % , octocrylene 5 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2018-04-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02468808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95734
AVON SUN LIP BALM SPF 15
octinoxate 7.5 % , oxybenzone 2 %;
Number of active ingredients: 2.00;
2000-04-06;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02240745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64334
DEEP MOISTURE RENEWAL WITH SPF 15
octinoxate 7.5 % , oxybenzone 2.5 %;
Number of active ingredients: 2.00;
2008-09-11;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
DIN: 02308576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79420
SUN-SHADES LIP BALM SPF 15 – PINA COLADA STK
octinoxate 7.5 % , oxybenzone 3 %;
Number of active ingredients: 2.00;
1994-12-31;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MELALEUCA OF CANADA INC.
DIN: 02045613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42332
AVON MOISTURE SHIELD-TINTED SPF 15 CRM
octinoxate 7.5 % , oxybenzone 3.5 %;
Number of active ingredients: 2.00;
1996-09-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02050773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=32792
REPLENISHING MOISTURE LOTION SPF 15
octinoxate 7.5 % , oxybenzone 5 % , octisalate 5 %;
Number of active ingredients: 3.00;
2007-11-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
H.J. SUTTON INDUSTRIES LTD.
DIN: 02300605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78589
LIP BALM SPF 30
octinoxate 7.5 % , oxybenzone 5.5 % , octisalate 3 %;
Number of active ingredients: 3.00;
2008-06-09;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CROC BLOC PRODUCTS INC.
DIN: 02305283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79082
HYDRAPHASE UV
octinoxate 7.5 % , terephthalylidene dicamphor sulfonic acid 4 % , titanium dioxide 2.5 %;
Number of active ingredients: 3.00;
2004-09-23;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02256940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74217
THE RADIANT SKINTINT SPF 30
octinoxate 7.5 % , titanium dioxide 5.3 % , octisalate 2 %;
Number of active ingredients: 3.00;
2015-05-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAX HUBER RESEARCH LABS DIST
DIN: 02430746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91518
REVERSA CRÈME ANTI-RIDES CONTOUR DES YEUX FPS 15
octinoxate 7.5 % / w/w , avobenzone 2 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2002-04-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 02241273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64883
DOUBLE-DUTY FACE MOISTURIZER SPF 20
octinoxate 7.5 % / w/w , avobenzone 2.2 % / w/w;
Number of active ingredients: 2.00;
2013-07-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JACK BLACK LLC
DIN: 02381990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86786
CRÈME DE JOUR
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
1998-01-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02232205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51733
MATRIX SUPPORT WITH SUNSCREEN BROAD SPECTRUM SPF 30
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2018-09-24;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NEOSTRATA COMPANY, INC
DIN: 02470527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95951
SHEER HYDRATION SUNSCREEN BROAD SPECTRUM SPF 40
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2019-12-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NEOSTRATA COMPANY, INC
DIN: 02482010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97249
ARTISTRY YOUTH XTEND PROTECTING CREAM
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , oxybenzone 1 % / w/w;
Number of active ingredients: 3.00;
2013-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02391023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87640
ARTISTRY YOUTH XTEND PROTECTING LOTION
octinoxate 7.5 % / w/w , avobenzone 3 % / w/w , oxybenzone 1 % / w/w;
Number of active ingredients: 3.00;
2013-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02391031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87641
LIFT SPF 15
octinoxate 7.5 % / w/w , ensulizole 1.7 % / w/w;
Number of active ingredients: 2.00;
2010-10-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02355795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84099
BOBBI BROWN EXTRA REPAIR MOISTURIZING BALM SPF 25
octinoxate 7.5 % / w/w , homosalate 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2012-01-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
DIN: 02368714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85370
SUN ULTIMATE SPRAY SPF/FPS 30
octinoxate 7.5 % / w/w , homosalate 7 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 4.00;
2016-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS CANADA INC.
DIN: 02450585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93674
CLINIQUE FIT WORKOUT MAKEUP SPF 40
octinoxate 7.5 % / w/w , octisalate 2 % / w/w , titanium dioxide 1.6 % / w/w;
Number of active ingredients: 3.00;
2018-02-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02462613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95039
OLAY COMPLETE ALL DAY MOISTURE WITH SUNSCREEN BROAD SPECTRUM SPF 30 SENSITIVE
octinoxate 7.5 % / w/w , octisalate 2.5 % / w/w , octocrylene 2.5 % / w/w , zinc oxide 7 % / w/w;
Number of active ingredients: 4.00;
2015-04-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02422379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90706
BABY LIPS
octinoxate 7.5 % / w/w , octisalate 3 % / w/w;
Number of active ingredients: 2.00;
2011-12-06;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAYBELLINE CANADA
DIN: 02369486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85441
BOBBI BROWN LIP BALM SPF 15
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2013-06-03;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
DIN: 02397579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88251
CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 VERY DRY TO DRY
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
Number of active ingredients: 3.00;
2012-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02384825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87051
CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 DRY COMBINATION TO COMBINATION OILY
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
Number of active ingredients: 3.00;
2012-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02384833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87052
CLINIQUE REPAIRWEAR LASER FOCUS LINE SMOOTHING CREAM SPF 15 VERY DRY TO DRY COMBINATION
octinoxate 7.5 % / w/w , octisalate 3.5 % / w/w , titanium dioxide 1.7 % / w/w;
Number of active ingredients: 3.00;
2015-11-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02440547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92492
MAGIX FACE PERFECTOR
octinoxate 7.5 % / w/w , octisalate 4 % / w/w;
Number of active ingredients: 2.00;
2008-07-24;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02309068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79466
MATTE MOISTURIZER SPF 15
octinoxate 7.5 % / w/w , octisalate 4 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 3.00;
2006-02-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KAMINS DERMATOLOGICS INC
DIN: 02274345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75980
MOISTURE SURGE SHEERTINT HYDRATOR SPF 25
octinoxate 7.5 % / w/w , octisalate 4.5 % / w/w , titanium dioxide 3.8 % / w/w , zinc oxide 3.6 % / w/w;
Number of active ingredients: 4.00;
2020-02-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02492059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98206
ANEW PLATINUM DAY CREAM
octinoxate 7.5 % / w/w , octisalate 4.75 % / w/w , oxybenzone 4 % / w/w , avobenzone 2.85 % / w/w;
Number of active ingredients: 4.00;
2011-01-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02353873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83908
FOUNDATION PRIMER PLUS SPF 15
octinoxate 7.5 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 2.00;
2011-07-26;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02368455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85341
LIP CONDITIONER SPF 15
octinoxate 7.5 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 2.00;
2011-06-30;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02368463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85343
ESTEE LAUDER DAYWEAR MULTI-PROTECTION SHEER TINT RELEASE MOISTURIZER SPF 15 ALL SKINTYPES
octinoxate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2003-08-04;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02246876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71101
ESTEE LAUDER ADVANCED TIME ZONE AGE REVERSING LINE/WRINKLE CREME OIL-FREE SPF 15 FOR NORMAL/COMBINATION SKIN
octinoxate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02392887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87815
CORRECTION CODE (A.M.) DAILY MOISTURIZER BROAD SPECTRUM SPF 25
octinoxate 7.5 % / w/w , octisalate 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2013-09-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ALOETTE COSMETICS INC.
DIN: 02399288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88418
VITAMIN C GLOW-PROTECT LOTION SPF 30
octinoxate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2011-02-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
DIN: 02351498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83677
SPF/FPS 30 ECO-LUX SIZE/FORMAT ÉCOLUX BODY / CORPS
octinoxate 7.5 % / w/w , octocrylene 7 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2020-07-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02482169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97263
SPF/FPS 30 BODY/CORPS
octinoxate 7.5 % / w/w , octocrylene 7 % / w/w , octisalate 4 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2019-07-26;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02483955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97425
ARTISTRY YOUTH XTEND LIFTING SMOOTHING FOUNDATION
octinoxate 7.5 % / w/w , oxybenzone 0.5 % / w/w;
Number of active ingredients: 2.00;
2015-12-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02435829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92017
TIMELESS ILLUMINATING MAKEUP BROAD SPECTRUM SPF 30
octinoxate 7.5 % / w/w , oxybenzone 2 % / w/w;
Number of active ingredients: 2.00;
2017-03-28;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02460327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94764
FLAWLESS EFFECT LIQUID FOUNDATION BROAD SPECTRUM SPF 15
octinoxate 7.5 % / w/w , oxybenzone 3 % / w/w;
Number of active ingredients: 2.00;
2008-06-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MERLE NORMAN COSMETICS INC
DIN: 02306441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79215
MARCELLE SHEER TINT MOISTURIZER HYDRATANT TEINTÉ TRANSLUCIDE SPF 30 FPS
octinoxate 7.5 % / w/w , oxybenzone 3 % / w/w;
Number of active ingredients: 2.00;
2019-02-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02464748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95288
CHAPSTICK MOISTURIZER
octinoxate 7.5 % / w/w , oxybenzone 3.5 % / w/w;
Number of active ingredients: 2.00;
1997-08-22;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02229613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47540
SUN AND SNOW SPORT SPF 15
octinoxate 7.5 % / w/w , oxybenzone 3.5 % / w/w;
Number of active ingredients: 2.00;
2011-07-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DAVID ASTLEY AND COMPANY INC.
DIN: 02363909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84886
MARCELLE REVIVAL+ SKIN RENEWAL ANTI-AGING DAY CREAM SPF 15
octinoxate 7.5 % / w/w , oxybenzone 4 % / w/w , ensulizole 2.5 % / w/w;
Number of active ingredients: 3.00;
2017-06-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02462079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94981
REVERSA CREME FPS30
octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2015-05-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 02435101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91939
MOISTURIZING ANTIOXIDANT DAY CRÈME SPF 20
octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2013-12-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUTHY-RENKER LLC
DIN: 02361639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84670
MEANINGFUL BEAUTY CINDY CRAWFORD SKIN BRIGHTENING DÉCOLLETÉ AND NECK TREATMENT SPF 15
octinoxate 7.5 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2014-11-26;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUTHY-RENKER LLC
DIN: 02367505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85235
BOBBI BROWN SKIN FOUNDATION SPF 15
octinoxate 7.5 % / w/w , titanium dioxide 1 % / w/w;
Number of active ingredients: 2.00;
2009-02-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
DIN: 02310430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79607
CLINIQUE REPAIRWEAR LASER FOCUS LINE SMOOTHING CREAM SPF 15 COMBINATION OILY TO OILY
octinoxate 7.5 % / w/w , titanium dioxide 1.5 % / w/w;
Number of active ingredients: 2.00;
2015-11-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02440539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92491
ESTEE LAUDER PERFECTIONIST YOUTH-INFUSING MAKEUP SPF 25
octinoxate 7.5 % / w/w , titanium dioxide 1.9 % / w/w;
Number of active ingredients: 2.00;
2014-07-15;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02405113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88994
LA MER THE SOFT FLUID LONG WEAR FOUNDATION SPF 20
octinoxate 7.5 % / w/w , titanium dioxide 1.9 % / w/w;
Number of active ingredients: 2.00;
2016-10-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAX HUBER RESEARCH LABS DIST
DIN: 02447622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93320
RÉNERGIE LIFT
octinoxate 7.5 % / w/w , titanium dioxide 3.1 % / w/w;
Number of active ingredients: 2.00;
2017-07-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02438615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92299
RÉNERGIE LIFT MAKEUP
octinoxate 7.5 % / w/w , titanium dioxide 3.2 % / w/w;
Number of active ingredients: 2.00;
2020-09-25;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02495546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98544
CLINIQUE MOISTURE SURGE CC CREAM HYDRATING COLOUR CORRECTOR SPF 30
octinoxate 7.5 % / w/w , titanium dioxide 5.2 % / w/w , octisalate 5 % / w/w , zinc oxide 3.2 % / w/w;
Number of active ingredients: 4.00;
2013-05-20;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02402114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88698
CLINIQUE SPF 30 WITH SOLARSMART+ OIL-FREE FACE CREAM
octinoxate 7.5 % / w/w , zinc oxide 5 % / w/w , titanium dioxide 4.6 % / w/w , octisalate 4.5 % / w/w;
Number of active ingredients: 4.00;
2017-05-14;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02455587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94240
CLINIQUE SUPER CITY BLOCK OIL-FREE DAILY FACE PROTECTOR SPF 40
octinoxate 7.5 % / w/w , zinc oxide 6 % / w/w , titanium dioxide 5.2 % / w/w , octisalate 2 % / w/w;
Number of active ingredients: 4.00;
2015-02-06;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02404265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88905
ELTAMD SKINCARE UV FACIAL SPF 30
octinoxate 7.5 % / w/w , zinc oxide 7 % / w/w;
Number of active ingredients: 2.00;
2010-01-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02322277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80773
INDEFENSE30
octinoxate 7.5 % / w/w , zinc oxide 7 % / w/w;
Number of active ingredients: 2.00;
2017-04-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INDEED LABORATORIES INC
DIN: 02461161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94866
PREVENTION + DAILY MATTE MOISTURIZER OIL-FREE
octinoxate 7.5 % / w/w , zinc oxide 9 % / w/w;
Number of active ingredients: 2.00;
2015-02-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
IMAGE INTERNATIONAL MANUFACTURING LLC
DIN: 02437554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92188
ELTAMD SKINCARE UV CLEAR
octinoxate 7.5 % / w/w , zinc oxide 9 % / w/w;
Number of active ingredients: 2.00;
2020-06-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02496291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98618
PREVENTION + DAILY ULTIMATE PROTECTION MOISTURIZER
octinoxate 7.5 % / w/w , zinc oxide 9 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2015-02-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
IMAGE INTERNATIONAL MANUFACTURING LLC
DIN: 02437597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92192
DAILY MOISTURIZING CREAM SPF 15
octinoxate 7.5 g / 100 g , oxybenzone 3 g / 100 g , octisalate 3 g / 100 g;
Number of active ingredients: 3.00;
2005-09-08;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VIVIER CANADA INCORPORATED
DIN: 02246994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71227
REVERSA UV FLUIDE HYDRATANT NON GRAS FPS 15
octinoxate 8.5 % , oxybenzone 4 % , avobenzone 2 %;
Number of active ingredients: 3.00;
2002-03-11;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 02245318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69344
PROTECTIVE PROTECTRICE SUNSCREEN SPRAY LOTION LOTION ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 8
octisalate 1.4 % / w/w , octocrylene 1.4 % / w/w , avobenzone 1.2 % / w/w;
Number of active ingredients: 3.00;
2014-06-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02406209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89093
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 30 SENSITIVE
octisalate 2.5 % , octinoxate 7.5 % , octocrylene 2.5 % , zinc oxide 6.9 %;
Number of active ingredients: 4.00;
2018-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02461188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94867
OLAY TOTAL EFFECTS 7 IN ONE TONE CORRECTING MOISTURIZER WITH SUNSCREEN
octisalate 3 % , avobenzone 2 % , octocrylene 3 %;
Number of active ingredients: 3.00;
2009-01-22;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02306972
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79265
PROTECTIVE PROTECTRICE SUNSCREEN SPRAY LOTION LOTION ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 15
octisalate 3 % / w/w , octocrylene 2 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 3.00;
2014-06-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02406217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89094
MAKEUP SETTING SPRAY PULVÉRISATION POUR FIXER LE MAQUILLAGE
octisalate 3.94 % / w/w , avobenzone 3 % / w/w , homosalate 3.6 % / w/w;
Number of active ingredients: 3.00;
2020-07-09;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
COOLA LLC
DIN: 02482444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97289
BEAUTY BALM INSTANT SOLUTIONS BROAD SPECTRUM SPF 35
octisalate 4 % , octinoxate 7.5 % , oxybenzone 2.5 %;
Number of active ingredients: 3.00;
2017-09-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TRISH MCEVOY LTD
DIN: 02461846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94958
SUN AND SNOW SPORT SPRAY SPF 30
octisalate 4 % , octocrylene 8 % , octinoxate 6 % , oxybenzone 5 %;
Number of active ingredients: 4.00;
2004-04-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DAVID ASTLEY AND COMPANY INC.
DIN: 02247403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71649
OLAY REGENERIST WHIP
octisalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w , homosalate 8 % / w/w;
Number of active ingredients: 4.00;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02463938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95202
OLAY TOTAL EFFECTS WHIP
octisalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w , homosalate 8 % / w/w;
Number of active ingredients: 4.00;
2018-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02463946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95203
SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF/FPS 15
octisalate 4.5 % , homosalate 3 % , octocrylene 3 % , avobenzone 1.5 %;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02440105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92449
OLAY TOTAL EFFECTS 7IN1 ANTI-AGING MOISTURIZER WITH SUNSCREEN BROAD SPECTRUM SPF 15
octisalate 4.5 % , homosalate 4 % , avobenzone 3 % , octocrylene 2.6 %;
Number of active ingredients: 4.00;
2014-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02424665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90934
OLAY COMPLETE UV365* DAILY MOISTURIZING LOTION WITH SUNSCREEN BROAD SPECTRUM SPF 15 COMBINATION/OILY
octisalate 4.5 % , homosalate 4 % , avobenzone 3 % , octocrylene 2.6 %;
Number of active ingredients: 4.00;
2017-10-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02461269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94877
SHEER TOUCH TOUCHER SOYEUX OIL-FREE SUNSCREEN ÉCRAN SOLAIRE SANS HUILE SPF/FPS 50+
octisalate 4.5 % , homosalate 9 % , octocrylene 6 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2016-10-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02454572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94128
ESTÉE LAUDER RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME CRÈME TRI-PEPTIDE VISAGE ET COU SPF/FPS 15
octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2019-03-26;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02482614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97304
ESTEE LAUDER RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME CRÈME TRI-PEPTIDE VISAGE ET COU SPF/FPS 15 DRY SKIN PEAUX SÈCHES
octisalate 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2020-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02488566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97865
SHEER TOUCH/TOUCHER SOYEUX OIL-FREE SUNSCREEN/ÉCRAN SOLAIRE SANS HUILE SPF/FPS 15
octisalate 4.5 % / w/w , homosalate 3 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02409461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89417
OLAY TOTAL EFFECTS 7IN1 FEATHERWEIGHT MOISTURIZER WITH SUNSCREEN
octisalate 4.5 % / w/w , homosalate 4 % / w/w , avobenzone 3 % / w/w , octocrylene 2.6 % / w/w;
Number of active ingredients: 4.00;
2015-01-12;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
PROCTER & GAMBLE INC
DIN: 02424517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90920
HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF 30
octisalate 4.5 % / w/w , homosalate 5.5 % / w/w , octocrylene 4 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02440113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92450
HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION WITH HYDRATING RIBBONS SPF 50
octisalate 4.5 % / w/w , homosalate 8 % / w/w , octocrylene 5 % / w/w , avobenzone 2.7 % / w/w;
Number of active ingredients: 4.00;
2016-01-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02440121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92451
COPPERTONE MOUSSE SUNSCREEN SPF 50 WATERBABIES
octisalate 4.5 % / w/w , homosalate 9 % / w/w , octocrylene 9 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Aerosol, Foam;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02479702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97035
PHOTO REGUL CREAM / CRÈME
octisalate 5 % , octinoxate 4.9 % , homosalate 4 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2018-04-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02470799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95984
ELTAMD SKINCARE UV SPORT SPF 50
octisalate 5 % , octinoxate 7.5 % , zinc oxide 9 %;
Number of active ingredients: 3.00;
2010-03-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02314924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80045
SUN AND SNOW SPORT LOTION SPF 30
octisalate 5 % , octocrylene 2 % , octinoxate 7.5 % , oxybenzone 6 %;
Number of active ingredients: 4.00;
2004-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DAVID ASTLEY AND COMPANY INC.
DIN: 02247404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71650
BABY MINERAL SUNSCREEN LOTION
octisalate 5 % , titanium dioxide 3 % , zinc oxide 6 %;
Number of active ingredients: 3.00;
2018-03-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02466805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95516
ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME SPF 15 FOR NORMAL/ COMBINATION SKIN
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2011-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02352605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83786
CLINIQUE SUPERDEFENSE DAILY DEFENSE MOISTURIZER SPF 20 COMBINATION OILY TO OILY
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02409208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89392
CLINIQUE SUPERDEFENSE DAILY DEFENSE MOISTURIZER SPF 20 VERY DRY TO DRY COMBINATION
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02409216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89393
ÉMULSION HYDRATANTE ANTIRIDES
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2014-07-01;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02425556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91019
CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER VERY DRY TO DRY
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2016-01-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02440067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92445
CLINIQUE SMART SPF 15 CUSTOM-REPAIR MOISTURIZER DRY COMBINATION
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2016-01-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02440075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92446
CLINIQUE PEP-START HYDRORUSH MOISTURIZER SPF 20
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2017-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02453673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94023
CLINIQUE FOR MEN SUPER ENERGIZER SPF 25 ANTI-FATIGUE HYDRATING CONCENTRATE
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2019-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02473836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96352
SUPERDEFENSE FATIGUE + 1ST SIGNS OF AGE MULTI-CORRECTING CREAM CRÈME MULTI-CORRECTION FATIGUE + 1ERS SIGNES DE L’ÂGE COMBINATION OILY TO OILY / MIXTE À GRASSE SPF 25 FPS
octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2020-03-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02492024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98203
LOTION SOLAIRE ANTI-ÂGE
octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w;
Number of active ingredients: 3.00;
2014-07-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
INTEGA SCIENCES DE LA PEAU / INTEGA SKIN SCIENCES INC
DIN: 02425602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91024
SPORT FOR KIDS SUNSCREEN LOTION SPRAY SPF 50+
octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w , octocrylene 6 % / w/w;
Number of active ingredients: 4.00;
2017-01-03;
Topical;
Aerosol;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02456044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94289
ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME SPF 15 FOR DRY SKIN
octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2 % / w/w;
Number of active ingredients: 3.00;
2011-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02352613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83787
ALOE SOOTHING MOISTURE LOTION SPF 15
octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 2.9 % / w/w , octocrylene 2.2 % / w/w;
Number of active ingredients: 4.00;
2016-12-04;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
DIN: 02450739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93688
SEAWEED OIL-CONTROL LOTION SPF 15
octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 2.9 % / w/w , octocrylene 2.2 % / w/w;
Number of active ingredients: 4.00;
2017-02-24;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BODY SHOP CANADA LIMITED
DIN: 02450747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93689
ESTEE LAUDER ADVANCED TIME ZONE AGE REVERSING LINE/WRINKLE CREME SPF 15 FOR NORMAL/COMBINATION SKIN
octisalate 5 % / w/w , avobenzone 3 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 3.00;
2012-11-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02380870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86663
DAILY MOISTURIZING LOTION SPF 15
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 1.7 % / w/w , oxybenzone 3 % / w/w;
Number of active ingredients: 4.00;
2010-02-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02317508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80302
CLINIQUE EVEN BETTER SKIN TONE CORRECTING MOISTURIZER SPF 20
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2009-08-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02322072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80748
ESTEE LAUDER DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME OIL-FREE SPF 25
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2011-12-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02371316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85647
CLINIQUE EVEN BETTER LOTION SPF 20
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2012-05-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02375354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86076
ESTEE LAUDER RESILIENCE LIFT FIRMING/SCULPTING FACE AND NECK CREME SPF 15 FOR NORMAL/COMBINATION SKIN
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2013-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02380633
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86642
ESTEE LAUDER RESILIENCE LIFT FIRMING/SCULPTING FACE AND NECK CREME SPF 15 FOR DRY SKIN
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2013-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02380641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86643
ESTEE LAUDER RESILIENCE LIFT FIRMING/SCULPTING FACE AND NECK CREME OIL-FREE SPF 15 FOR NORMAL/COMBINATION SKIN
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
Number of active ingredients: 3.00;
2014-01-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02392879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87814
ULTRA LIFT ANTI-WRINKLE FIRMING MOISTURIZING CREAM
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 3 % / w/w;
Number of active ingredients: 3.00;
2014-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02419076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90361
MOISTURE RESCUE SPF 15
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 5 % / w/w;
Number of active ingredients: 3.00;
2016-06-17;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02448351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93405
CETAPHIL PRO DERMACONTROL OIL CONTROL MOISTURIZER
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7 % / w/w;
Number of active ingredients: 3.00;
2012-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GALDERMA CANADA INC
DIN: 02374536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85986
NO7 PROTECT & PERFECT INTENSE ADVANCED DAY CREAM
octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7.5 % / w/w;
Number of active ingredients: 3.00;
2017-01-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
DIN: 02453541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94010
CLINIQUE EVEN BETTER HAND CREAM SPF 15
octisalate 5 % / w/w , homosalate 3 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2012-03-05;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02375281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86068
SUN EXPERT
octisalate 5 % / w/w , homosalate 4 % / w/w , octinoxate 7.5 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 4.00;
2016-06-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
NAOS
DIN: 02455471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94228
FIRMARINE DAY CREAM SPF 30 CRÈME DE JOUR SPF 30
octisalate 5 % / w/w , octinoxate 7.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2012-09-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ERNO LASZLO
DIN: 02389681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87518
SPORT SUNSCREEN CONTINUOUS SPRAY SPF 50+
octisalate 5 % / w/w , octocrylene 4 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w;
Number of active ingredients: 4.00;
2020-03-21;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02491052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98108
BLUE THERAPY MOISTURIZING CREAM DRY SKIN SPF 15
octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 1 % / w/w;
Number of active ingredients: 4.00;
2012-09-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BIOTHERM CANADA
DIN: 02387565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87317
BLUE THERAPY MOISTURIZING CREAM NORMAL/COMBINATION SKIN SPF 15
octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 1 % / w/w;
Number of active ingredients: 4.00;
2012-09-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BIOTHERM CANADA
DIN: 02387573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87318
NEUTROGENA HEALTHY SKIN FACE LOTION SPF 15
octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2015-04-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02404753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88954
NEUTROGENA MOISTURE OIL-FREE SPF 15
octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2015-08-10;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02416905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90151
NEUTROGENA HEALTHY SKIN ANTI-WRINKLE CREAM SPF 15
octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2015-04-23;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02416913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90152
HAWAIIAN TROPIC SUNSCREEN LOTION ÉCRAN SOLAIRE 4
octocrylene 1 % / w/w , oxybenzone 0.5 % / w/w;
Number of active ingredients: 2.00;
2010-01-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02329212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81490
SUNLOTION LOTIONSOLAIRE SPF/FPS 4
octocrylene 1 g / 100 g , oxybenzone 0.5 g / 100 g;
Number of active ingredients: 2.00;
2016-02-22;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02447355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93293
OMBRELLE – LOTION EXTREME SPF 30
octocrylene 10 % , avobenzone 3 % , titanium dioxide 2.2 % , terephthalylidene dicamphor sulfonic acid 1 %;
Number of active ingredients: 4.00;
2000-02-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02241277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64887
DRY-TOUCH SUNSCREEN SPF 45
octocrylene 10 % , homosalate 10 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02487780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97794
REVERSA URBAN PROTECTION HYDRATING CARE SPF 30 SOIN HYDRATANT PROTECTION URBAINE FPS 30
octocrylene 10 % , octinoxate 7.5 % , octisalate 5 % , avobenzone 2 %;
Number of active ingredients: 4.00;
2018-04-21;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 02473178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96253
OMBRELLE SPORT SPRAY
octocrylene 10 % , oxybenzone 6 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 4.00;
2007-03-27;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02290472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77578
OMBRELLE STICK SPF 60
octocrylene 10 % , titanium dioxide 6.25 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
Number of active ingredients: 4.00;
2007-03-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02285738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77122
ULTRA PROTECTION SUNSCREEN STICK SPF 60
octocrylene 10 % , titanium dioxide 6.25 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
Number of active ingredients: 4.00;
2007-04-20;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
DIN: 02285746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77123
GLOWSCREEN
octocrylene 10 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2021-01-26;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TAYLOR JAMES LLC
DIN: 02503107
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99261
FACE SUNSCREEN SPF 45
octocrylene 10 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02487764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97790
REVERSA CRÈME RADIANCE FPS 30
octocrylene 10 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2015-07-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 02435802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92015
WATER DRENCH
octocrylene 10 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-06-01;
Topical;
Lotion;
-;
Otc;
PETER THOMAS ROTH LABS LLC
DIN: 02506971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99639
COOLZONE INSTANTLY COOLS & REFRESHES RAFRAÎCHIT INSTANTANÉMENT SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 50
octocrylene 10 % / w/w , oxybenzone 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2013-01-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02387050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87262
SPORT PERFORMANCE SUNSCREEN STICK ECRAN SOLAIRE EN BÂTONNET SPF FPS 50
octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2009-05-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02317036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80254
KIDS SUNSCREEN STICK ÉCRAN SOLAIRE EN BÂTONNET POUR ENFANTS SPF FPS 50
octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2009-05-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02317745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80328
SUNSCREEN STICK ÉCRAN SOLAIRE EN BÂTONNET WITH ALOE VERA/AVEC ALOÈS
octocrylene 10 % / w/w , oxybenzone 6 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2009-05-01;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02317990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80350
NOURISHING DAY CREAM
octocrylene 2 % / w/w , ensulizole 2 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 3.00;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02466570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95491
SUN LOGIC 20 FPS UVA UVB SPF MOYENNE MEDIUM PROTECTION LARGE SPECTRE BROAD SPECTRUM LAIT SOLAIRE CORPS SUNSCREEN LOTION BODY
octocrylene 2.7 % , avobenzone 2.9 % , homosalate 12 %;
Number of active ingredients: 3.00;
2019-04-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GUINOT
DIN: 02480484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97100
SHISEIDO BENEFIANCE NUTRIPERFECT DAY CREAM SPF 15
octocrylene 3 % , octinoxate 5 % , ensulizole 2 %;
Number of active ingredients: 3.00;
2009-02-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICA INC
DIN: 02306468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79216
REFRESHING DAY CREAM
octocrylene 3 % / w/w , ensulizole 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02466589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95492
MATTIFYING DAY CREAM
octocrylene 3 % / w/w , ensulizole 2 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2018-04-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02466597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95493
URBAN ENVIRONMENT UV PROTECTION CREAM
octocrylene 3 % / w/w , octinoxate 2.9 % / w/w , zinc oxide 10.6 % / w/w;
Number of active ingredients: 3.00;
2014-12-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02423901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90864
URBAN ENVIRONMENT OIL-FREE UV PROTECTOR
octocrylene 3 % / w/w , octinoxate 4.9 % / w/w , zinc oxide 12.5 % / w/w;
Number of active ingredients: 3.00;
2014-12-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02423928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90865
HIGH PERFORMANCE SUNSCREEN SPRAY SPF 15
octocrylene 3.5 % / w/w , homosalate 5 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 3.00;
2017-01-03;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02454564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94127
NO 7 MEN PROTECT & PERFECT INTENSE MOISTURISER SPF 15
octocrylene 4 % / w/w , avobenzone 3 % / w/w , octisalate 3 % / w/w;
Number of active ingredients: 3.00;
2016-04-07;
Topical;
Suspension;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
DIN: 02443341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92799
ROSALIAC UV LEGERE
octocrylene 4.6 % / w/w , octisalate 3.3 % / w/w , avobenzone 2 % / w/w , drometrizole trisiloxane 1 % / w/w;
Number of active ingredients: 4.00;
2010-06-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02330792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81654
ROSALIAC UV RICHE
octocrylene 4.6 % / w/w , octisalate 3.3 % / w/w , avobenzone 2 % / w/w , drometrizole trisiloxane 1 % / w/w;
Number of active ingredients: 4.00;
2009-11-02;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02330857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81660
BANANA BOAT SPORT PERFORMANCE WITH POWERSTAY TECHNOLOGY SUNSCREEN LOTION SPF 30
octocrylene 5 % / w/w , avobenzone 1.8 % / w/w , homosalate 7 % / w/w;
Number of active ingredients: 3.00;
2014-12-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02423545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90826
HAWAIIAN TROPIC PROTECTIVE DRY OIL SUNSCREEN SPRAY SPF/FPS 10
octocrylene 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 2.00;
2015-03-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02421844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90652
DRY BALANCE SUNSCREEN LOTION SPF 50+
octocrylene 5 % / w/w , homosalate 9 % / w/w , octisalate 4 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02456028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94287
ULTRA SUN PROTECTION LOTION TI
octocrylene 5 % / w/w , octinoxate 4.9 % / w/w , oxybenzone 3 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 4.00;
2017-11-28;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02463660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95176
ESTEE LAUDER REVITALIZING SUPREME+ GLOBAL ANTI-AGING CREME SPF 15
octocrylene 5 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2018-10-09;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ESTEE LAUDER DIST.
DIN: 02473828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96345
HAWAIIAN TROPIC SILK HYDRATION FACE OIL-FREE SUNSCREEN
octocrylene 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2015-02-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02424681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90936
ISLAND SPORT SUNSCREEN LOTION SPF 30
octocrylene 5 % / w/w , oxybenzone 3 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2017-07-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02449269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93509
VITA LIFT SPF 15 DAILY MOISTURIZER
octocrylene 5.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2 % / w/w;
Number of active ingredients: 4.00;
2014-06-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
DIN: 02419068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90360
FACIAL FUEL
octocrylene 5.9 % / w/w , homosalate 8.8 % / w/w , octisalate 4.9 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-03-19;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
DIN: 02483777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97412
LIP PROTECTOR SPF 15 SUNSCREEN
octocrylene 6 % / w/w , avobenzone 2.5 % / w/w , octinoxate 2 % / w/w;
Number of active ingredients: 3.00;
2014-03-24;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MARY KAY COSMETICS LTD
DIN: 02375419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86083
HAWAIIAN TROPIC DUO DEFENCE REFRESH SUNSCREEN MIST SPF 30
octocrylene 6 % / w/w , avobenzone 2.7 % / w/w , homosalate 6 % / w/w;
Number of active ingredients: 3.00;
2019-02-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02477866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96871
BRIGHT BOOST MOISTURIZER SPF 30
octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2020-01-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02488116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97821
CLEAR COMPLEXION SHEER DAILY MOISTURIZER
octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2020-03-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02491842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98184
PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 30
octocrylene 6 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w;
Number of active ingredients: 4.00;
2021-01-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02496798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98664
HYDRO BOOST WATER GEL LOTION SUNSCREEN SPF 30
octocrylene 6 % / w/w , octisalate 4 % / w/w , avobenzone 1.5 % / w/w , homosalate 5 % / w/w;
Number of active ingredients: 4.00;
2019-01-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02463172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95108
HAWAIIAN TROPIC KIDS SUNSCREEN LOTION SPF/FPS 50+
octocrylene 6 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2015-01-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02423219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90795
BIENFAIT MULTI-VITAL SPF 30
octocrylene 7 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2005-12-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02270161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75557
BIENFAIT MULTI-VITAL (SPF 30)
octocrylene 7 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2007-01-22;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02283379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76898
REDERMIC [C] UV – SPF 25
octocrylene 7 % , octisalate 5 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2015-04-06;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02431882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91635
CRÈME RAJEUNISSANTE HAUTE FERMETÉ JOUR
octocrylene 7 % , oxybenzone 3 % , avobenzone 3 %;
Number of active ingredients: 3.00;
2014-04-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02418088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90267
OMBRELLE SPORT LOTION SPF 30
octocrylene 7 % , titanium dioxide 2.5 % , avobenzone 1.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
Number of active ingredients: 4.00;
2006-04-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02269902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75527
OMBRELLE SPORT LOTION SPF 45
octocrylene 7 % , titanium dioxide 3.3 % , avobenzone 1.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
Number of active ingredients: 4.00;
2006-04-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
OMBRELLE CANADA
DIN: 02269910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75528
SPF 30 IDEAL SOLEIL LIP PROTECTION STICK
octocrylene 7 % / w/w , avobenzone 2.5 % / w/w , drometrizole trisiloxane 4 % / w/w;
Number of active ingredients: 3.00;
2013-06-18;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
DIN: 02393956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87913
FUTUR E SPF 15 MOISTURIZING LOTION
octocrylene 7 % / w/w , ensulizole 2 % / w/w;
Number of active ingredients: 2.00;
2013-06-18;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
DIN: 02390671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87609
TOLERIANE SENSITIVE CRÈME UV
octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-06-10;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02492458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98246
ABSOLUE VELVET CREAM WITH BROAD SPECTRUM SPF 15
octocrylene 7 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-09-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02495252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98518
COPPERTONE SPRAY SUNSCREEN SPF 30 SUN GUARD
octocrylene 7 % / w/w , homosalate 8 % / w/w , octisalate 4.5 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 4.00;
2020-02-05;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96904
CHAPSTICK ACTIVE SPF 30
octocrylene 7 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , oxybenzone 5 % / w/w;
Number of active ingredients: 4.00;
2003-03-14;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02245381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69420
LIFTACTIV UV
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2012-05-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
DIN: 02374528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85985
RENERGIE LIFT MULTI-ACTION SPF 15 FIRMING MOISTURIZING CREAM ALL SKIN TYPES
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2015-06-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02438232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92260
REVITALIFT ANTI-WRINKLE + FIRMING DAY CREAM
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2018-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
DIN: 02466724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95508
RÉNERGIE LIFT MULTI-ACTION ULTRA SPF30
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2019-12-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02492962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98294
SPF 30 WRINKLE REDUCING CREAM
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2.7 % / w/w;
Number of active ingredients: 4.00;
2013-07-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
DIN: 02404214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88900
AGE PERFECT ROSY TONE DAY CREAM
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 2.7 % / w/w;
Number of active ingredients: 4.00;
2020-03-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
DIN: 02490501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98055
MULTI-ACTION CREAM SPF 30
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 5 % / w/w;
Number of active ingredients: 4.00;
2016-10-24;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KIEHLS CANADA
DIN: 02446979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93254
AQUALIA THERMAL UV
octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 6 % / w/w;
Number of active ingredients: 4.00;
2013-06-25;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VICHY CANADA
DIN: 02393948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87912
RÉNERGIE LIFT MULTI-ACTION ULTRA
octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-08-30;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LANCOME CANADA
DIN: 02484005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97434
REVITALIFT TRIPLE POWER LZR DAY LOTION
octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-15;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’ OREAL CANADA
DIN: 02491141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98116
AQUALIA THERMAL UV DEFENSE MOISTURIZING CREAM SPF30
octocrylene 7 % / w/w , octisalate 5 % / w/w , homosalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-01-05;
Topical;
Cream;
-;
Otc;
VICHY CANADA
DIN: 02491265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98127
WRINKLE EXPERT AGE DEFENSE UV LOTION
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-03-08;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
L’OREAL CANADA INC.
DIN: 02498324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98810
HYALU-MELON WITH CONDITIONING (HYALURONIC ACID + WATERMELON)
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02507048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99645
PINEA-C
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02507056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99646
NIACINA-B
octocrylene 7.2 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2021-02-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02508982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99830
COOLZONE INSTANTLY COOLS & REFRESHES RAFRAÎCHIT INSTANTANÉMENT SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR SPF/FPS 30
octocrylene 7.4 % / w/w , oxybenzone 3 % / w/w , avobenzone 1 % / w/w;
Number of active ingredients: 3.00;
2013-01-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02387042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87261
SPF/FPS 30 BROAD SPECTRUM ALCOHOL FREE SUNSCREEN
octocrylene 7.5 % , octinoxate 7.5 % , octisalate 5 % , avobenzone 2.5 %;
Number of active ingredients: 4.00;
2018-06-01;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BU BRANDS, LLC
DIN: 02462184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94991
NO7 EARLY DEFENCE GLOW ACTIVATING DAY CREAM
octocrylene 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2016-09-19;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
DIN: 02444429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92947
SPF 50+ FPS ULTRA LOTION
octocrylene 7.5 % / w/w , octisalate 5 % / w/w , octinoxate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2016-07-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMPACK SPRAYTECH INC
DIN: 02449617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93545
HYDRANCE OPTIMALE SPF 25
octocrylene 8 % , octinoxate 7.5 % , titanium dioxide 3.2 %;
Number of active ingredients: 3.00;
2005-09-07;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES DERMATOLOGIQUES AVÈNE
DIN: 02270269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75565
COPPERTONE LOTION SUNSCREEN SPF 50 DEFEND & CARE FACE
octocrylene 8 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2019-01-30;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02467070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95547
COPPERTONE LOTION SUNSCREEN SPF 50 SPORT
octocrylene 8 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , oxybenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02475413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96580
ULTRA SHEER DRY-TOUCH SUNSCREEN SPF 30
octocrylene 8 % / w/w , homosalate 6 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02486407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97662
CLEAR FACE SUNSCREEN LOTION
octocrylene 8 % / w/w , homosalate 8 % / w/w , octisalate 5 % / w/w , avobenzone 2.5 % / w/w;
Number of active ingredients: 4.00;
2020-01-20;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02487845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97800
FACE & NECK MULTI ACTION VISAGE ET COU MULTI ACTION DAY CREAM / CRÈME DE JOUR SPF 30 / FPS 30
octocrylene 8 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 3.00;
2019-05-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE BOOTS COMPANY PLC
DIN: 02476118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96704
COPPERTONE CLEAR SUNSCREEN SPF 30 SPORT
octocrylene 9 % / w/w , homosalate 10 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
Number of active ingredients: 4.00;
2020-02-07;
Topical;
Gel;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02488345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97844
URBAN SKIN DEFENCE
octocrylene 9 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.75 % / w/w;
Number of active ingredients: 3.00;
2019-02-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02478471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96925
CLINOLEIC 20%
olive oil 16 % / w/w , soybean oil 4 % / w/w;
Number of active ingredients: 2.00;
2012-03-28;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
DIN: 02344327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82981
OLMETEC PLUS
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 02319616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80508
ACT OLMESARTAN HCT
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02443112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92768
APO-OLMESARTAN/HCTZ
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-06-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02453606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94016
GLN-OLMESARTAN HCTZ
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2020-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02475707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96608
AURO-OLMESARTAN HCTZ
olmesartan medoxomil 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2019-01-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02476487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96741
OLMETEC PLUS
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 02319624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80509
ACT OLMESARTAN HCT
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02443120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92771
APO-OLMESARTAN/HCTZ
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-05-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02453614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94017
GLN-OLMESARTAN HCTZ
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2020-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02475715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96609
AURO-OLMESARTAN HCTZ
olmesartan medoxomil 40 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2019-01-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02476495
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96742
OLMETEC PLUS
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2008-12-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ORGANON CANADA INC.
DIN: 02319632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80510
ACT OLMESARTAN HCT
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2017-05-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02443139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92772
APO-OLMESARTAN/HCTZ
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2017-05-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02453622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94018
GLN-OLMESARTAN HCTZ
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2020-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02475723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96610
AURO-OLMESARTAN HCTZ
olmesartan medoxomil 40 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2019-01-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02476509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96743
SANDOZ OPIUM & BELLADONNA
opium 65 mg , belladonna 15 mg;
Number of active ingredients: 2.00;
1991-12-31;
Rectal;
Suppository;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 01901869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11257
CHOLEDYL EXPECTORANT ELIXIR
oxtriphylline 100 mg / 5 ml , guaifenesin 50 mg / 5 ml;
Number of active ingredients: 2.00;
1981-12-31;
Oral;
Elixir;
48:16.00 – EXPECTORANTS , 86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00476374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4258
COPPERTONE SUNSCREEN LOTION SPF 8 DEFEND & GLOW
oxybenzone 2 % / w/w , octinoxate 7 % / w/w;
Number of active ingredients: 2.00;
1970-12-31;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 01931199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41935
HIGH PERFORMANCE SUNSCREEN LOTION SPF 15
oxybenzone 2 % / w/w , octocrylene 3 % / w/w , avobenzone 2 % / w/w;
Number of active ingredients: 3.00;
2017-01-03;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02454289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94080
SUN-SHADES LIP BALM SPF 15 – VANILLA STK
oxybenzone 3 % , octinoxate 7.5 %;
Number of active ingredients: 2.00;
1994-12-31;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MELALEUCA OF CANADA INC.
DIN: 02045672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42329
DRY BALANCE SUNSCREEN SPRAY SPF 30
oxybenzone 3 % / w/w , avobenzone 2 % / w/w , octocrylene 1.5 % / w/w , homosalate 7 % / w/w;
Number of active ingredients: 4.00;
2017-01-03;
Topical;
Spray;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EDGEWELL PERSONAL CARE CANADA, ULC
DIN: 02456060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94291
MARCELLE FLAWLESS AIR SERUM FOUNDATION SÉRUM DE TEINT PEAU PARFAITE SPF 15 FPS
oxybenzone 3 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2017-06-05;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02461080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94858
DAY CREAM SPF 15
oxybenzone 5 % , octinoxate 7 % , avobenzone 2 %;
Number of active ingredients: 3.00;
2003-10-01;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
KAMINS DERMATOLOGICS INC
DIN: 02246708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70903
TARGIN
oxycodone hydrochloride 10 mg , naloxone hydrochloride 5 mg;
Number of active ingredients: 2.00;
2010-10-05;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02339609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82520
TARGIN
oxycodone hydrochloride 20 mg , naloxone hydrochloride 10 mg;
Number of active ingredients: 2.00;
2010-10-05;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02339617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82521
TARGIN
oxycodone hydrochloride 40 mg , naloxone hydrochloride 20 mg;
Number of active ingredients: 2.00;
2010-10-05;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02339625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82522
TEVA-OXYCOCET
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
Number of active ingredients: 2.00;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 00608165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5778
RIVACOCET
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
Number of active ingredients: 2.00;
2001-12-12;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
LABORATOIRE RIVA INC.
DIN: 02242468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66193
SANDOZ OXYCODONE/ACETAMINOPHEN
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
Number of active ingredients: 2.00;
2008-05-01;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02307898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79356
APO-OXYCODONE/ACET
oxycodone hydrochloride 5 mg , acetaminophen 325 mg;
Number of active ingredients: 2.00;
2009-04-15;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS , 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02324628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81005
TARGIN
oxycodone hydrochloride 5 mg , naloxone hydrochloride 2.5 mg;
Number of active ingredients: 2.00;
2012-10-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS , 28:10.00 – OPIATE ANTAGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02387425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87301
AIR USP
oxygen 19.5 % , nitrogen 80.5 %;
Number of active ingredients: 2.00;
1993-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13885
HELIUM OXYGEN MIXTURE
oxygen 20 % , helium 80 %;
Number of active ingredients: 2.00;
1911-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 00572896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5689
MEDICAL AIR U.S.P.
oxygen 23.5 % / v/v , nitrogen 76.5 % / v/v;
Number of active ingredients: 2.00;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
DIN: 02154781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19291
OXYGEN USP, HELIUM USP, MEDICAL GAS MIXTURE
oxygen 24 % , helium 76 %;
Number of active ingredients: 2.00;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13890
HELIOX
oxygen 50 % , helium 50 %;
Number of active ingredients: 2.00;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
LINDE CANADA LIMITED
DIN: 02154846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19290
HELIUM-OXYGEN MIX GAS
oxygen 50 % , helium 50 %;
Number of active ingredients: 2.00;
1997-05-02;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 01906801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46353
ENTONOX
oxygen 50 % , nitrous oxide 50 %;
Number of active ingredients: 2.00;
1995-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
LINDE CANADA LIMITED
DIN: 02154757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19102
OXYGEN CARBON DIOXIDE MIXTURE
oxygen 95 % , carbon dioxide 5 %;
Number of active ingredients: 2.00;
1911-12-31;
Inhalation;
Gas;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 00572853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5686
ZEPOSIA
ozanimod (ozanimod hydrochloride) 0.23 mg , ozanimod (ozanimod hydrochloride) 0.46 mg;
Number of active ingredients: 2.00;
2020-11-12;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
DIN: 02506009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99536
COPHYLAC
p-hydroxyephedrine hydrochloride 20 mg / ml , normethadone hydrochloride 10 mg / ml;
Number of active ingredients: 2.00;
1997-01-23;
Oral;
Drops;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
BAUSCH HEALTH, CANADA INC.
DIN: 02224577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37358
BLISTEX LIP BALM
padimate o 6.6 % , oxybenzone 2.5 % , dimethicone 2 %;
Number of active ingredients: 3.00;
1993-12-31;
Topical;
Ointment;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BLISTEX CORPORATION
DIN: 02013878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42159
ELIZABETH ARDEN LIP PROTECTANT STICK SPF 15
padimate o 8 % , oxybenzone 3 %;
Number of active ingredients: 2.00;
2005-05-15;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELIZABETH ARDEN (CANADA) LIMITED
DIN: 02250071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73489
AKYNZEO
palonosetron (palonosetron hydrochloride) 0.5 mg , netupitant 300 mg;
Number of active ingredients: 2.00;
2017-11-20;
Oral;
Capsule;
56:22.00 – ANTIEMETICS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 02468735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95721
PLEGRIDY
peginterferon beta-1a 63 mcg / 0.5 ml , peginterferon beta-1a 94 mcg / 0.5 ml;
Number of active ingredients: 2.00;
2015-09-25;
Subcutaneous;
Kit , Liquid;
08:18.20 – INTERFERONS;
Prescription , Schedule D;
BIOGEN CANADA INC
DIN: 02444402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92944
VIACORAM
perindopril arginine 14 mg , amlodipine (amlodipine besylate) 10 mg;
Number of active ingredients: 2.00;
2016-04-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
SERVIER CANADA INC
DIN: 02451557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93784
APO-PERINDOPRIL/AMLODIPINE
perindopril arginine 14 mg , amlodipine (amlodipine besylate) 10 mg;
Number of active ingredients: 2.00;
2019-06-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02468581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95701
VIACORAM
perindopril arginine 3.5 mg , amlodipine (amlodipine besylate) 2.5 mg;
Number of active ingredients: 2.00;
2016-04-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
SERVIER CANADA INC
DIN: 02451530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93782
APO-PERINDOPRIL/AMLODIPINE
perindopril arginine 3.5 mg , amlodipine (amlodipine besylate) 2.5 mg;
Number of active ingredients: 2.00;
2019-06-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02468565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95699
APO-PERINDOPRIL/AMLODIPINE
perindopril arginine 7 mg , amlodipine (amlodipine besylate) 5 mg;
Number of active ingredients: 2.00;
2019-06-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
DIN: 02468573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95700
COVERSYL PLUS LD
perindopril erbumine 2 mg , indapamide 0.625 mg;
Number of active ingredients: 2.00;
2003-05-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
DIN: 02246568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70751
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD
perindopril erbumine 2 mg , indapamide 0.625 mg;
Number of active ingredients: 2.00;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02470411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95939
COVERSYL PLUS
perindopril erbumine 4 mg , indapamide 1.25 mg;
Number of active ingredients: 2.00;
2002-12-19;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
DIN: 02246569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70752
APO-PERINDOPRIL-INDAPAMIDE
perindopril erbumine 4 mg , indapamide 1.25 mg;
Number of active ingredients: 2.00;
2021-02-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
APOTEX INC
DIN: 02297574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78291
TEVA-PERINDOPRIL/INDAPAMIDE
perindopril erbumine 4 mg , indapamide 1.25 mg;
Number of active ingredients: 2.00;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02464020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95216
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE
perindopril erbumine 4 mg , indapamide 1.25 mg;
Number of active ingredients: 2.00;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02470438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95940
COVERSYL PLUS HD
perindopril erbumine 8 mg , indapamide 2.5 mg;
Number of active ingredients: 2.00;
2009-05-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
DIN: 02321653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80705
TEVA-PERINDOPRIL/INDAPAMIDE
perindopril erbumine 8 mg , indapamide 2.5 mg;
Number of active ingredients: 2.00;
2018-03-07;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02464039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95215
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD
perindopril erbumine 8 mg , indapamide 2.5 mg;
Number of active ingredients: 2.00;
2018-03-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02470446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95941
PERJETA-HERCEPTIN
pertuzumab 420 mg / 14 ml , trastuzumab 440 mg / vial;
Number of active ingredients: 2.00;
2013-05-09;
Intravenous;
Solution , Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02405024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88985
SEBAMED DIAPER RASH CREAM
petrolatum 10 % , mineral oil 7 %;
Number of active ingredients: 2.00;
2000-04-17;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LOFCO CANADA INC.
DIN: 02240541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64111
SOOTHE NIGHT TIME
petrolatum 80 % , mineral oil 20 %;
Number of active ingredients: 2.00;
1994-12-31;
Ophthalmic;
Ointment;
52:13.00* – ARTIFICIAL TEARS;
Otc;
BAUSCH & LOMB INC
DIN: 02125706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16777
VISINE FOR ALLERGY WITH ANTIHISTAMINE
pheniramine maleate 0.3 % / w/v , naphazoline hydrochloride 0.025 % / w/v;
Number of active ingredients: 2.00;
2003-12-29;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
JOHNSON & JOHNSON INC
DIN: 02242764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66582
ROBITUSSIN AC
pheniramine maleate 7.5 mg / 5 ml , guaifenesin 100 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
Number of active ingredients: 3.00;
1993-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01934740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13494
PREPARATION H-PE GEL
phenylephrine hydrochloride 0.25 % / w/w , hamamelis virginiana 50 % / w/w;
Number of active ingredients: 2.00;
1997-05-05;
Rectal , Topical;
Gel;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02209594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36788
DRISTAN NASAL MIST
phenylephrine hydrochloride 0.5 % / w/v , pheniramine maleate 0.2 % / w/v;
Number of active ingredients: 2.00;
1992-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 01929313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41952
DIMETAPP-C
phenylephrine hydrochloride 1 mg / ml , brompheniramine maleate 0.4 mg / ml , codeine phosphate 2 mg / ml;
Number of active ingredients: 3.00;
2001-09-05;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Narcotic (Cdsa I);
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02244078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68031
DIMETANE EXPECTORANT C
phenylephrine hydrochloride 1 mg / ml , brompheniramine maleate 0.4 mg / ml , codeine phosphate 2 mg / ml , guaifenesin 20 mg / ml;
Number of active ingredients: 4.00;
2001-09-28;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02244079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68034
NEOCITRAN COLD & SORE THROAT NIGHT
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 325 mg / sachet , pheniramine maleate 20 mg / sachet;
Number of active ingredients: 3.00;
2003-06-18;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02246602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70790
NEOCITRAN EXTRA STRENGTH COLD & CONGESTION
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet;
Number of active ingredients: 2.00;
1989-12-31;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 00843792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10188
DAYTIME COLD
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , dextromethorphan hydrobromide 20 mg / sachet;
Number of active ingredients: 3.00;
2020-01-14;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
DIN: 02487276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97743
NIGHTTIME COLD
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , diphenhydramine hydrochloride 25 mg / sachet;
Number of active ingredients: 3.00;
2020-01-14;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
DIN: 02487233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97739
NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet;
Number of active ingredients: 3.00;
1996-09-04;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02215403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37051
NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT – APPLE CINNAMON
phenylephrine hydrochloride 10 mg / sachet , acetaminophen 650 mg / sachet , pheniramine maleate 20 mg / sachet;
Number of active ingredients: 3.00;
2017-08-01;
Oral;
Powder For Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02456982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94410
DIMETAPP EXTRA STRENGTH
phenylephrine hydrochloride 10 mg / 5 ml , brompheniramine maleate 4 mg / 5 ml;
Number of active ingredients: 2.00;
2002-08-01;
Oral;
Syrup;
04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02245075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69079
EXTRA STRENGTH TYLENOL COLD DAYTIME
phenylephrine hydrochloride 5 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 10 mg;
Number of active ingredients: 3.00;
2006-07-24;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02276186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76185
DIMETAPP
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml;
Number of active ingredients: 2.00;
2001-07-23;
Oral;
Syrup;
04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02243980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67924
ROBITUSSIN CHILDREN’S COLD
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml;
Number of active ingredients: 2.00;
2013-07-17;
Oral;
Syrup;
04:04.20 – PROPYLAMINE DERIVATIVES , 12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02394693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87984
DIMETAPP DM COUGH & COLD
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml , dextromethorphan hydrobromide 10 mg / 5 ml;
Number of active ingredients: 3.00;
2001-07-25;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02243969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67912
DIMETANE EXPECTORANT DC
phenylephrine hydrochloride 5 mg / 5 ml , brompheniramine maleate 2 mg / 5 ml , guaifenesin 100 mg / 5 ml , hydrocodone bitartrate 1.8 mg / 5 ml;
Number of active ingredients: 4.00;
2001-09-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
FOUNDATION CONSUMER BRANDS, LLC
DIN: 02244080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68035
BLES
phospholipid 27 mg / ml , surfactant-associated proteins sp-b and sp-c 500 mcg / ml;
Number of active ingredients: 2.00;
2002-02-05;
Intratracheal;
Suspension;
48:36.00 – PULMONARY SURFACTANTS;
Ethical;
BLES BIOCHEMICALS INC
DIN: 02245464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69524
MAVIRET
pibrentasvir 40 mg , glecaprevir 100 mg;
Number of active ingredients: 2.00;
2017-09-13;
Oral;
Tablet;
08:18.40.20 – HCV Protease Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
ABBVIE CORPORATION
DIN: 02467550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95591
VISKAZIDE
pindolol 10 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
1983-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
XEDITON PHARMACEUTICALS INC
DIN: 00568627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5156
VISKAZIDE
pindolol 10 mg , hydrochlorothiazide 50 mg;
Number of active ingredients: 2.00;
1983-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
XEDITON PHARMACEUTICALS INC
DIN: 00568635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5157
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
piperacillin (piperacillin sodium) 12 g / vial , tazobactam (tazobactam sodium) 1.5 g / vial;
Number of active ingredients: 2.00;
2010-03-10;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02330547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81627
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 12 g / vial , tazobactam (tazobactam sodium) 1.5 g / vial;
Number of active ingredients: 2.00;
2012-03-13;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
DIN: 02377748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86356
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
Number of active ingredients: 2.00;
2007-11-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02299623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78500
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
Number of active ingredients: 2.00;
2011-08-29;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
DIN: 02362619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84762
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
Number of active ingredients: 2.00;
2015-03-11;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02401312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88623
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 2 g / vial , tazobactam (tazobactam sodium) 0.25 g / vial;
Number of active ingredients: 2.00;
2021-06-09;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
AURO PHARMA INC
DIN: 02402068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88693
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
Number of active ingredients: 2.00;
2007-11-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02299631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78501
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
Number of active ingredients: 2.00;
2011-08-29;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
DIN: 02362627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84763
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
Number of active ingredients: 2.00;
2013-06-17;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02370166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85518
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 3 g / vial , tazobactam (tazobactam sodium) 0.375 g / vial;
Number of active ingredients: 2.00;
2021-06-09;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
AURO PHARMA INC
DIN: 02402076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88694
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 36 g / vial , tazobactam (tazobactam sodium) 4.5 g / vial;
Number of active ingredients: 2.00;
2015-09-11;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
DIN: 02439131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92352
PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
Number of active ingredients: 2.00;
2007-11-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02299658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78502
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
Number of active ingredients: 2.00;
2011-08-29;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
STERIMAX INC
DIN: 02362635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84764
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
Number of active ingredients: 2.00;
2013-06-17;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02370174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85519
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
Number of active ingredients: 2.00;
2015-03-05;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02401339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88625
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
piperacillin (piperacillin sodium) 4 g / vial , tazobactam (tazobactam sodium) 0.5 g / vial;
Number of active ingredients: 2.00;
2021-06-09;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
AURO PHARMA INC
DIN: 02402084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88695
PREVNAR 13
pneumococcal polysaccharide serotype 1 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6a 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 4.4 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 2.2 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 34 mcg / 0.5 ml;
Number of active ingredients: 14.00;
2010-03-01;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
PFIZER CANADA ULC
DIN: 02335204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82074
PNEUMOVAX 23
pneumococcal polysaccharide serotype 1 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 2 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 8 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9n 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 10a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 11a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 12f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 15b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 17f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 20 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 22f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 33f 25 mcg / 0.5 ml;
Number of active ingredients: 23.00;
2021-04-07;
Intramuscular , Subcutaneous;
Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02436442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92078
PNEUMOVAX 23
pneumococcal polysaccharide serotype 1 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 8 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9n 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 10a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 11a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 12f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 15b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 17f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 20 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 22f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 33f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 2 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 25 mcg / 0.5 ml;
Number of active ingredients: 23.00;
1978-12-31;
Intramuscular , Subcutaneous;
Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 00431648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2969
SYSTANE LUBRICANT EYE DROPS
polyethylene glycol 400 0.4 % / w/v , propylene glycol 0.3 % / w/v;
Number of active ingredients: 2.00;
2004-04-08;
Ophthalmic;
Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
ALCON CANADA INC
DIN: 02248967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73342
TRIPLE ANTIBIOTIC OINTMENT
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin (bacitracin zinc) 500 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 3.00;
1994-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
MELALEUCA OF CANADA INC.
DIN: 02088339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16171
BIODERM OINTMENT
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin 500 unit / g;
Number of active ingredients: 2.00;
1987-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
ODAN LABORATORIES LTD
DIN: 00621366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8398
POLYSPORIN ANTIBIOTIC OINTMENT
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g;
Number of active ingredients: 2.00;
1998-08-13;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02237227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60546
POLYSPORIN TRIPLE ANTIBIOTIC OINTMENT
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 3.00;
1998-08-13;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02237226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60545
TRIPLE ANTIBIOTIC OINTMENT
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 3.00;
2003-01-20;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02246693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70888
POLYSPORIN COMPLETE
polymyxin b (polymyxin b sulfate) 10000 unit / g , bacitracin zinc 500 unit / g , gramicidin 0.25 mg / g , lidocaine 50 mg / g;
Number of active ingredients: 4.00;
2005-05-24;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02240568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64139
POLYSPORIN ANTIBIOTIC CREAM
polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 2.00;
1997-08-07;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02230844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50105
POLYSPORIN PLUS PAIN RELIEF
polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
Number of active ingredients: 3.00;
1999-06-18;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02239201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62658
POLYSPORIN FOR KIDS
polymyxin b (polymyxin b sulfate) 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
Number of active ingredients: 3.00;
2004-04-05;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02248189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72525
POLYSPORIN EYE AND EAR DROPS STERILE
polymyxin b (polymyxin b sulfate) 10000 unit / ml , gramicidin 0.025 mg / ml;
Number of active ingredients: 2.00;
2000-02-12;
Ophthalmic , Otic;
Drops;
52:04.04 – ANTIBACTERIALS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02239156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62612
POLYSPORIN PLUS PAIN RELIEF EAR DROPS
polymyxin b (polymyxin b sulfate) 10000 unit / ml , lidocaine hydrochloride 50 mg / ml;
Number of active ingredients: 2.00;
1999-12-29;
Otic;
Drops;
52:04.04 – ANTIBACTERIALS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02239155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62611
POLYTRIM OPHTHALMIC SOLUTION
polymyxin b (polymyxin b sulfate) 10000 unit / ml , trimethoprim (trimethoprim sulfate) 1 mg / ml;
Number of active ingredients: 2.00;
1993-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
ALLERGAN INC
DIN: 02011956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13628
BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC
polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
Number of active ingredients: 2.00;
1998-04-06;
Topical;
Ointment , Pad;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02236954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60248
ANTIBIOTIC OINTMENT
polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
Number of active ingredients: 2.00;
2012-05-16;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02372037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85716
POLYSPORIN SINGLES
polymyxin b sulfate 10000 unit / g , bacitracin zinc 500 unit / g;
Number of active ingredients: 2.00;
2019-10-28;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02481618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97207
ORIGINAL ANTIBIOTIC CREAM
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 2.00;
2010-10-26;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02317656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80317
ANTIBIOTIC CREAM
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g;
Number of active ingredients: 2.00;
2012-03-22;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02372029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85715
COMPLETE ANTIBIOTIC OINTMENT
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine 50 mg / g , bacitracin zinc 500 unit / g;
Number of active ingredients: 4.00;
2009-01-23;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02304465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78975
ANTIBIOTIC CREAM PLUS PAIN RELIEF FOR KIDS
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 40 mg / g;
Number of active ingredients: 3.00;
2012-07-11;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 02377187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86278
ANTIBIOTIC PLUS PAIN RELIEF CREAM
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
Number of active ingredients: 3.00;
2009-07-30;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02304457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78974
ANTIBIOTIC CREAM FOR KIDS
polymyxin b sulfate 10000 unit / g , gramicidin 0.25 mg / g , lidocaine hydrochloride 50 mg / g;
Number of active ingredients: 3.00;
2009-07-30;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02315033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80057
SANDOZ POLYTRIMETHOPRIM
polymyxin b sulfate 10000 unit / ml , trimethoprim (trimethoprim sulfate) 1 mg / ml;
Number of active ingredients: 2.00;
2012-08-02;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02239234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62695
CLEAR EYES TRIPLE ACTION RELIEF
polyvinyl alcohol 0.5 % , povidone 0.6 % , tetrahydrozoline hydrochloride 0.05 %;
Number of active ingredients: 3.00;
2008-03-26;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
DIN: 02301687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78699
MURINE
polyvinyl alcohol 5 mg / ml , povidone 6 mg / ml;
Number of active ingredients: 2.00;
2004-03-24;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
PRESTIGE BRANDS INC
DIN: 02247538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71788
POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE
potassium chloride 0.15 g / 100 ml , sodium chloride 0.9 g / 100 ml;
Number of active ingredients: 2.00;
2008-04-07;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 02299100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78450
POTASSIUM PHOSPHATES
potassium phosphate monobasic 224 mg / ml , potassium phosphate dibasic 236 mg / ml;
Number of active ingredients: 2.00;
1989-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00804789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10509
POTASSIUM PHOSPHATES INJECTION, USP
potassium phosphate monobasic 224 mg / ml , potassium phosphate dibasic 236 mg / ml;
Number of active ingredients: 2.00;
1984-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02139545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19442
POLYSPORIN POLY TO GO
pramoxine hydrochloride 1 % , benzalkonium chloride 0.13 %;
Number of active ingredients: 2.00;
2009-03-12;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES , 84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02318946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80442
PROCTODAN-HC OINTMENT
pramoxine hydrochloride 1 % , hydrocortisone acetate 0.5 % , zinc sulfate 0.5 %;
Number of active ingredients: 3.00;
1998-01-23;
Rectal , Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02234466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55837
POLYSPORIN ITCH RELIEF
pramoxine hydrochloride 1 % , zinc acetate 0.1 %;
Number of active ingredients: 2.00;
2003-04-02;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02246156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70300
ANUSOL PLUS OINTMENT
pramoxine hydrochloride 1 % , zinc sulfate 0.5 %;
Number of active ingredients: 2.00;
1992-12-31;
Rectal , Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 01945912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12764
ITCH RELIEF LOTION
pramoxine hydrochloride 1 % / w/w , zinc acetate 0.1 % / w/w;
Number of active ingredients: 2.00;
2009-09-09;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CRLS
DIN: 02318423
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80391
PROCTODAN-HC SUPPOSITORIES
pramoxine hydrochloride 20 mg , hydrocortisone acetate 10 mg , zinc sulfate 10 mg;
Number of active ingredients: 3.00;
2000-03-23;
Rectal;
Suppository;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02240851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64442
ANUSOL PLUS SUPPOSITORIES
pramoxine hydrochloride 20 mg , zinc sulfate 10 mg;
Number of active ingredients: 2.00;
1992-12-31;
Rectal;
Suppository;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 01945904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12763
ORAQIX
prilocaine 2.5 % , lidocaine 2.5 %;
Number of active ingredients: 2.00;
2010-02-11;
Topical;
Gel;
52:16.00 – LOCAL ANESTHETICS;
Otc;
DENTSPLY CANADA LIMITED
DIN: 02325993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81134
PRILOCAINE HCL 4% EPINEPH 1:200000INJ
prilocaine hydrochloride 40 mg / ml , epinephrine 0.005 mg / ml;
Number of active ingredients: 2.00;
1977-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 00393746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2828
4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000
prilocaine hydrochloride 40 mg / ml , epinephrine 0.005 mg / ml;
Number of active ingredients: 2.00;
2011-01-18;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02347695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83307
SECARIS
propylene glycol 20 % / w/w , macrogol 15 % / w/w;
Number of active ingredients: 2.00;
1982-12-31;
Nasal;
Gel;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00551805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4885
RHINARIS NASAL MIST
propylene glycol 5 % / w/w , macrogol 15 % / w/w;
Number of active ingredients: 2.00;
2012-01-11;
Nasal;
Spray, Metered Dose;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02354551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83972
VIOKACE
protease 57100 unit , lipase 10440 unit , amylase 56400 unit;
Number of active ingredients: 3.00;
1997-01-23;
Oral;
Tablet;
56:16.00 – DIGESTANTS;
Prescription;
NESTLE ENTERPRISES S.A.
DIN: 02230019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48551
ENTEX LA
pseudoephedrine hydrochloride 120 mg , guaifenesin 600 mg;
Number of active ingredients: 2.00;
2004-02-02;
Oral;
Tablet (Extended-Release);
48:16.00 – EXPECTORANTS;
Otc;
PURDUE PHARMA
DIN: 02246971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71201
ROBITUSSIN CHILDREN’S COUGH AND COLD
pseudoephedrine hydrochloride 15 mg / 5 ml , dextromethorphan hydrobromide 7.5 mg / 5 ml;
Number of active ingredients: 2.00;
1993-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02044013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14551
BUCKLEY’S COMPLETE + MUCUS RELIEF
pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2010-08-02;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02335948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82152
COMPLETE DAYTIME LIQUID CAPSULES
pseudoephedrine hydrochloride 30 mg , acetaminophen 250 mg , dextromethorphan hydrobromide 10 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2015-05-01;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02428113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91260
BUCKLEYS COLD & SINUS
pseudoephedrine hydrochloride 30 mg , acetaminophen 325 mg , dextromethorphan hydrobromide 15 mg;
Number of active ingredients: 3.00;
2008-07-21;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02307111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79278
EXTRA STRENGTH SINUS RELIEF DAYTIME
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
1996-10-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02050242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27225
COLD AND FLU-IN-ONE EXTRA STRENGTH
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2007-04-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02281147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76681
TOTAL COLD AND FLU
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2007-01-29;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02286394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77185
FLU, COUGH & COLD COMPLETE
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg;
Number of active ingredients: 4.00;
2012-05-05;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02380447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86625
EXTRA STRENGTH SINUTAB SINUS NIGHTTIME
pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
Number of active ingredients: 3.00;
1998-03-05;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02215241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37037
BUCKLEY’S NIGHTTIME COLD AND SINUS
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , doxylamine succinate 6.25 mg;
Number of active ingredients: 4.00;
2008-07-21;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02307014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79269
BUCKLEY’S COMPLETE NIGHTTIME SOFTGELS
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , doxylamine succinate 6.25 mg;
Number of active ingredients: 4.00;
2010-08-02;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02335239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82084
EXTRA STRENGTH COLD MEDICATION DAYTIME RELIEF
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
1995-12-31;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02083736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17880
BUCKLEY’S COMPLETE EXTRA STRENGTH COUGH, COLD & FLU DAY
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2000-08-08;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
THE BUCKLEY’S COMPANY
DIN: 02241593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65250
EXTRA STRENGTH FLU RELIEF DAYTIME
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg;
Number of active ingredients: 3.00;
2004-03-01;
Oral;
Tablet;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02248580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72935
NIGHTTIME COLD & FLU LIQUID CAPSULES
pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg , acetaminophen 325 mg;
Number of active ingredients: 4.00;
2005-01-10;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02258927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74415
COLD + SINUS PLUS
pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2011-04-19;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02359243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84427
COLD + SINUS NIGHTTIME
pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg , chlorpheniramine maleate 2 mg;
Number of active ingredients: 3.00;
2015-01-01;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02369559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85448
DM-DECONGESTANT-EXPECTORANT SYRUP
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 3.00;
2000-03-06;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02241490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65130
COUGH & COLD RELIEF
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 100 mg / 5 ml;
Number of active ingredients: 3.00;
2013-08-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02405873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89064
DM-DECONGESTANT-EXPECTORANT (EXTRA STRENGTH) SYRUP
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 3.00;
2000-02-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02241489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65129
COUGH & COLD RELIEF EXTRA STRENGTH
pseudoephedrine hydrochloride 30 mg / 5 ml , dextromethorphan hydrobromide 15 mg / 5 ml , guaifenesin 200 mg / 5 ml;
Number of active ingredients: 3.00;
2013-07-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
DIN: 02405881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89065
EXTRA STRENGTH SUDAFED HEAD COLD & SINUS
pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2000-08-15;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02239159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62615
EXTRA STRENGTH HEAD COLD AND SINUS
pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2004-04-01;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02248646
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73003
EXTRA STRENGTH TYLENOL SINUS PRESSURE & PAIN
pseudoephedrine hydrochloride 60 mg , acetaminophen 500 mg;
Number of active ingredients: 2.00;
2019-06-11;
Oral;
Tablet;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02478110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96884
CLARITIN ALLERGY + SINUS EXTRA STRENGTH
pseudoephedrine sulfate 240 mg , loratadine 10 mg;
Number of active ingredients: 2.00;
2005-03-01;
Oral;
Tablet (Immediate And Extended Release);
04:08.00 – SECOND GENERATION ANTIHISTAMINES , 12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Otc;
BAYER INC
DIN: 02260557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74601
R & C SHAMPOO WITH CONDITIONER
pyrethrins 0.33 % , piperonyl butoxide 3 %;
Number of active ingredients: 2.00;
1995-12-31;
Topical;
Shampoo;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
MEDTECH PRODUCTS INC
DIN: 02125447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18634
LICE KILLING SHAMPOO
pyrethrins 0.33 % , piperonyl butoxide 4 %;
Number of active ingredients: 2.00;
2008-03-05;
Topical;
Shampoo;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02298015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78333
LICE SHAMPOO
pyrethrins 0.33 % / w/w , piperonyl butoxide 4 % / w/w;
Number of active ingredients: 2.00;
2014-04-24;
Topical;
Shampoo;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
PERRIGO INTERNATIONAL
DIN: 02409321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89404
APO-DOXYLAMINE/B6
pyridoxine hydrochloride 10 mg , doxylamine succinate 10 mg;
Number of active ingredients: 2.00;
2017-08-11;
Oral;
Tablet (Delayed-Release);
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Prescription;
APOTEX INC
DIN: 02413248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89791
Z-PLUS SHAMPOO
pyrithione zinc 2 % , menthol 0.3 %;
Number of active ingredients: 2.00;
1990-12-31;
Topical;
Shampoo;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DORMER LABORATORIES INC.
DIN: 00800686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10999
ACCURETIC
quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
1998-10-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PFIZER CANADA ULC
DIN: 02237367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60690
APO-QUINAPRIL/HCTZ
quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-08-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02408767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89352
AURO-QUINAPRIL HCTZ
quinapril (quinapril hydrochloride) 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2019-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02473291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96270
ACCURETIC
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
1998-10-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PFIZER CANADA ULC
DIN: 02237368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60691
APO-QUINAPRIL/HCTZ
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-08-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02408775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89353
AURO-QUINAPRIL HCTZ
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2019-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02473305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96271
ACCURETIC
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2003-06-02;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PFIZER CANADA ULC
DIN: 02237369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60692
APO-QUINAPRIL/HCTZ
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2013-08-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02408783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89354
AURO-QUINAPRIL HCTZ
quinapril (quinapril hydrochloride) 20 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2019-02-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02473321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96273
ALTACE HCT
ramipril 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02283166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76878
PMS-RAMIPRIL-HCTZ
ramipril 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2010-02-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02342154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82765
TARO-RAMIPRIL HCTZ
ramipril 10 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02449455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93529
ALTACE HCT
ramipril 10 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02283182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76880
PMS-RAMIPRIL-HCTZ
ramipril 10 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2010-02-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02342170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82767
TARO-RAMIPRIL HCTZ
ramipril 10 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02449471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93531
ALTACE HCT
ramipril 2.5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02283131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76876
TARO-RAMIPRIL HCTZ
ramipril 2.5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02449439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93527
ALTACE HCT
ramipril 5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02283158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76877
TARO-RAMIPRIL HCTZ
ramipril 5 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02449447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93528
ALTACE HCT
ramipril 5 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2006-11-16;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02283174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76879
TARO-RAMIPRIL HCTZ
ramipril 5 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2017-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02449463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93530
CERVARIX
recombinant human papillomavirus type 16 l1 protein 20 mcg / 0.5 ml , recombinant human papillomavirus type 18 l1 protein 20 mcg / 0.5 ml;
Number of active ingredients: 2.00;
2010-02-10;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02342227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82773
BEXSERO
recombinant neisseria meningitidis group b nhba fusion protein 50 mcg / 0.5 ml , recombinant neisseria meningitidis group b nada protein 50 mcg / 0.5 ml , recombinant neisseria meningitidis group b fhbp fusion protein 50 mcg / 0.5 ml , outer membrane vesicles (neisseria meningitidis group b nz98/254 strain) 25 mcg / 0.5 ml;
Number of active ingredients: 4.00;
2014-02-26;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02417030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90167
CABENUVA
rilpivirine 300 mg / ml , cabotegravir 200 mg / ml;
Number of active ingredients: 2.00;
2020-09-21;
Intramuscular;
Suspension (Extended-Release) , Kit;
08:18.08.12 – HIV INTEGRASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02497247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98709
TEVA-COMBO STERINEBS
salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml , ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg / 2.5 ml;
Number of active ingredients: 2.00;
2005-11-18;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02272695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75820
TARDAN SHP
salicylic acid 2 % , triclosan 0.3 % , coal tar 5 %;
Number of active ingredients: 3.00;
1973-12-31;
Topical;
Shampoo;
84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
Otc;
ODAN LABORATORIES LTD
DIN: 00266493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1667
CANTHARONE PLUS
salicylic acid 30 % , podophyllin 2 % , cantharidin 1 %;
Number of active ingredients: 3.00;
1984-12-31;
Topical;
Liquid;
84:28.00 – KERATOLYTIC AGENTS;
Prescription;
DORMER LABORATORIES INC.
DIN: 00772011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9361
SEBCUR-T
salicylic acid 4 % , coal tar 10 %;
Number of active ingredients: 2.00;
1986-12-31;
Topical;
Shampoo;
84:28.00 – KERATOLYTIC AGENTS , 84:32.00 – KERATOPLASTIC AGENTS;
Otc;
DERMTEK PHARMA INC
DIN: 00666114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6848
ADVAIR 125
salmeterol (salmeterol xinafoate) 25 mcg / act , fluticasone propionate 125 mcg / act;
Number of active ingredients: 2.00;
2001-12-21;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS , 48:10.08.08 – ORALLY INHALED PREPARATIONS , 48:12.04.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02245126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69136
ADVAIR 250
salmeterol (salmeterol xinafoate) 25 mcg / act , fluticasone propionate 250 mcg / act;
Number of active ingredients: 2.00;
2001-12-21;
Inhalation;
Aerosol, Metered Dose;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02245127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69137
ADVAIR 100 DISKUS
salmeterol (salmeterol xinafoate) 50 mcg / act , fluticasone propionate 100 mcg / act;
Number of active ingredients: 2.00;
1999-09-24;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02240835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64426
ADVAIR 250 DISKUS
salmeterol (salmeterol xinafoate) 50 mcg / act , fluticasone propionate 250 mcg / act;
Number of active ingredients: 2.00;
1999-09-24;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02240836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64427
ADVAIR 500 DISKUS
salmeterol (salmeterol xinafoate) 50 mcg / act , fluticasone propionate 500 mcg / act;
Number of active ingredients: 2.00;
1999-09-24;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02240837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64428
VIVAXIM
salmonella typhi vi capsular polysaccharide vaccine 25 mcg / 0.5 ml , hepatitis a vaccine – inactivated 160 unit / 0.5 ml;
Number of active ingredients: 2.00;
2005-11-09;
Intramuscular;
Solution , Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02248361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72706
KOMBOGLYZE
saxagliptin (saxagliptin hydrochloride) 2.5 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2013-04-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02389185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87469
KOMBOGLYZE
saxagliptin (saxagliptin hydrochloride) 2.5 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2013-04-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02389169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87467
KOMBOGLYZE
saxagliptin (saxagliptin hydrochloride) 2.5 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2013-04-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02389177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87468
ARTISS
sealer protein (human) 125 mg / ml , aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 4 unit / ml , calcium chloride 40 mcmol / ml;
Number of active ingredients: 4.00;
2011-12-18;
Topical;
Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
BAXTER CORPORATION
DIN: 02326167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81150
TISSEEL
sealer protein (human) 125 mg / ml , aprotinin (synthetic) 3000 kiu / ml , thrombin (human) 500 unit / ml , calcium chloride 40 mcmol / ml;
Number of active ingredients: 4.00;
2011-12-14;
Topical;
Kit;
20:28.16 – HEMOSTATICS;
Schedule D;
BAXTER CORPORATION
DIN: 02326132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81147
SENOKOT S
sennosides 8.6 mg , docusate sodium 50 mg;
Number of active ingredients: 2.00;
1975-12-31;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PURDUE PHARMA
DIN: 00026123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2133
SENNA S. TABLETS
sennosides 8.6 mg , docusate sodium 50 mg;
Number of active ingredients: 2.00;
2003-10-29;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TANTA PHARMACEUTICALS INC
DIN: 02246951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71178
SANDOZ SENNA S
sennosides 8.6 mg , docusate sodium 50 mg;
Number of active ingredients: 2.00;
2004-12-10;
Oral;
Tablet;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANDOZ CANADA INCORPORATED
DIN: 02247390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71635
NUWIQ
simoctocog alfa 1000 unit / vial , water 2.5 ml / syr;
Number of active ingredients: 2.00;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02432986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91742
NUWIQ
simoctocog alfa 2000 unit / vial , water 2.5 ml / syr;
Number of active ingredients: 2.00;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02432994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91743
NUWIQ
simoctocog alfa 250 unit / vial , water 2.5 ml / syr;
Number of active ingredients: 2.00;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02432951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91740
NUWIQ
simoctocog alfa 3000 unit / vial , water 2.5 ml / syr;
Number of active ingredients: 2.00;
2018-07-25;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02474050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96406
NUWIQ
simoctocog alfa 4000 unit / vial , water 2.5 ml / syr;
Number of active ingredients: 2.00;
2018-07-25;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02474069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96407
NUWIQ
simoctocog alfa 500 unit / vial , water 2.5 ml / syr;
Number of active ingredients: 2.00;
2015-12-22;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02432978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91741
JANUMET XR
sitagliptin (sitagliptin phosphate monohydrate) 100 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2015-01-13;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02416808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90141
JANUMET
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2009-10-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02333872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81956
JANUMET XR
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 1000 mg;
Number of active ingredients: 2.00;
2014-01-15;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02416794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90140
JANUMET
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2009-10-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02333856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81954
JANUMET XR
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 500 mg;
Number of active ingredients: 2.00;
2015-01-13;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02416786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90139
JANUMET
sitagliptin (sitagliptin phosphate monohydrate) 50 mg , metformin hydrochloride 850 mg;
Number of active ingredients: 2.00;
2009-10-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES , 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02333864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81955
H.E.L.P. ACETATE BUFFER PH 4.85
sodium acetate 27.22 g / l , acetic acid 6.82 g / l;
Number of active ingredients: 2.00;
2012-03-09;
Dialysis;
Solution;
40:04.00 – ACIDIFYING AGENTS;
Ethical;
B. BRAUN AVITUM AG
DIN: 02373807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85902
BICART SELECT COMBI-PAK
sodium bicarbonate 720 g / cartridge , sodium chloride 1200 g / cartridge;
Number of active ingredients: 2.00;
2016-02-22;
Dialysis;
Kit , Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02425246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90988
SAG-M
sodium chloride 0.877 % / w/v , adenine 0.0169 % / w/v , dextrose 0.9 % / w/v , mannitol 0.525 % / w/v;
Number of active ingredients: 4.00;
2013-01-20;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
HAEMONETICS CORPORATION
DIN: 02386925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87250
PHENOL SALINE INJ
sodium chloride 0.9 % , phenol 0.4 %;
Number of active ingredients: 2.00;
1963-12-31;
Intradermal , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
ALK-ABELLO INC
DIN: 00298409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1911
GLYCERINATED PHENOL SALINE
sodium chloride 0.9 % , phenol 0.4 % , glycerine 50 %;
Number of active ingredients: 3.00;
1963-12-31;
Intradermal , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
ALK-ABELLO INC
DIN: 00298417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1912
ACID CONCENTRATE D12203
sodium chloride 263 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
Number of active ingredients: 4.00;
1989-12-31;
Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 00860468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9848
POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP
sodium chloride 450 mg / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 2.00;
2008-03-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 02269414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75479
REGIOCIT
sodium chloride 5.03 g / l , sodium citrate 5.29 g / l;
Number of active ingredients: 2.00;
2020-07-27;
Extracorporeal;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02496755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98660
LACTATED RINGER’S INJECTION
sodium chloride 6 mg / ml , potassium chloride 0.3 mg / ml , calcium chloride 0.2 mg / ml , sodium lactate 3.1 mg / ml;
Number of active ingredients: 4.00;
1951-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00039470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1745
LACTATED RINGER’S IRRIGATION
sodium chloride 600 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml , sodium lactate 310 mg / 100 ml;
Number of active ingredients: 4.00;
1988-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00758566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8601
POTASSIUM CHLORIDE IN LACTATED RINGER’S INJECTION
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 179 mg / 100 ml , calcium chloride 20 mg / 100 ml;
Number of active ingredients: 4.00;
2001-05-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 02243421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67329
LACTATED RINGER’S INJECTION, USP
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml;
Number of active ingredients: 4.00;
1957-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 00061085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1628
LACTATED RINGER’S IRRIGATION SOL
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml;
Number of active ingredients: 4.00;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00799971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9830
LACTATED RINGER’S INJECTION USP
sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml , potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml;
Number of active ingredients: 4.00;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01931636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12186
ADDITIVE SOLUTION SODIUM ADENINE GLUCOSE MANNITOL (SAGM)
sodium chloride 8.77 g / l , adenine 0.169 g / l , dextrose 9 g / l , mannitol 5.25 g / l;
Number of active ingredients: 4.00;
2016-08-22;
0-Unassigned;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MACO PHARMA
DIN: 02444097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92892
RINGER’S INJECTION USP
sodium chloride 860 mg / 100 ml , calcium chloride 33 mg / 100 ml , potassium chloride 30 mg / 100 ml;
Number of active ingredients: 3.00;
1996-09-10;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01936034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=21999
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ
sodium chloride 9 mg / ml , heparin (heparin sodium) 2 unit / ml;
Number of active ingredients: 2.00;
1990-12-31;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
BAXTER CORPORATION
DIN: 00828750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10521
(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP
sodium chloride 900 mg / 100 ml , potassium chloride 150 mg / 100 ml;
Number of active ingredients: 2.00;
1989-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 00786209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9826
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP
sodium chloride 900 mg / 100 ml , potassium chloride 300 mg / 100 ml;
Number of active ingredients: 2.00;
1989-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 00786217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9827
SODIUM PHOSPHATES INJECTION USP
sodium phosphate monobasic 276 mg / ml , sodium phosphate dibasic 268 mg / ml;
Number of active ingredients: 2.00;
1991-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00896187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11258
HARVONI
sofosbuvir 400 mg , ledipasvir 90 mg;
Number of active ingredients: 2.00;
2014-10-16;
Oral;
Tablet;
08:18.40.16 – HCV Polymerase Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02432226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91668
EPCLUSA
sofosbuvir 400 mg , velpatasvir 100 mg;
Number of active ingredients: 2.00;
2016-08-02;
Oral;
Tablet;
08:18.40.16 – HCV Polymerase Inhibitors , 08:18.40.24 – HCV Replication Complex Inhibitors;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02456370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94324
VOSEVI
sofosbuvir 400 mg , velpatasvir 100 mg , voxilaprevir 100 mg;
Number of active ingredients: 3.00;
2017-09-18;
Oral;
Tablet;
08:18.40.16 – HCV Polymerase Inhibitors;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02467542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95590
SEROSTIM
somatropin 5 mg / kit , water 1 ml / kit;
Number of active ingredients: 2.00;
1999-07-28;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02239046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62499
SORBITOL MANNITOL IRRIGATION
sorbitol 27 mg / ml , mannitol 5.4 mg / ml;
Number of active ingredients: 2.00;
1980-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00498807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3823
SMOFKABIVEN ELECTROLYTE FREE
soybean oil 1.14 g / 100 ml , medium chain triglycerides (mct) 1.14 g / 100 ml , olive oil 0.95 g / 100 ml , fish oil 0.57 g / 100 ml , dextrose 12.7 g / 100 ml , lysine (lysine acetate) 0.34 g / 100 ml , phenylalanine 0.26 g / 100 ml , leucine 0.38 g / 100 ml , valine 0.31 g / 100 ml , threonine 0.22 g / 100 ml , methionine 0.22 g / 100 ml , isoleucine 0.25 g / 100 ml , tryptophan 0.1 g / 100 ml , alanine 0.71 g / 100 ml , arginine 0.61 g / 100 ml , glycine 0.56 g / 100 ml , proline 0.57 g / 100 ml , histidine 0.15 g / 100 ml , serine 0.33 g / 100 ml , taurine 0.05 g / 100 ml , tyrosine 0.02 g / 100 ml , nitrogen 0.8 g / 100 ml;
Number of active ingredients: 22.00;
2015-09-15;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02440687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92505
SMOFLIPID 20%
soybean oil 6 % / w/v , medium chain triglycerides (mct) 6 % / w/v , olive oil 5 % / w/v , fish oil 3 % / w/v;
Number of active ingredients: 4.00;
2013-05-08;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02396963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88197
TEVA-SPIRONOLACTONE/HCTZ
spironolactone 25 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
1984-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00613231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5858
TEVA-SPIRONOLACTONE/HCTZ
spironolactone 50 mg , hydrochlorothiazide 50 mg;
Number of active ingredients: 2.00;
1986-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00657182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6892
ALLERGENIC EXTRACTS, K-O-R-T GRASS MIXTURE
standardized kentucky blue/june grass pollen 100000 unit / ml , standardized orchard grass pollen 100000 unit / ml , standardized redtop grass pollen 100000 unit / ml , standardized timothy grass pollen 100000 unit / ml;
Number of active ingredients: 4.00;
2015-11-10;
Intracutaneous , Subcutaneous;
Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02447304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93285
ALLERGENIC EXTRACT – MIXTURE OF 4 STANDARDIZED GRASS POLLEN
standardized timothy grass pollen 25000 unit / ml , standardized orchard grass pollen 25000 unit / ml , standardized kentucky blue/june grass pollen 25000 unit / ml , standardized redtop grass pollen 25000 unit / ml;
Number of active ingredients: 4.00;
2011-03-22;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81091
BLEPHAMIDE
sulfacetamide sodium 10 % , prednisolone acetate 0.2 %;
Number of active ingredients: 2.00;
1989-12-31;
Ophthalmic;
Drops;
52:04.08 – SULFONAMIDES , 52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
DIN: 00807788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10169
SULFATRIM PEDIATRIC
sulfamethoxazole 100 mg , trimethoprim 20 mg;
Number of active ingredients: 2.00;
1979-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
AA PHARMA INC
DIN: 00445266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3677
SULFATRIM
sulfamethoxazole 400 mg , trimethoprim 80 mg;
Number of active ingredients: 2.00;
1979-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
AA PHARMA INC
DIN: 00445274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3678
SULFATRIM DS
sulfamethoxazole 800 mg , trimethoprim 160 mg;
Number of active ingredients: 2.00;
1979-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
AA PHARMA INC
DIN: 00445282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3679
NEO-MEDROL ACNE LOTION
sulfur 50 mg / ml , methylprednisolone acetate 2.5 mg / ml , neomycin sulfate 2.5 mg / ml , aluminum chlorohydrate 100 mg / ml;
Number of active ingredients: 4.00;
1965-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS , 84:28.00 – KERATOLYTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 00195057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1394
SUVEXX
sumatriptan (sumatriptan succinate) 85 mg , naproxen sodium 500 mg;
Number of active ingredients: 2.00;
2020-07-24;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
DIN: 02496305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98619
PIPERACILLIN AND TAZOBACTAM FOR INJECTION
tazobactam (tazobactam sodium) 0.375 g / vial , piperacillin (piperacillin sodium) 3 g / vial;
Number of active ingredients: 2.00;
2015-03-11;
Intravenous;
Powder For Solution;
08:12.16.16 – EXTENDED-SPECTRUM PENICILLINS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02401320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88624
TEVA-TELMISARTAN HCTZ
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02330288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81603
TELMISARTAN HCTZ
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02390302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87575
TEVA-TELMISARTAN HCTZ
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02379252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86513
TELMISARTAN HCTZ
telmisartan (telmisartan sodium) 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02390310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87576
TWYNSTA
telmisartan 40 mg , amlodipine (amlodipine besylate) 10 mg;
Number of active ingredients: 2.00;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02371030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85623
TWYNSTA
telmisartan 40 mg , amlodipine (amlodipine besylate) 5 mg;
Number of active ingredients: 2.00;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02371022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85622
TWYNSTA
telmisartan 80 mg , amlodipine (amlodipine besylate) 10 mg;
Number of active ingredients: 2.00;
2011-08-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02371057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85625
AA-TELMISARTAN-AMLODIPINE
telmisartan 80 mg , amlodipine (amlodipine besylate) 10 mg;
Number of active ingredients: 2.00;
2021-05-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
AA PHARMA INC
DIN: 02473496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96289
AA-TELMISARTAN-AMLODIPINE
telmisartan 80 mg , amlodipine (amlodipine besylate) 5 mg;
Number of active ingredients: 2.00;
2021-05-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:28.08 – DIHYDROPYRIDINES;
Prescription;
AA PHARMA INC
DIN: 02473488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96288
MICARDIS PLUS
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2001-08-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02244344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68312
JAMP TELMISARTAN-HCT
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02389940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87541
SANDOZ TELMISARTAN HCT
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02393557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87877
TELMISARTAN/HCTZ
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-11-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02395355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88046
TELMISARTAN-HCTZ
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02395525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88061
ACH-TELMISARTAN HCTZ
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2014-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02419114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90365
AURO-TELMISARTAN HCTZ
telmisartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2016-08-23;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02456389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94325
MICARDIS PLUS
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2008-12-02;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02318709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80418
JAMP TELMISARTAN-HCT
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02389959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87542
SANDOZ TELMISARTAN HCT
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-09-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02393565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87878
TELMISARTAN/HCTZ
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-11-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02395363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88047
TELMISARTAN-HCTZ
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02395533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88062
ACH-TELMISARTAN HCTZ
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2014-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02419122
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90366
AURO-TELMISARTAN HCTZ
telmisartan 80 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2016-08-23;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02456397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94326
STRIBILD
tenofovir disoproxil fumarate 300 mg , cobicistat 150 mg , emtricitabine 200 mg , elvitegravir 150 mg;
Number of active ingredients: 4.00;
2012-12-20;
Oral;
Tablet;
08:18.08.12 – HIV INTEGRASE INHIBITORS , 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS , 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02397137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88208
TRUVADA
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
Number of active ingredients: 2.00;
2006-04-06;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02274906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76043
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
Number of active ingredients: 2.00;
2017-07-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02443902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92868
APO-EMTRICITABINE-TENOFOVIR
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
Number of active ingredients: 2.00;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02452006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93840
PMS-EMTRICITABINE-TENOFOVIR
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
Number of active ingredients: 2.00;
2019-09-12;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02461110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94861
JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
Number of active ingredients: 2.00;
2019-07-23;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02487012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97716
AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE
tenofovir disoproxil fumarate 300 mg , emtricitabine 200 mg;
Number of active ingredients: 2.00;
2020-11-09;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02496356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98623
ALLERGY EYE DROPS
tetrahydrozoline hydrochloride 0.05 % / w/v , zinc sulfate 0.25 % / w/v;
Number of active ingredients: 2.00;
2007-05-23;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02290596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77592
VISINE MULTI-SYMPTOM
tetrahydrozoline hydrochloride 0.05 % / w/v , zinc sulfate 0.25 % / w/v;
Number of active ingredients: 2.00;
2012-03-21;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02338602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82425
8-SYMPTOM RELIEF
tetrahydrozoline hydrochloride 0.05 % / w/v , zinc sulfate 0.25 % / w/v;
Number of active ingredients: 2.00;
2016-07-22;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02448955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93478
SYMDEKO
tezacaftor 100 mg , ivacaftor 150 mg , ivacaftor 150 mg;
Number of active ingredients: 3.00;
2018-06-28;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02478080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96881
TRIKAFTA
tezacaftor 50 mg , ivacaftor 75 mg , ivacaftor 150 mg , elexacaftor 100 mg;
Number of active ingredients: 4.00;
2021-06-22;
Oral;
Tablet;
48:14.04 – Cystic Fibrosis Transmembrane Conductance Regulator Correctors , 48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription Recommended;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02517140
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100648
AZARGA
timolol (timolol maleate) 0.5 % / w/v , brinzolamide 1 % / w/v;
Number of active ingredients: 2.00;
2009-08-25;
Ophthalmic;
Suspension;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02331624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81730
XALACOM
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
Number of active ingredients: 2.00;
2002-10-24;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
UPJOHN CANADA ULC
DIN: 02246619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70807
GD-LATANOPROST/TIMOLOL
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
Number of active ingredients: 2.00;
2013-05-01;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
UPJOHN CANADA ULC
DIN: 02373068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85818
SANDOZ LATANOPROST/TIMOLOL
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
Number of active ingredients: 2.00;
2013-03-04;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02394685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87982
JAMP-LATANOPROST/TIMOLOL
timolol (timolol maleate) 5 mg / ml , latanoprost 50 mcg / ml;
Number of active ingredients: 2.00;
2020-02-07;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02453770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94031
INSPIOLTO RESPIMAT
tiotropium (tiotropium bromide monohydrate) 2.5 mcg / act , olodaterol (olodaterol hydrochloride) 2.5 mcg / act;
Number of active ingredients: 2.00;
2015-05-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02441888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92626
BOBBI BROWN SKIN WEIGHTLESS LONG-WEAR FOUNDATION SPF15 FULL COVER OIL-FREE SHINE CONTROL
titanium dioxide 1.6 % / w/w , octinoxate 3 % / w/w;
Number of active ingredients: 2.00;
2017-10-30;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
DIN: 02462605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95040
UV 50 ECRAN MULTI-PROTECTION SPF 50
titanium dioxide 10.9 g / 100 g , homosalate 4 g / 100 g , octocrylene 4 g / 100 g , oxybenzone 1.5 g / 100 g;
Number of active ingredients: 4.00;
2016-02-15;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02446529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93187
BB CREAM SPF 15 BROAD SPECTRUM 5-IN-1 MIRACLE SKIN PERFECTOR
titanium dioxide 2.1 % / w/w , octinoxate 4 % / w/w;
Number of active ingredients: 2.00;
2021-04-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02503530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99300
GLOW TINTED MOISTURIZER SPF 15
titanium dioxide 2.9 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2020-04-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
TOM FORD BEAUTY DIST.
DIN: 02491435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98144
BB CREAM SPF 15 BROAD SPECTRUM 5-IN-1 MIRACLE ANTI-AGING SKIN PERFECTOR
titanium dioxide 3.6 % / w/w , octinoxate 3 % / w/w;
Number of active ingredients: 2.00;
2021-04-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02503573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99304
SKIN LONG-WEAR FLUID POWDER FOUNDATION SPF 20
titanium dioxide 3.7 % / w/w , ensulizole 2 % / w/w , zinc oxide 1.8 % / w/w;
Number of active ingredients: 3.00;
2020-03-02;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
DIN: 02490374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98042
BB CREAM SPF 20 BROAD SPECTRUM 5-IN-1 MIRACLE SKIN PERFECTOR
titanium dioxide 4.7 % / w/w , octinoxate 3 % / w/w;
Number of active ingredients: 2.00;
2021-04-15;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GARNIER CANADA
DIN: 02503565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99303
THE SOFT MOISTURE POWDER FOUNDATION SPF 30
titanium dioxide 6 % / w/w , octinoxate 5.1 % / w/w;
Number of active ingredients: 2.00;
2021-01-01;
Topical;
Powder;
84:80.00 – SUNSCREEN AGENTS;
Otc;
MAX HUBER RESEARCH LABS DIST
DIN: 02486415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97661
BOBBI BROWN INTENSIVE SKIN SERUM FOUNDATION SPF 40 LYCHEE, BAMBOO GRASS & CORDYCEPS EXTRACTS
titanium dioxide 6.1 % , octinoxate 3.9 % , zinc oxide 3.8 %;
Number of active ingredients: 3.00;
2015-04-08;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BOBBI BROWN PROFESSIONAL COSMETICS DIST
DIN: 02431459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91578
ROSALIAC CC CREME
titanium dioxide 6.2 % / w/w , octocrylene 4.5 % / w/w , octisalate 3.5 % / w/w , octinoxate 3 % / w/w;
Number of active ingredients: 4.00;
2014-09-17;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02427400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91193
FIX+ SPF 30 SUN SPRAY
titanium dioxide 6.25 % , octocrylene 10 % , avobenzone 3 % , drometrizole trisiloxane 2 %;
Number of active ingredients: 4.00;
2007-04-12;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
LABORATOIRES LA ROCHE-POSAY CANADA
DIN: 02288400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77383
URBAN ENVIRONMENT TINTED UV PROTECTOR
titanium dioxide 7.2 % / w/w , octinoxate 7.4 % / w/w , ensulizole 2 % / w/w;
Number of active ingredients: 3.00;
2014-12-29;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02423936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90866
CLINIQUE SUPERBALANCED SILK MAKEUP SPF 15
titanium dioxide 7.8 % / w/w , octinoxate 7 % / w/w , octisalate 4.5 % / w/w , zinc oxide 1.9 % / w/w;
Number of active ingredients: 4.00;
2016-10-05;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02446219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93149
MARCELLE/CC/CREAM/CRÈME COMPLETE CORRECTION/CORRECTION COMPLÈTE/SPF 35 FPS
titanium dioxide 8.35 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2013-07-18;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
GROUPE MARCELLE INC
DIN: 02406926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89158
UV 50 ECRAN TEINTÉ MULTI-PROTECTION SPF 50
titanium dioxide 8.4 % , homosalate 4 % , octocrylene 4 % , oxybenzone 1.5 %;
Number of active ingredients: 4.00;
2017-02-15;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLARINS CANADA INC
DIN: 02456273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94316
FACE IT POWER PERFECTION BB CREAM SPF 37/PA++
titanium dioxide 9.7 % / w/w , octinoxate 5 % / w/w , zinc oxide 2.94 % / w/w;
Number of active ingredients: 3.00;
2017-09-12;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
THE FACE SHOP CO., LTD
DIN: 02412519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89719
TOBRADEX
tobramycin 0.3 % / w/v , dexamethasone 0.1 % / w/v;
Number of active ingredients: 2.00;
1990-12-31;
Ophthalmic;
Suspension;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00778907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11068
TOBRADEX
tobramycin 0.3 % / w/w , dexamethasone 0.1 % / w/w;
Number of active ingredients: 2.00;
1990-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS , 52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00778915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10971
JINARC
tolvaptan 15 mg , tolvaptan 15 mg;
Number of active ingredients: 2.00;
2020-03-26;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02491575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98156
JINARC
tolvaptan 30 mg , tolvaptan 15 mg;
Number of active ingredients: 2.00;
2020-03-26;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02491583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98157
JINARC
tolvaptan 45 mg , tolvaptan 15 mg;
Number of active ingredients: 2.00;
2015-06-01;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02437503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92184
JINARC
tolvaptan 60 mg , tolvaptan 30 mg;
Number of active ingredients: 2.00;
2015-06-01;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02437511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92185
JINARC
tolvaptan 90 mg , tolvaptan 30 mg;
Number of active ingredients: 2.00;
2015-06-01;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02437538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92186
PHESGO
trastuzumab 40 mg / ml , pertuzumab 80 mg / ml;
Number of active ingredients: 2.00;
2021-04-08;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02512912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100216
OGIVRI
trastuzumab 440 mg / vial , water 20 ml / vial;
Number of active ingredients: 2.00;
2019-06-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
DIN: 02474433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96454
PHESGO
trastuzumab 60 mg / ml , pertuzumab 60 mg / ml;
Number of active ingredients: 2.00;
2021-04-09;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02512920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100217
DUOTRAV PQ
travoprost 0.004 % / w/v , timolol (timolol maleate) 0.5 % / w/v;
Number of active ingredients: 2.00;
2006-04-11;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02278251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76384
APO-TRAVOPROST-TIMOP PQ
travoprost 0.004 % / w/v , timolol (timolol maleate) 0.5 % / w/v;
Number of active ingredients: 2.00;
2018-12-06;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS , 52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
APOTEX INC
DIN: 02415305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89992
VIADERM KC CRM
triamcinolone acetonide 1 mg / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g , nystatin 100000 unit / g;
Number of active ingredients: 4.00;
1983-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 00717002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9448
VIADERM KC ONT
triamcinolone acetonide 1 mg / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g , nystatin 100000 unit / g;
Number of active ingredients: 4.00;
1983-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 00717029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9449
TEVA-TRIACOMB
triamcinolone acetonide 1 mg / g , nystatin 100000 unit / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g;
Number of active ingredients: 4.00;
1992-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00550507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12862
THERADERM CREAM
triamcinolone acetonide 1 mg / g , nystatin 100000 unit / g , neomycin (neomycin sulfate) 2.5 mg / g , gramicidin 0.25 mg / g;
Number of active ingredients: 4.00;
1993-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS , 84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BIMEDA-MTC ANIMAL HEALTH INC
DIN: 02022818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15598
TEVA-TRIAMTERENE/HCTZ
triamterene 50 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
1981-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00532657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4523
APO TRIAZIDE
triamterene 50 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
1984-12-31;
Oral;
Tablet;
40:28.16 – POTASSIUM-SPARING DIURETICS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 00441775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5672
ANTISEPTIC HAND SOAP
triclosan 0.6 % , bronopol 0.1 %;
Number of active ingredients: 2.00;
1983-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
DUSTBANE PRODUCTS LTD
DIN: 00564311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5480
LONSURF
trifluridine 15 mg , tipiracil (tipiracil hydrochloride) 6.14 mg;
Number of active ingredients: 2.00;
2018-03-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAIHO PHARMA CANADA, INC.
DIN: 02472104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96138
LONSURF
trifluridine 20 mg , tipiracil (tipiracil hydrochloride) 8.19 mg;
Number of active ingredients: 2.00;
2018-03-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAIHO PHARMA CANADA, INC.
DIN: 02472112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96139
SEPTRA INJECTION
trimethoprim 16 mg / ml , sulfamethoxazole 80 mg / ml;
Number of active ingredients: 2.00;
1982-12-31;
Intravenous;
Solution;
08:12.20 – SULFONAMIDES;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 00550086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4703
TEVA-COTRIDIN
triprolidine hydrochloride 2 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
Number of active ingredients: 3.00;
1996-07-30;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES , 04:04.20 – PROPYLAMINE DERIVATIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02169126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20329
TEVA-COTRIDIN EXPECTORANT
triprolidine hydrochloride 2 mg / 5 ml , pseudoephedrine hydrochloride 30 mg / 5 ml , guaifenesin 100 mg / 5 ml , codeine phosphate 10 mg / 5 ml;
Number of active ingredients: 4.00;
1994-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02053403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15618
ARTHRITIS PAIN RELIEF
trolamine salicylate 10 % / w/w , menthol 1.25 % / w/w , capsaicin 0.035 % / w/w;
Number of active ingredients: 3.00;
2019-10-28;
Topical;
Lotion;
28:08.04.24 – SALICYLATES;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02486725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97690
ANORO ELLIPTA
umeclidinium (umeclidinium bromide) 62.5 mcg / act , vilanterol (vilanterol trifenatate) 25 mcg / act;
Number of active ingredients: 2.00;
2014-03-14;
Inhalation;
Powder;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02418401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90298
ENTRESTO
valsartan (sacubitril valsartan sodium hydrate complex) 103 mg , sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg;
Number of active ingredients: 2.00;
2015-11-13;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:32.92 – RENIN-ANGIOTENSINE-ALDOSTERONE SYSTEM INHIBITORS, MISC.;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02446944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93251
ENTRESTO
valsartan (sacubitril valsartan sodium hydrate complex) 26 mg , sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg;
Number of active ingredients: 2.00;
2015-11-13;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:32.92 – RENIN-ANGIOTENSINE-ALDOSTERONE SYSTEM INHIBITORS, MISC.;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02446928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93249
ENTRESTO
valsartan (sacubitril valsartan sodium hydrate complex) 51 mg , sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg;
Number of active ingredients: 2.00;
2015-11-13;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 24:32.92 – RENIN-ANGIOTENSINE-ALDOSTERONE SYSTEM INHIBITORS, MISC.;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02446936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93250
DIOVAN-HCT
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2000-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02241901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65571
SANDOZ VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84183
TEVA-VALSARTAN/HCTZ
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02357003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84211
VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02367017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85183
VALSARTAN-HCTZ
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02367777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85261
VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02384744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87043
AURO-VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02408120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89287
DIOVAN-HCT
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2003-01-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02246955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71182
SANDOZ VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84184
TEVA-VALSARTAN/HCTZ
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02357011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84212
VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02367025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85184
VALSARTAN-HCTZ
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02367785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85262
VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02384752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87044
AURO-VALSARTAN HCT
valsartan 160 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02408139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89288
DIOVAN-HCT
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2008-05-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02308908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79451
SANDOZ VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84185
TEVA-VALSARTAN/HCTZ
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02357038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84213
VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02367033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85185
VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02384760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87045
AURO-VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02408147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89289
DIOVAN-HCT
valsartan 320 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2008-05-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02308916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79452
SANDOZ VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84186
TEVA-VALSARTAN/HCTZ
valsartan 320 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02357046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84214
VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02367041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85186
AURO-VALSARTAN HCT
valsartan 320 mg , hydrochlorothiazide 25 mg;
Number of active ingredients: 2.00;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02408155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89290
DIOVAN-HCT
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2000-05-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02241900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65570
SANDOZ VALSARTAN HCT
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84182
TEVA-VALSARTAN/HCTZ
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02356996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84210
VALSARTAN HCT
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02367009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85182
VALSARTAN-HCTZ
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02367769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85260
VALSARTAN HCT
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02384736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87042
AURO-VALSARTAN HCT
valsartan 80 mg , hydrochlorothiazide 12.5 mg;
Number of active ingredients: 2.00;
2013-06-19;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS , 40:28.20 – THIAZIDE DIURETICS;
Prescription;
AURO PHARMA INC
DIN: 02408112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89280
CHAMPIX
varenicline (varenicline tartrate) 0.5 mg , varenicline (varenicline tartrate) 1 mg;
Number of active ingredients: 2.00;
2007-10-02;
Oral;
Kit , Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
PFIZER CANADA ULC
DIN: 02298309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78360
TEVA-VARENICLINE
varenicline (varenicline tartrate) 0.5 mg , varenicline (varenicline tartrate) 1 mg;
Number of active ingredients: 2.00;
2019-04-23;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
TEVA CANADA LIMITED
DIN: 02426781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91135
APO-VARENICLINE
varenicline (varenicline tartrate) 0.5 mg , varenicline (varenicline tartrate) 1 mg;
Number of active ingredients: 2.00;
2018-06-12;
Oral;
Kit , Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
APOTEX INC
DIN: 02435675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92001
VARILRIX
varicella-zoster virus vaccine live attenuated (oka-strain) 2000 unit / 0.5 ml , water 0.5 ml;
Number of active ingredients: 2.00;
2003-04-09;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02241047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64641
PROQUAD
varicella-zoster virus vaccine live attenuated (oka/merck strain) 3.99 log10 pfu / 0.5 ml , measles virus vaccine live attenuated (edmonston b strain) 3 log10 tcid50 / 0.5 ml , mumps virus vaccine live attenuated (jeryl lynn strain) 4.3 log10 tcid50 / 0.5 ml , rubella virus vaccine live attenuated (wistar ra27/3 strain) 3 log10 tcid50 / 0.5 ml;
Number of active ingredients: 4.00;
2014-05-09;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02399229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88411
VENCLEXTA
venetoclax 10 mg , venetoclax 50 mg , venetoclax 100 mg;
Number of active ingredients: 3.00;
2016-10-31;
Oral;
Kit , Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
DIN: 02458063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94512
BREO ELLIPTA
vilanterol (vilanterol trifenatate) 25 mcg / act , fluticasone furoate 100 mcg / act;
Number of active ingredients: 2.00;
2013-11-29;
Inhalation;
Powder;
68:04.00 – ADRENALS , 12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02408872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89362
VIIBRYD
vilazodone hydrochloride 10 mg , vilazodone hydrochloride 20 mg;
Number of active ingredients: 2.00;
2018-07-06;
Oral;
Kit , Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
DIN: 02443759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92850
HUMATE-P
von willebrand factor (human) 1680 unit / 10 ml , antihemophilic factor (human) 600 unit / 10 ml;
Number of active ingredients: 2.00;
2004-12-06;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02261227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74662
EXTRA STRENGTH DIAPER RASH OINTMENT
white petrolatum 38 % / w/w , zinc oxide 40 % / w/w;
Number of active ingredients: 2.00;
2010-08-29;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
DIN: 02352702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83796
CAVILON MOISTURE BARRIER OINTMENT
white petrolatum 68.4 % / w/w , dimethicone 10 % / w/w;
Number of active ingredients: 2.00;
2016-01-08;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
3M CANADA COMPANY
DIN: 02443333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92798
MEDLINE REMEDY ESSENTIALS PROTECTANT PASTE
white petrolatum 75 % , zinc oxide 20 %;
Number of active ingredients: 2.00;
2019-07-22;
Topical;
Paste;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
MEDLINE INDUSTRIES INCORPORATED
DIN: 02455463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94227
ALEXANDER’S RASH EASE FOR ADULTS
white petrolatum 88.7 % , zinc oxide 5 %;
Number of active ingredients: 2.00;
2012-10-08;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ALTACOMP ENTERPRISES INC
DIN: 02390361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87581
HYMENOPTERA VENOM PRODUCT-MIXED VESPID VENOM PROTEIN (1650 MCG)
yellow jacket venom protein 550 mcg / vial , white faced hornet venom protein 550 mcg / vial , yellow hornet venom protein 550 mcg / vial;
Number of active ingredients: 3.00;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02221314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43302
CHILDREN’S BENADRYL BUG BITE RELIEF
zinc acetate 0.1 % , diphenhydramine hydrochloride 2 %;
Number of active ingredients: 2.00;
2019-03-04;
Topical;
Solution;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02478072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96880
TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 50+ SUNSCREEN
zinc oxide 10 % / w/w , octinoxate 7.5 % / w/w , homosalate 6 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 4.00;
2017-05-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SKINMEDICA, AN ALLERGAN COMPANY
DIN: 02439891
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92429
SKIN RENEWING DAY CREAM
zinc oxide 10.5 % , octinoxate 7.5 %;
Number of active ingredients: 2.00;
2018-09-07;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CERAVE CANADA
DIN: 02473852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96358
ZINCOFAX
zinc oxide 15 % , white petrolatum 69 %;
Number of active ingredients: 2.00;
1999-12-15;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
PALADIN LABS INC.
DIN: 02239162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62617
DIAPER RASH OINTMENT
zinc oxide 15 % , white petrolatum 72 %;
Number of active ingredients: 2.00;
2014-03-14;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
DIN: 02302241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78758
COPPERTONE SUNSCREEN STICK WATERBABIES
zinc oxide 15 % / w/w , octinoxate 7.5 % / w/w , octocrylene 10 % / w/w;
Number of active ingredients: 3.00;
2018-01-22;
Topical;
Stick;
84:80.00 – SUNSCREEN AGENTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02467100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95550
DIAPER RASH CREAM
zinc oxide 15 % / w/w , white petrolatum 80.3 % / w/w;
Number of active ingredients: 2.00;
2010-04-19;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
H.J. SUTTON INDUSTRIES LTD.
DIN: 02337452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82304
UNIVERSAL DEFENSE E
zinc oxide 15.4 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w;
Number of active ingredients: 3.00;
2019-12-16;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02488531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97863
CLÉ DE PEAU BEAUTÉ 50+ CRÈME PROTECTRICE UV
zinc oxide 16.4 % / w/w , octocrylene 3 % / w/w , octinoxate 7.4 % / w/w;
Number of active ingredients: 3.00;
2017-02-03;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02450216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93625
UV ESSENTIAL MULTI PROTECTION
zinc oxide 17.1 % / w/w , octinoxate 7.5 % / w/w , titanium dioxide 3.8 % / w/w;
Number of active ingredients: 3.00;
2020-06-26;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CHANEL CANADA ULC
DIN: 02495791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98569
ULTRA SUN PROTECTOR CREAM CRÈME SOLAIRE ULTRA PROTECTION 50+
zinc oxide 19.4 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , titanium dioxide 3.8 % / w/w;
Number of active ingredients: 4.00;
2020-12-11;
Topical;
Cream;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SHISEIDO AMERICAS CORPORATION DIST
DIN: 02496879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98672
CLINIQUE EVEN BETTER GLOW LIGHT REFLECTING MAKEUP SPF 15
zinc oxide 3 % / w/w , octinoxate 6 % / w/w , titanium dioxide 3.8 % / w/w;
Number of active ingredients: 3.00;
2017-09-01;
Topical;
Liquid;
84:80.00 – SUNSCREEN AGENTS;
Otc;
CLINIQUE LABORATORIES DIST
DIN: 02456540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94351
ZINCOFAX EXTRA STRENGTH
zinc oxide 40 % , white petrolatum 47 %;
Number of active ingredients: 2.00;
1999-11-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
PALADIN LABS INC.
DIN: 02239160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62616
ALEXANDER’S RASH EASE – FOR BABIES
zinc oxide 5 % , white petrolatum 88.7 %;
Number of active ingredients: 2.00;
2010-05-29;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ALTACOMP ENTERPRISES INC
DIN: 02342421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82792
ALEXANDER’S RASH EASE – SPORT CREAM
zinc oxide 5 % / w/w , white petrolatum 88.7 % / w/w;
Number of active ingredients: 2.00;
2017-09-17;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
ALTACOMP ENTERPRISES INC
DIN: 02462540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95030
CARAMEL LATTE TINTED MOISTURIZER
zinc oxide 6 % / w/w , octinoxate 6 % / w/w;
Number of active ingredients: 2.00;
2011-03-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
DIN: 02363550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84853
VANILLA LATTE TINTED MOISTURIZER
zinc oxide 6 % / w/w , octinoxate 6 % / w/w;
Number of active ingredients: 2.00;
2012-06-01;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
EMINENCE ORGANIC SKIN CARE
DIN: 02371928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85703
TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN
zinc oxide 8 % / w/w , octinoxate 7.5 % / w/w , octisalate 3 % / w/w;
Number of active ingredients: 3.00;
2017-05-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SKINMEDICA, AN ALLERGAN COMPANY
DIN: 02439875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92426
TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN TINTED
zinc oxide 8 % / w/w , octinoxate 7.5 % / w/w , titanium dioxide 3.5 % / w/w , octisalate 3 % / w/w;
Number of active ingredients: 4.00;
2017-05-23;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
SKINMEDICA, AN ALLERGAN COMPANY
DIN: 02439867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92417
ELTAMD SKINCARE UV DEFENSE SPF 45
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2009-10-21;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02322293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80775
ELTAMD SKINCARE UV DAILY SPF 40
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2010-01-29;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02322307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80776
UV DAILY TINTED
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2015-04-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02431343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91576
ELTAMD SKINCARE UV CLEAR TINTED
zinc oxide 9 % / w/w , octinoxate 7.5 % / w/w;
Number of active ingredients: 2.00;
2021-05-13;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
ELTAMD INC
DIN: 02510073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99933
ESSENTIALS BY ARTISTRY MULTI-PROTECT LOTION
zinc oxide 9.19 % / w/w , octinoxate 7.49 % / w/w , ensulizole 3 % / w/w;
Number of active ingredients: 3.00;
2018-05-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMWAY CORP.
DIN: 02470136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95908
LANEIGE BB CUSHION
zinc oxide 9.8 % / w/w , octinoxate 7 % / w/w , titanium dioxide 4.15 % / w/w;
Number of active ingredients: 3.00;
2018-02-14;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
AMOREPACIFIC CORPORATION
DIN: 02462273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95002
SHEER BROAD SPECTRUM SPF 45
zinc oxide 9.9 % / v/v , octinoxate 7.5 % / v/v , octisalate 5 % / v/v , octocrylene 8 % / w/w;
Number of active ingredients: 4.00;
2016-02-09;
Topical;
Lotion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
VIVIER CANADA INCORPORATED
DIN: 02437775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92215
VISINE FOR ALLERGY 3 SYMPTOM RELIEF
zinc sulfate 0.25 % / w/v , tetrahydrozoline hydrochloride 0.05 % / w/v;
Number of active ingredients: 2.00;
1996-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02144093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42685

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut